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CHAPTER I
STATEMENT OF PROBLEM
The elderly population is more susceptible to illnesses and infections (1). The
increased mortality and morbidity due to infections in the elderly population is the result
of a decline in functions of the immune system (1). The mammalian immune system
functions to protect against various pathogens and can be divided into two branches: the
innate immune system and the adaptive immune system. The innate immune system is
the body’s first line of defense against invading pathogens and is non specific to the
pathogens. In contrast, the adaptive branch is pathogen specific and results in
immunological memory that mounts a faster and more robust response to the pathogens
upon re-infection. With age, the functions of both the innate and adaptive immune
branches decline. The adaptive branch of the immune system is primarily composed of T
cells and B cells. In response to an invading pathogen and upon activation, B cells
produce antibodies to fight against the infections. T cells function to activate B cells as
well as to kill the infected cells. Aging results in both a decrease in T cell functions, and
more importantly, a reduction in the continued generation of T cells from the thymus to
replenish and maintain the peripheral T cell pool.
In post natal life, the thymus is the primary organ for thymopoiesis, a
developmental program that orchestrates the generation of T cells from T cell progenitors
derived from the bone marrow (BM) (2, 3). The thymus is composed of an intricate 31

2
dimensional network of thymic epithelial cells (TEC) that are essential for the
development of T cells (4-9). T cell progenitors in the thymus are non-self renewing and
the thymus relies on the BM for a continuous supply of T cell progenitors to maintain
thymopoiesis (10, 11). Despite its critical role in the generation and production of T
cells, the thymus decreases in size and functions, as well as undergoes alterations in the
3-dimensional epithelial network; this age-associated deterioration of thymic function is
termed thymic involution. Within the involuting thymus, contraction of the epithelial
compartments and a decline in the numbers of T cell progenitors coming from the BM
contribute to decline in T cell production (4-9, 12, 13). Currently, the exact cellular and
molecular mechanisms that govern thymic involution are not completely known.
Previously, it was shown that the initial decline in thymocyte number correlates
with a decline in the expression of the epithelial specific Forkhead box N1 (Foxn1) in
thymic stroma (14). Foxn1 is a transcription factor that is required for thymic
organogenesis and TEC differentiation during embryonic development and mutations in
Foxn1 result in hairless and athymic conditions observed in nude mice (15, 16). Induced
deletion of the Foxn1 gene causes reduced Foxn1 expression and premature thymic
involution in the thymus of young mice, suggesting that expression of Foxn1 is important
for maintaining thymic function in the post natal thymus (17, 18). Besides not having a
functional thymus, nude mice also have alterations in their BM. Nude BM has decreased
number of nucleated cells and is ineffective in preventing against lethal irradiation when
adoptive transferred (19); together, the above observations lead to the notion that Foxn1
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has a novel function in the BM. A direct demonstration of Foxn1 in the BM and its effect
on hematopoiesis in the BM has not been investigated.
I hypothesized that maintaining Foxn1 expression with age prevents alterations in
TEC compartments and is important for the production and survival of T cell progenitors
in the thymus and in the BM.
A Foxn1 transgenic mouse model (Foxn1Tg) in which Foxn1 is over expressed
under the control of the human keratin 14 promoter was utilized to test this hypothesis.
Aim 1 was to test if over expression of Foxn1 prevents age-associated changes in TEC
architecture and T cell progenitors in the thymus, thus preventing a decline in
thymopoiesis. Aim 2 was to determine if over expression of Foxn1 promotes the
generation of T cell progenitors in the BM and prevents their decline with age. In Aim 3,
I examined whether over expression of Foxn1 affects other BM lineages including the B
cell lineage and the myeloid lineage. Aim 4 was to identify Foxn1 expressing cells in the
BM.
Improving and maintaining T cell development with age require preventing ageassociated alterations in the thymus and in the BM. The results from this dissertation
firmly establish a function of Foxn1 in thymic function and thymopoiesis, thus providing
a functional framework for further development of novel approaches to manipulate
Foxn1 expression and providing a potential therapeutic intervention to boost immune
responses in the elderly.

CHAPTER II
REVIEW OF THE LITERATURE
Introduction to the Aged Immune System
Several clinical reports have documented that the elderly are more susceptible to
bacterial and viral infections (20, 21). Furthermore, vaccines designed to protect against
various infections have been shown less effective in the elderly population (22).
Changes with age in both the innate and adaptive branches of the immune systems
contribute to the reduced immune response reported in the elderly. Toll like receptors
(TLR) recognize molecular patterns on pathogens; however, expression of TLR on innate
macrophages is reduced in the elderly (23). Furthermore, aged macrophages display a
reduced response to TRL ligands compared to young macrophages (23). In the adaptive
branch of the immune system, the number of naïve B cells is reduced with age, as well as
the production of high affinity antibodies from activated B cells (24-26). Perhaps the
best characterized adaptive immune cell type affected by aging is the T cell. Both CD4pos
T helper cells and CD8pos cytotoxic T cells have altered functions with age. Helper T
cells provide stimulatory signals to B cells that are required for the activation of B cells to
secrete antibodies. The activation of B cells by aged CD4pos T helper cells is reduced,
contributing to decreased antibody protection (27, 28) and reduced vaccine efficacy (29,
30). One function of cytotoxic T cells is to lyse virally infected cells; the number and
diversity of cytotoxic CD8pos T cells that respond to influenza decline with age resulting
4
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in an increased risk of infection (31). Several factors contribute to decline in immune
function with age. However, perturbations in the number and function of peripheral T
cells with age are the result of thymic involution, which is the age-related decrease in
thymus size, organization, and thymopoiesis.

The Thymus
The discovery of the thymus as an organ that produces T cells
The thymus is a lymphoid-epithelial organ that is located in the mediastinal cavity
deep to the sternum and superior to the heart. For many years, it was believed that the
thymus did not have any biological significance. A protective role of the thymus in viral
infection was observed when neonatal thymectomized mice died shortly after inoculation
with a virus (32, 33). It was later shown that neonatal thymectomized mice did not reject
allogeneic skin grafts leading to a hypothesis that the thymus produces
immunocompetent cells (34). At this point in time, it was known that immune cells
produce antibody or contribute to an immune response in a cell-mediated manner;
however, it was thought that the immune cells were a homogenous population (35).
Together these findings led to a false assumption that the thymus produced antibody
secreting cells. Histological examination of lymph nodes and spleens from neonatal
thymectomized mice revealed that the areas where antibody producing cells are found
were histologically normal; however, the areas that contained the cell mediated immunity
were disrupted (36). This suggested that the thymus may not be the organ responsible for
the production of antibody cells after all. Experiments performed by Claman et al. in
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irradiated mice demonstrated that antibody production required cells from both the bone
marrow (BM) and the thymus (37). A series of experiments later demonstrated that
antibody producing cells were derived from the BM and that thymus derived cells were
essential in assisting the production of antibody from BM-derived cells (38-40). The cells
produced in the BM were called “B cells” and the cells produced in the thymus were
called “T cells”.
Since the 1960s, a great deal of information about the function of the thymus has
been revealed. In the mid 70’s, it was discovered that the thymus produces two types of
lymphocytes, which could be distinguished based on the expression of different cell
surface molecules (41-43). These two subsets are known as CD4pos T helper cells and
CD8pos cytotoxic T cells. The thymus does not contain any stem cells; to maintain the
production of naïve T cells the thymus relies on a continuous seeding of progenitors from
the BM (10, 11). Upon arrival in the thymus, T cell progenitors interact with thymic
epithelial cells (TEC) that provide signals for T cell development (4, 5, 7-9, 44, 45).
Committed T cell progenitors proceed through a series of differentiation stages, resulting
in the production of naïve T cells. Naïve T cells exit the thymus and function in the
periphery to protect against invading pathogens. The thymus of a young mouse produces
approximately 108 T cells a day but only exports 106 naïve T cells per day (46, 47).
The T cell receptor (TCR) is expressed on T cells and is responsible for antigen
specific recognition of pathogens (48). CD4pos T cells recognize antigen presented in
context of major histocompatibility complex (MHC) class II and CD8pos T cells recognize
antigen presented in MHC class I (49, 50). As thymopoiesis progresses, T cells that
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express a TCR that recognizes antigen in the context of MHC molecules are signaled to
survive in a process termed positive selection (51-54). The thymus must produce naïve T
cells with a broad repertoire of T cell receptors (TCR) that are capable of recognizing a
plethora of different pathogens. To generate a broad spectrum of TCR specificity, genes
encoding TCR undergo gene rearrangement resulting in a diversification of TCRs that
have the potential of responding to a multitude of different pathogenic antigens. This
rearrangement of TCR genes results in the production of TCRs that may also react to host
antigens. To protect against a possible attack on the body by T cells, the thymus must
also function to ensure that potentially auto-reactive T cells are deleted in a process
termed negative selection (52, 55).
The thymus also functions as an endocrine organ to promote intra thymic and
extra thymic T cell maturation. TEC produce cytokines and growth factors that influence
the development and proliferation of thymocytes, and in turn thymocytes secrete
cytokines that affect TEC proliferation. The hormone thymulin is secreted from TEC
(56-58). When bound to zinc, thymulin assists in the proliferation of IL2 receptor
expressing mature T cells in the thymus as well as in the periphery (59). Thymulin
secretion by TEC is regulated by IL-1 (60). Thus, the thymus not only produces T cells
but regulates their proliferation in the periphery through thymulin secretion.

Cellular and Structural Compositions of the Thymus
The thymus can be divided into two parts: the cortex and the medulla. The cortex
is composed primarily of cortical TEC (cTEC) and immature or developing thymocytes
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while the medulla is primarily composed of medullary TEC (mTEC) with predominantly
mature thymocytes (61-63). The cortical-medullary junction (CMJ) is the boundary
between the cortex and the medulla. The CMJ is the location at which T cell progenitors
enter the thymus from the BM though high endothelial venules (64-70). Surrounding the
thymus is the capsule, which is composed of primarily fibroblasts. The capsule gives rise
to trabeculae that penetrates the thymus forming and dividing the two thymic lobes into
smaller incomplete lobules. Also present in the thymus are dendritic cells (DC) and
macrophages which play an important role in presentation of antigens to the developing T
cells as well as in the removal of apoptotic cells (7, 71).
In H&E histological sections, the cortex of the thymus appears dark while the
medulla has a lighter appearance due to the different density of thymocytes within each
region (Fig. 1). The dense appearance of the cortex is the result of the numerous
immature T cells that occupy that region. The most immature T cells are negative for the
cluster of differentiation (CD) markers 4 and 8, thus are referred to as double negative
(DN) cells (72). The DN subset can further be subdivided into 4 distinct cell populations
based on the expression of CD44 and CD25: the DN1 are CD44pos CD25neg, DN2 are
CD44pos CD25pos, DN3 are CD44neg CD25pos, and DN4 are CD44neg CD25neg (73). DN
cells in the cortex migrate in an arch pattern from the cortical-medullary junction toward
the subcapsular space and then back towards the cortical-medullary junction as they
differentiate from the DN1 stage to the DN4 stage (Fig. 1). The migration of the DN
subsets through the cortex requires CXCR4 expression on DN cells and CXCL12
production by cTEC (74). After completion of the DN stages, the developing T cells
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Figure 1: Thymus structure and localization of thymocyte populations. The thymus can
be divided into the cortex (C) and the medulla (M) which is demarcated by the
corticomedullary junction. Mature single positive (SP) CD4 and CD8 T cell are located
in the medulla. Developing immature thymocytes are located in the cortex and can be
divided into DN1, DN2, DN3 and DN4 subsets. As the DN subsets differentiate towards
the double positive stage (DP), the cells migrate from the corticomedullary junction
toward the subcapsular space and back towards the corticomedullary junction and
medullary region.
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express both CD4 and CD8 on their cell surface and are referred to as double positive
(DP) thymocytes. Developing T cells that have successfully passed through the DP stage
will then mature into either single positive (SP) CD4 or CD8 T cells and will migrate to
the medulla (75). The number of single positive T cells in the medulla is not as numerous
as the immature T cells in the cortex, and thus, the medulla is less dense in appearance
(Fig. 1).
TEC form a three dimensional network in which the developing thymocytes
physically interact with TEC. The three dimensional structure of TEC is critical for their
ability to support T cell development (76). Cortical TEC and medullary TEC can be
distinguished from each other based on the anatomical regions within the thymus, the
patterns of keratin expression, and the expression of specific cell surface molecules.
Functionally mature cortical TEC express predominantly keratin 8 and lack keratin 5
while medullary TEC express keratin 5 and lack keratin 8 (77). In contrast, TEC
progenitors reside within the corticomedullary junction and express both keratin 5 and
keratin 8; these cells have the potential to differentiate into either cTEC or mTEC (77-79)
(Fig. 2). Recently, various cell surface markers have been used to distinguish cTEC and
mTEC. Both cTEC and mTEC lack the expression of CD45 and express the major
histocompatibility complex (MHC) II. Cortical TEC express Ly51 and EpCAM (80).
Medullary TEC are EpCAMpos but do not express Ly51 (81). A population of mTEC that
express high levels of MHCII are transient amplifying cells; these cells are actively
dividing and are responsible for maintain the mTEC pool (81) (Fig. 2). Taken together,
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and EpCAM , while cTEC are
pos

CD45neg MHCIIpos LY51pos and EpCAMpos.

Thymopoiesis
Thymopoiesis is the development of naïve T cells from T cell progenitors in the
thymus (Fig. 3). The majority of T cells produced in the thymus have TCRs composed of
an alpha chain and a beta chain (αβ T cells). Within the DN1 subset, the earliest T cell
progenitor (ETP) has been identified as negative for lineage-specific T, B, NK, and
myeloid markers (Linneg) as well as negative for CD25 and CD127, but express CD117
and CD44 (82, 83). ETP have not yet committed to T lineage as they possess myeloid
and B lineage potential (82, 84, 85). Upon initial commitment to the T lineage, the first
cell surface molecules that are up regulated is CD90 (Thy 1) and CD25; expression of
these molecules marks the differentiation to DN2 or DN3 stages of T cell development
(86, 87) (Fig. 3). DN2 cells lost B lineage potential, however retain myeloid potential
(88). Irreversible and full commitment to the T lineage occurs at the DN3 upon
successful rearrangement of the Vβ genes (89, 90). Signaling of the completion of β
chain gene rearrangement in the DN4 stage results in differentiation to the DP subset,
which begins to rearrange the α chain genes of the TCR (91, 92). Upon rearrangement of
α TCR and expressing TCRα and β, the DP cells undergo positive and negative selection
and mature into the SP stage.
Thymopoiesis requires Notch signaling for the commitment and differentiation of
ETP toward T lineage (88, 93). The Notch 1 receptor expressed on ETP binds to its
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Figure 3. Cell surface phenotype of developing thymocytes. Cell surface molecules are
used to identify different stages of thymopoiesis. The DN1 subset is defined as Linneg
CD44pos and CD25neg. Within the DN1 subset, the earliest T cell progenitor (ETP) is
defined as Linneg CD117pos CD44hi CD127neg and CD25neg. The DN2 subset is defined as
Linneg CD44pos CD25pos. The DN3 subset is defined as Linneg CD44neg CD25pos. The DN4
subset is defined as Linneg CD44neg CD25neg.
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ligand, delta like 1 or 4 (Dl1 and Dl4) expressed on TEC (44, 45). While both DL1 and
DL4 signal through Notch to induce T lineage commitment and differentiation, DL4 is
believe to be the physiological ligand (94). The importance of Notch signaling in T cell
development has been demonstrated both in vivo and in vitro. When Notch is deleted
from T cell progenitors in vivo, B cells develop in the thymus instead of T cells (85).
Similarly, when intracellular Notch is over expressed in the BM, T cell development
occurs instead of B cell development (95). Prior to the discovery that Notch signaling is
required for T lineage development thymocytes could not be generated in vitro using a
two dimensional monolayer of stromal cells. Instead generation of thymocytes from T
cell progenitors and could only be achieved in the fetal thymus organ culture system.
The establishment of the OP9 bone marrow murine cell line that over expresses
DL1(OP9-DL1) made it possible to generate T cells in vitro from T progenitors;
however, these developing thymocytes only develop to the DP stage as this system does
not support positive selection (45, 96). T cell progenitors cultured on OP9 cells that lack
DL1 results in the development of B cells (97). Taken together these data demonstrate
that Notch signaling is critical for T lineage commitment and development toward T
lineage and that without Notch signaling T cell progenitors default to B lineage.
In the cortex, rearrangement of the TCR genes is initiated in the DN2 stage and
completed in the DP stage. The TCR functions to identify foreign pathogens. To combat
the vast number of pathogens that the body is exposed to, developing T cells randomly
rearrange a combination of variable (V), diversity (D), and joining (J) genes to increase
the diversity of the β chain of the TCR. T cells also rearrange a combination of V genes
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and J genes for the α chain of the TCR. Rearrangement of the DNA requires expression
of the recombination activation gene (RAG) 1 and 2; mice deficient in RAG expression
do not have mature T cells or B cells (98, 99). The β chain rearrangement is initiated at
the DN2 stage and is completed in the DN3 stage (100-102). The TCR β chain
rearrangement consists of one of two D genes rearranging to one of twelve J genes. The
rearranged DJ segment then rearranges with one of 28 V β genes. Completion of the β
chain gene rearrangement occurs when the VDJ segment joins with a constant region.
The TCR β chain gene rearrangement is completed in the DN3 stage, at which point the
rearranged β chain pairs with a surrogate pre-T alpha chain (ptα) forming a pre-TCR
complex (103-108). Signaling through the pre-TCR is essential for progression to the
double positive (DP) stage, leading to TCRα gene rearrangement; the TCR α chain
rearrangement is completed in the DP stage (91, 92). During α chain rearrangement one
of 70-100 V α genes combines to one of 50 J α genes. The rearrangement of the α TCR
genes results in the production of signal joint TCR excision circles (sj-TREC), which are
the circular DNA segment that contain the deleted δ genes during rearrangement of the
TCR α chain (Fig. 4). Successful rearrangement of both the β chain and the α chain
genes result in a complete TCR complex that is required for positive and negative
selections. Figure 5 summarizes the molecular events that occur at each stage of
thymopoiesis.
T cells that express TCRαβ on the cell surface undergo both positive selection
and negative selection. As previously mentioned, the random rearrangement of TCR
genes may result in a TCR that has the potential to recognize host antigenic peptides.
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Figure 4: TCR Vα chain rearrangement and generation of a sjTRECs. During Vα chain
rearrangement, the δRec (a Vα pseudogene) and the ψJα rearrange resulting in the
deletion of δ locus. This process requires expression of Rag and generates a circular
sjTREC DNA. The presence of sjTREC marks recently produced naïve T cells.
Recombination signal sequences (RSS) are represented by yellow triangles.
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Figure 5: Check points of important stages in T cell development. ETP are a subset of
the DN1 population and in a young mouse comprise approximately 0.01% of total
thymocytes and 0.001% of thymocytes in an aged mouse. Notch signaling-induced ETP
progresses through a series of different stages and develops into naïve T cells. Notch
signaling is required for all stages of T cell development. ETP progress to DN2, however
up to this point myeloid potential is maintained. TCR β chain rearrangement is initiated at
the end of the DN2 stage. In the DN3 stage, β chain rearrangement is completed
resulting in T lineage commitment. TCRα gene rearrangement is initiated and completed
in the DP stage. Single positive cells that express a functional TCRαβ that recognize self
MHC/peptide undergo positive selection and negative selection.
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Peptides are presented to T cells in the context of MHC molecules. In order to fully
mature and be exported from the thymus, T cells must express a TCR that recognizes and
binds to MHC/peptide but does not bind too strongly to MHC or self peptide presented in
MHC. T cells that have rearranged a TCR that will bind and recognize MHC will receive
a signal to survive in a process termed positive selection (51-54). T cells that have not
successfully received TCR stimulation at the DP stage though interaction with MHC and
antigens will undergo cell death. In the thymus, self peptides are presented to DP T cells
on MHC expressed by TEC (109). Expression of autoimmune regulator (AIRE) by
mTEC ensures that certain organ specific peripheral antigens are expressed in the thymus
and function in the deletion of auto-reactive T cells (110). T cells that express a TCR that
recognize self peptides in MHC with high affinity are signaled to undergo cell death
through a process termed negative selection (52, 55). Thus, the strength of a TCR signal
determines survival or deletion of T cells (109); TCRs that bind with low affinity survive,
while TCRs that bind with high affinity to a peptide presented in MHC will be deleted
(109).
Selection in the thymus is dependent on how endogenous peptides are loaded onto
MHC I and exogenous peptides onto MHC II. CD8pos T cells recognize MHC class I
molecules and CD4pos T cells recognize MHC class II (49, 50). Intracellular peptides are
loaded onto MHC class I and MHC class II are known to present exogenous peptides
acquired externally from the endocytic pathway (111-114). Intracellular proteins can be
presented in MHC class II (115); however, the mechanism by which self peptides are
presented on MHC class II for the deletion of auto-reactive CD4pos T cells remains to be
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fully elucidated. One mechanism in which it is believed that self peptides are presented
on MHC class II is through the regular turn over of TEC. When TEC undergo apoptosis
they are phagocytosed by surrounding dendritic cells and macrophages. Dendritic cells
and macrophages in the thymus can then present self peptide on MHC class II through
the exogenous pathway (116). Recently, it was identified that autophagy in TEC
contributes to the presentation of self antigens onto MHC class II molecules and assists in
shaping the T cell repertoire (117). Interruption of autophagy in TEC resulted in the
escape of auto-reactive T cells that are responsible for colitis and inflammation,
indicating that autophagy in TEC is required for the generation of self-tolerant T cells
(118). Furthermore, mTEC with high levels of MHC class II demonstrated high
autophagy while MHCIIlow mTEC had little autophagy (118); thus, it is likely that the
MHCIIhi mTEC play a critical role in negative selection.

Thymic Organogenesis
Organogenesis of the thymus is a complex process as different cellular
components of the thymus arise from different embryonic germ layers. Developing T
lymphocytes are hematopoietic in origin and are derived from mesoderm. The capsule of
the thymus is derived from neural crest cells of the ectoderm (119). While it was once
proposed that cTEC are ectodermaly derived and mTEC are endodermal in origin, current
data suggest that both cTEC and mTEC are derived from a common precursor that is
endodermal in origin (120, 121).
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TEC are the predominant stromal cell type of the thymus and are derived from
endodermal cells of the third pharyngeal pouch, which also gives rise to the parathyroid
(122). The earliest TEC progenitors can be identified at embryonic day (E) 11.5 (123).
At E11.5 to 11.75 the thymic/parathyroid primordium detaches from the pharynx and
begins its decent toward the thoracic cavity. During its migration, toward the chest cacity
the parathyroid detaches from the thymic primordium and remains in the neck region
while the thymic primordium continues its decent to its final anatomical location. Due to
its course of migration, functional secondary thymic tissue has been identified in the neck
(124, 125). Detailed signaling event that result in endodermal cell commitment of the
third pharyngeal pouch to the thymus or to the parathyroid remain to be elucidated. It is
known that the differential pattern expression of two proteins dictates differentiation of
cells toward either the parathyroid or thymus. At E 9.5, the differentiating endodermal
cells destined to become the parathyroid express glial cell missing homolog 2 gene
(Gcm2), while cells differentiating into thymic tissue begin to express forkhead box n1
(Foxn1) at embryonic day 11.5 (123). It is not known what controls the patterning of
Gcm2 and Foxn1 expression. Signals generated from interaction between the endodermal
cells of the third pharyngeal pouch and neural crest cells that surround the primordium
play a role. When the number of neural crest cells that surround the thymic and
parathyroid primordium are reduced, the patterning of Gcm2 and Foxn1 are altered,
resulting in an increased number of progenitor cells expressing Foxn1 and fewer cells
expressing Gcm2. This ultimately results in a larger thymus and a smaller parathyroid
(126). Sonic hedgehog (Shh) also contributes to the patterning of the primordium. Shh
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null embryos have a larger portion of the third pharyngeal pouch expressing Foxn1,
suggesting that expression of Shh may negatively regulate Foxn1 expression limiting the
number of cells that develop into TEC (127).
Development of mature TEC requires interaction of TEC progenitors with
hematopoietic stem cells. At E11.5, hematopoietic cells migrate to the thymic
primordium prior to vascularization (E15.5) due to secretion of the chemokines CCL25
and CCL21 by the thymic primordium (128). Epithelial cells of the thymic primordium
express MTS24 and these cells also express both keratin 8 and keratin 5, suggesting that
these cells are the early thymic epithelial cell progenitors which subsequently
differentiate into keratin 5pos mTEC or keratin 8pos cTEC (129-131). Hematopoietic stem
cells interactions with thymic epithelial progenitor cells are also required for further
functional differentiation to cortical and medullary thymic epithelial subsets (132-134).
The single most important gene for thymic organogenesis is Foxn1. The Foxn1
gene was first identified in nude mice, which lack a functional thymus (16).
Identification of the gene that results in the athymic condition has allowed for the
examination of a functional role of Foxn1 in thymic organogenesis. Mutation in Foxn1
results in normal formation of the thymic primordium; however, further development is
arrested at E11.5 (15). Despite its arrested development, the thymic anlage migrates to
its final location in the thoracic cavity indicating that expression of Foxn1 is not required
for migration (135). Deletion of the N terminal region of Foxn1 demonstrated that Foxn1
is not required for the development of thymic epithelial progenitors but is needed for their
functional maturation as seen by the block in differentiation of the keratin 5 and keratin 8
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double positive epithelial cells (136). In nude mice, thymic epithelial cells are not
colonized by hematopoietic cells despite the presence of the hematopoietic cells in the
surrounding mesenchyme, indicating that Foxn1 is required for functional TEC to recruit
hematopoietic cells (137). The nude thymic anlage does not express the Notch ligands
Dl1 and Dl4 required for T cell development, suggesting that Foxn1 may be required for
their expression (138, 139). Although direct evidence has not been proved, Foxn1 levels
are directly proportional to the expression of DL4 and CCL25 in TEC at E 12.5,
suggesting that Foxn1 regulates these genes during thymic organogenesis (140).
Together, an abundance of data shows that Foxn1 expression is critical for thymic
organogenesis, yet regulation of Foxn1 during thymic organogenesis has not been clearly
delineated.

Age-Associated Thymic Involution
Despite being the primary site for the development of naïve T cells in post natal
life, with age the thymus involutes. In humans, thymic involution begins within the first
year of life, but is accelerated with puberty (4). Using sj-TREC as a molecular maker for
naïve T cells, it was showed that with age the number of T cells in the periphery that
contain sj-TREC is reduced, indicative of reduced T cell development and export (116,
141, 142). To maintain the peripheral T cells numbers, memory T cells undergo
homeostatic proliferation, resulting in the expansion of the memory T cells and in
contraction of the T cell repertoire (143-146). In addition to skewing of the peripheral T
cell pool to a memory phenotype, peripheral T cell functions are also reduced, resulting
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in a poor immune response to various viral and bacterial pathogens (147, 148).
Reduction in the number of naïve T cells exported from the aged thymus is the result of
both changes in the number and function of T cell progenitors, as well as alteration in the
thymic environment.

Thymic Structure and Aging
T cell progenitors require interaction with TEC for the development of naïve T
cells. With age, the organization of TEC and the architecture of thymus are disrupted (4,
5, 149). The once well defined cortical-medullary junction becomes unorganized and
distinction of the cortex from medulla compartment is lost (149). Histological analysis
on the aged thymus demonstrates a reduction in the cortical and medullary TEC networks
(149). Mesenchymal tissue that does not support thymopoiesis expands with age, while
the cortex and medulla, which are required for thymopoiesis contracts (4, 5). In the post
natal thymus, the number of CD45neg MHCIIpos TEC and their proliferation decline with
age (81). On the other hand, the number of fibroblasts and adiopcytes present in the aged
thymus increases (150, 151).
It has been suggested that epithelial to mesenchymal transition (EMT) is one
mechanism responsible for the increase in adiopcytes and fibroblasts, with a simultaneous
reduction in the number of TEC in the aged thymus (152). TEC that once expressed
Foxn1 were shown to differentiate to fibroblasts via EMT (152). Fibroblasts generated
from epithelial cells express fibroblast specific protein -1 (FSP-1), a strong indicator of
the EMT pathway (153). Thymic involution is associated with an increase in FSP-1
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protein expression in mTEC (152, 154), suggesting that the EMT pathway contributes to
age associated increase in fibroblasts during thymic involution. EMT cells in the aged
thymus express the peroxisome proliferator-activated receptor gamma (PPARγ), a proadipogenesis transcription factor (150, 154), suggesting that TEC may transition to
adiopcytes through the EMT pathway. Thus the decline in TEC number and the increase
in the number of fibroblast and adiopcytes in the aged thymus may be the result of TEC
transitioning to fibroblast and adipocytes.
The decline in the number of TEC with age contributes to the decline in the
deletion of auto-reactive T cells as well as a reduction in the secretion of thymulin from
the thymus. Autophagy in TEC assists in the negative selection of auto-reactive T cells
(118). With age the number of autophagic vesicles declines in cTEC and mTEC (155),
suggesting that cross presentation of self peptides required for deletion of auto-reactive
CD4pos T cell may be compromised, consequently leading to autoimmune disease (118).
Examination of autophagy in aged TEC and its contribution to shaping the T cell
repertoire is only beginning to be examined. Thymulin affects T cell proliferation and is
produced by cTEC and mTEC; however, expression of thymulin is more prominent in
mTEC (156, 157). With age, production of thymulin decreases as the number of TEC
that produce thymulin decline (158). These data suggest that preventing the decline in
TEC would prevent a decline in autophagy and thymulin secretion.
Foxn1 expression is required for thymic organogenesis (15); however, a role for
Foxn1 in age-associated thymic involution remains to be fully elucidated. Expression of
Foxn1 in thymic stroma, which is comprised primarily of TEC, declines with age and
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correlated to the decline in thymocyte number (14). In the post natal thymus, mTEC
express the highest level of Foxn1 (17). When Foxn1 expression levels are reduced in
the postnatal thymus, the numbers of mTEC are decreased and mTEC proliferation
declines, suggesting that expression of Foxn1 is required for the maintenance of the post
natal mTEC pool (17). The number of mTEC is greater than cTEC; however, in 12
month old mice the ratio of mTEC to cTEC declined compared to mice 4 weeks of age
(81), indicating that mTEC are more sensitive to the effects of aging. Taken together,
these data suggest that preventing the decline in Foxn1 expression may result in
maintained TEC number and architecture required for the development of thymocytes.

Aging and Thymopoiesis
The number of DN1 cells in the thymus increases with age (159). At first, this led
to the hypothesis that the age-associated alterations in T cell development were not the
result of a decrease in the number of T cell progenitors. Later, it was revealed that only a
small subset of the DN1 population contains the ETP (82, 83). With age, there is a
decline in the frequency and number of ETP (12); ETP from aged thymi also have
decreased cell cycle and increased cell death (12). When cultured, aged ETP gave rise to
fewer thymocytes compared to young ETP indicating a functional decline in aged ETP
(12). Taken together these data indicate that with age there is not only a decline in the
number of ETP but also their function, both contributes to reduced thymopoiesis.
Despite the decline in number and function of ETP, naïve T cells are still
produced in the aged thymus but at a lower number (142, 160). The distribution of
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thymocyte populations are not altered with age (161, 162), suggesting that thymopoiesis
is functionally active. Although thymopoiesis is active in the aged thymus, functions of
the thymocytes produced from the aged thymus are reduced. Aged thymocytes express
lower levels of CD3 and CD3 signaling is required for T cell activation (163). The lower
level of CD3 expression may explain the diminished activation and function of naïve T
cells produced from the aged thymus (147, 164). Of the aged T cells that are activated,
these T cells demonstrate reduced proliferation in vitro (162). Thus, while the aged
thymus is capable of producing naïve T cells, the activation and function of the naïve T
cells as well as their number are diminished.

Peripheral Effects of Thymic Involution
Functional defects in aged T cells in the periphery contribute to the reduced
immune response in the elderly. The use of TCR transgenic mice that recognized pigeon
cytochrome c allowed for functional examination of aged naïve T cells. The function of
both CD8pos and CD4pos T cells are altered with age. Naïve CD4pos T cells from aged
TCR transgenic mice showed reduced recruitment of signaling molecules to the
immunological synapse required for the activation of naïve T cells by antigen presenting
cells (165, 166). Reduced proliferation and reduced production of IL2 were observed in
aged naïve CD4pos T cells compared to young, suggesting a reduction in effector
functions (167-171). Aged naïve CD4pos T cells were ineffective in their ability to
activate B cells. When the same number of young and aged CD4pos TCR transgenic cells
were adoptively transferred into young host and immunologically challenged, host mice
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that received aged cells showed a reduction in antibody production and B cell expansion
(27). While the production of naïve T cells decreases with age, the thymus is still
functional and naïve T cell are produced at low numbers (161, 172). During thymic
involution, it is believed that the longevity of naïve T cells in the periphery is increased
as a result of decreased thymic output (167-171, 173). It has also been documented that
recent emigrates from an aged thymus also have reduced IL2 production and proliferation
(147, 164). With age, both recently produced naïve T cells as well as aged naïve T cells
in the periphery demonstrate defects in their activation and effector functions.
Age associated reductions in naïve T cell function are not specific to CD4pos T
cells as aged CD8pos T cells also have reduced function. Aged CD8pos T cells
demonstrate reduced clearance of viruses after infection and aged CD8pos T cells
produced less INF-γ in response to viral infection (174, 175). Naïve CD8pos T cells show
decreased TCR diversity when subjected to DNA spectratyping (176), which results in
the inability to respond and clear viral infections rapidly. Again, a decrease in TCR
diversity is the result of decreased thymic output due to thymic involution. Specifically,
a decrease in diversity of the CD8pos T cell repertoire was directly shown to affect the
ability of CD8pos T cells to protect against influenza (31). Aged CD8pos T cells also show
diminished ability to generate memory T cells after infection (175). The number of
memory CD8pos T cells generated after infection with influenza is reduced and results in
decreased clearance upon secondary infection (31). Thus, thymic involution results in the
expansion of memory peripheral T cells leading to decreased TCR diversity as well as an
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increase in the life span of peripheral T cells whose functions are decreased. Preventing
or reversing thymic involution may restore proper function of peripheral T cells.

HSC and Hematopoiesis
In the 1800s, Franz Ernst Christian Neumann first identified the BM as the
location for the development of blood cells, also known as hematopoiesis (177). The BM
is located in the central cavity of bones and contains two types of marrow. Yellow
marrow that is made up of fat cells, and red marrow which contains the hematopoietic
cells. Hematopoietic cells consist of T cell progenitors that will seed the thymus for
further maturation as well as developing and mature red blood cells, B cells, and myeloid
cells. The stroma of the BM is the non-hematopoietic tissue, which consists of
fibroblasts, macrophages, osteoclasts, osteoblasts, endothelial cells, adiopcytes, and
adventitial reticular cells, and provides the supportive environment required for the
development new blood cells from HSC (178, 179). Franz Ernst Christian Neumann was
also the first to propose that all blood cells develop from stem cells (177). However, it
wasn’t until the 1960s when the stem cell theory was supported though experiments in
which BM cells were adoptively transferred into irradiated mice and the number of
myeloid colonies generated in the host spleen (CFU-S) was proportional to the number of
cells injected (180, 181). It is now well accepted that all hematopoietic cells developed
from hematopoietic stem cells (HSC).
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Embryonic Origins of HSC
HSC maintain the development of all mature blood cells, but the embryonic origin
of HSC has been challenging to identify. The difficulty in identifying the origin of HSC
was due to multiple reasons: 1) hematopoiesis occurs in two waves, 2) HSC can be
identified in multiple locations in the developing embryo, and 3) cell surface markers
used to identify adult HSC are not exclusively expressed on embryonic HSC (182-184).
At E7.5-8, the first wave of HSC develops from the yolk sac and generates erythrocytes
and a few myeloid cells thought to be required primarily for oxygen exchange of the
developing embryo (185, 186). The second wave generates the postnatal HSC from the
aorta gonad-mesonephros (AGM) region that will eventually seed the BM and generate
all mature blood cells in the adult (187). While it is now generally accepted that there are
two waves of HSC development, the fact that HSC could be identified in the yolk sac as
well as the AGM in the developing embryo led to conflicting results and extensive effort
were examined to clarify the origin of HSC.
To determine the origin of embryonic HSC, colony forming assays were used to
detect stem cell activity within a group of isolated cells since cell surface molecules could
not be used to identify embryonic HSC. Cells believed to contain HSC can be injected
into lethally irradiated hosts and after several weeks the spleen can be isolated and
examined for colony forming unit spleen (CFU-S). HSC give rise to colonies in the
spleen when transferred into irradiated host. Each colony counted in the irradiated host’s
spleen developed from one individual HSC. Stem cells and progenitor cell activity can
also be measured in vitro in semi-solid methylcellulose cultures. Each individual stem
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cell or progenitor cell capable of proliferating and differentiating will generate a cluster
of cells or colony in the methylcellulose media. Each CFU can be examined to determine
if the cells in the colony are homozygous and developed from a lineage specific
progenitor, or heterogeneous and developed from a progenitor that contains multiple
types of lineage potential. HSC give rise to the most heterogeneous CFU as these cells
have the potential to give rise to all blood cells.
At first, it was believed that the extra embryonic yolk sac was the origin of HSC
as cells from the yolk sac were able to generate different CFU in vitro and in vivo (185).
However, experiments in which quail embryos were grafted to a chick yolk sac
demonstrated that mature cells in the spleen and thymus were quail in origin and not
chick, indicating that adult HSC do not originate from the yolk sac but from an intra
embryonic source (119). A model of HSC embryogenesis suggests that the first wave of
hematopoiesis originates in the yolk sac from blood islands forming primitive HSC but
that these cells do not contribute to the adult HSC pool. HSC in the adult BM develop
independently from the yolk sac and are established in the second wave of hematopoiesis.
HSC that contribute to the adult HSC pool can be identified in the yolk sac but only after
E11 and after generation of HSC from the AGM region (188, 189).
The identification that cells from the wall of the aorta of the chick can form CFU
of monocytes (CFU-M), granulocytes (CFU-G), granulocyte/monocytic (CFU-GM), and
erythroid (CFU-E), first implicated the aorta as a possible origin for HSC that
subsequently establish the pool of HSC in the adult (190). Later it was identified that
cells from the AGM region contained long term repopulation capacity when transplanted
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into primary host as well as when serially transplanted into several hosts (189). The
confirmation that AGM-derived cells give rise to HSC was demonstrated when cells
isolated from AGM autonomously generated HSC (191). At E11.5, HSC are formed in
the dorsal aorta (192, 193). HSC develop from the dorsal aortic endothelium (194);
transition of endothelial cells of the dorsal aorta to HSC is regulated by Runx1 (195,
196). Notch signaling regulates Gata2 expression which in turn regulates the expression
of Runx1 in the development of HSC (197-199). Thus, proper Notch signaling regulates
the development of HSC during embryonic development from the dorsal aorta.
At E11.5, HSC from the AGM seed the fetal liver and this is the major organ for
hematopoiesis during embryogenesis. In the fetal liver, HSC rapidly proliferate and
expand in number (200). It remains to be determined if HSC from the AGM are the only
cells that seed the fetal liver or if HSC found in the yolk sac, placenta, and umbilical and
vitelline arteries contribute to the fetal liver pool as all of these anatomical sites also
demonstrate HSC activity (192, 201-203). At E17.5, HSC from the fetal liver seed the
BM which will be the permanent site of hematopoiesis in the adult mice. Seeding of the
BM by fetal HSC requires signaling mediated by the CXCR4 receptor on HSC and
CXCL12 (SDF-1) expressed in the BM (204). During embryogenesis, the size of the
adult HSC pool in the BM is regulated by the sry-related high mobility group box 17
(sox17) (205). At four weeks post birth, Sox17 expression is down regulated as highly
proliferative fetal HSC transition to the slowly proliferating adult phenotype, establishing
the adult HSC pool within the BM (205). After the establishment of the adult HSC pool,
HSC acquire the quiescent phenotype and display limited proliferative activity (206).
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The balance between the quiescent state and proliferation of adult HSC is regulated by
the HSC niche.

BM HSC Niche
The concept of a HSC niche was first demonstrated in 1978 by Schofield who
showed that HSC self renewal ability is lost when HSC are removed from the BM (207).
This suggested that regulation of HSC self renewal potential requires interaction with
other BM cells. Since then, two distinct HSC niches have been proposed: a vascular
niche and an endosteal niche (Fig. 6). The endosteal niche is thought to predominantly
contain the dormant long term HSC (LT-HSC) that have high self renewal capacity but
proliferate infrequently (208). On the other hand, the vascular niche supports the more
proliferative short term HSC (ST-HSC) with limited self-renewal that are differentiating
into multipotent progenitors (MPP) (208). HSC niches function to maintain HSC
numbers, regulate HSC self renewal, and induce HSC differentiation.
The endosteal niche is located adjacent to the endosteum, or the lining of the inner
bone surface within the marrow cavity. Evidence of an endosteal niche was
demonstrated in vivo as CFSE labeled HSC injected into host mice could be identified
next to the BM endosteum within 15 hours (209). A higher number of HSC are found in
the BM when the number of osteoblasts is increased, suggesting that the osteoblasts are a
key cell type of the endosteal HSC niche (210, 211). The interaction between
osteoblasts and HSC was also demonstrated ex vivo as the number of HSC increased
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Figure 6: Bone marrow endosteal and vascular niches. Two niches that support HSC
localization, proliferation, self renewal, and differentiation were identified in the BM; the
endosteal niche and the vascular niche. The endosteal niche is located adjacent to the
endosteum. Osteoblasts, osteoclasts, mesenchymal stem cells (MSC), osteomac, and
reticular cells that express CXCL12 (CAR cells) maintain HSC in the endosteal niche. In
the vascular niche HSC reside adjacent to endothelial cells and their self renewal,
proliferation, and differentiation are regulated by CAR cells, MSC, macrophages, and
megakaryocytes.
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when cultured with osteoblasts, indicating that osteoblasts promote HSC self-renewal
(212).
Regulation of HSC activity by osteoblasts occurs through secretion of cytokines
as well as direct interaction between cell surface molecules. Osteoblasts regulate HSC
number, proliferation, and survival though secretion of thrombopoietin and angiopoietin.
Osteoblasts secrete thrombopoietin and angiopoietin that regulate the quiescent state of
HSC by binding to their respective receptors MPL and Tie 1 and 2 expressed on HSC,
respectively (213-215). Mutant mice that do not express thrombopoietin or its receptor
MPL have a reduced number of HSC that fail to provide long term reconstitution in Wt
host (213, 215). In thrombopoietin deficient mice, HSC display increased cell cycling
due to reduced expression of p57 and p19INK4D leading to HSC exhaustion (213). Mice
deficient in Tie1 and 2 also have a reduced number of HSC; these HSC and their down
stream progenitors display a decline in their survival (214).
Cell-to-cell interactions between osteoblasts and HSC also regulate HSC renewal.
Osteoblasts express the Notch ligand Jagged; however, a role for Notch signaling in the
maintenance of HSC remains controversial. Deletion of Jagged 1 and Notch 1 signaling
in vivo suggests that Notch is not important for HSC self renewal and hematopoiesis
(216, 217). However, in vitro cultures demonstrated that Notch 1 signaling in HSC
promotes self renewal and prevents cell cycling-mediated exhaustion (218, 219). In vivo,
Notch 2 is required for the self renewal of HSC and generation of MPP following BM
damage as Notch 2 deficient mice show reduced ability to recover from 5-fluorouracil
treatment (220). Thus, the controversial role of Notch signaling in HSC hematopoiesis
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maybe the result of redundant function of multiple Notch receptors and ligands during
homeostasis, which may only become important in times of stress.
Changes in the expression of N-cadherin can alter HSC localization in the BM
and thus affect HSC proliferation and differentiation. N-Cadherin is an adhesion
molecule that is expressed on HSC and osteoblasts and is responsible for sequestering
HSC in the endosteal niche. N-Cadherin molecules mediate homotypic cell-cell
interaction by binding to other N-Cadherin molecules; both the short term and long term
HSC express N-Cadherin (221, 222). Reduced N-Cadherin by osteoblasts or HSC
promotes HSC migration from the niche. In experiments in which HSC over expressed
N-Cadherin, a larger number of HSC were found at the endosteal surface; these HSC
displayed a slower cell cycling (221). HSC that express higher levels of N-Cadherin
proliferate less and are important in long term maintenance of hematopoiesis (222). In
contrast, lower levels of N-Cadherin are associated with HSC that have higher
proliferation and differentiation potential (222).
Beside osteoblasts, osteoclasts also contribute to the HSC endosteal niche by
inducing a release of growth factors trapped in the bone matrix. The number of long term
HSC are reduced in mice with decreased bone matrix reapportion by osteoclasts; these
HSC demonstrate increased proliferation and differentiation (223). Osteoclasts degrade
bone matrix, releasing growth factors such as TGFβ1 and bone morophogenic proteins
(BMP) into the BM environment. In vitro, HSC cultured with physiological levels of
TGFβ1 maintained their quiescent state and showed lower proliferation and reduced cell
death (224). BMP-4 also prevents the proliferation and differentiation of HSC (225).
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During embryogenesis, prior to endochondral ossification, HSC in the fetal liver
undergo expansion, suggesting that HSC can be supported by a second niche separate
from the endosteal niche (200). The development of HSC from endothelial cells of the
dorsal aorta led to the belief that a vascular niche may also support HSC. HSC expansion
occurred when HSC were cultured with endothelial cells isolated from E9.5 yolk sac;
these HSC were capable of repopulating lethally irradiated hosts (226). Adult endothelial
cells isolated from various organs and cultured with adult HSC were also able to expand
HSC that are capable of generating CFU when transferred in to lethally irradiated hosts
(227). Together these experiments provided evidence that endothelial cells and the
vascular niche support the expansion of HSC. There is also in vivo evidence to support a
functional vascular niche in the BM. Endothelial cells in the BM of mice deficient in the
expression of gp130 fail to support hematopoiesis from Wt HSC (228). Imaging analysis
revealed that a large number of HSC localize to sinusoids in the BM (208), illustrating
the localization of HSC in the vicinity endothelial cells and further providing support for
a vascular niche.
Reticular cells that express CXCL12 (CAR cells) are important for maintaining
HSC number and cell cycling. CXCL12-GFP reporter mice demonstrate that Sca-1 and
c-kit expressing cells co-localized with CXCL12-GFP cells (CAR cells), suggesting that
HSC which express Sac-1 and c-kit are associated with CAR cells (229). Deletion of
CAR cells results in a decrease in the number of HSC and decreased HSC cell cycling as
measured by Ki-67 staining, indicating that CAR cells regulate HSC proliferation (230).
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In addition, CXCL12 CAR cells also secrete large amounts of stem cell factor (SCF)
known to induce HSC proliferation (230).
Megakaryocytes indirectly regulate HSC in the vascular niche. Megakaryocytes
are located within the vascular nice and are in contact with endothelial cells of sinusoids
(231). A potential mechanism by which megakaryocytes regulate HSC has been
suggested. Thrombopoietin was shown to maintain HSC in a quiescent state (213). The
serum level of thrombopoietin is inversely correlated with the number of megakaryocytes
(232, 233). It was shown that mice with an increased number of megakaryocytes have a
depletion of thrombopoietin from the circulation by megakaryocytes and starvation of
HSC (234). This results in HSC proliferation and differentiation, ultimately resulting in
HSC depletion (234). Thus, megakaryocytes can affect HSC by sequestering
thrombopoietin required to maintain HSC quiescence.
Recently, Nestinpos mesenchymal stem cells (MSC) have been identified as
another cellular component of the HSC vascular niche. In the BM, 88% of HSC are
localized to Nestinpos MSC and the majority of the Nestinpos MSC are located outside the
endosteal niche in the central marrow (235). When the number of Nestinpos MSC are
selectively deleted, the number of HSC in the BM as well as the number of HSC that are
able to home to the BM from the circulation are reduced (235). Nestinpos MSC also
express CXCL12, SCF, and angiopoietin-1 which have all been shown to be important
for maintaining HSC (235).
Surprisingly, the expression of CXCL12, SCF, and angiopoietin-1 by Nestinpos
MSC was reduced when CD169pos macrophages were depleted, suggesting that

pos

macrophages also regulate the HSC niche; depletion of CD169
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macrophages also

leaded to increased mobilization of HSC out of the BM (236). However, depletion of
CD169pos macrophages did not result in a decrease in the number of Nestinpos MSC (236).
The molecular mechanism by which macrophages regulate Nestinpos MSC expression of
CXCL12, SCF, and angiopoietin remains to be determined. A similar observation was
also made in the endosteal niche. When macrophage located near the endosteal surface
(osteomacs) were depleted, the expression of CXCL12, SCF, and angiopoietin-1 was
reduced in the endosteal stoma and the number HSC in BM was reduced (237). Thus
macrophages are an important cellular component of both the endosteal and vascular
HSC niche.
Evidence that an endosteal niche and a vascular niche are capable of supporting
HSC and hematopoiesis has been obtained, however it can not be ruled out if these two
niches are functionally distinct or that the two niches function together to regulate HSC.
While a higher percent of CAR cells and Nestinpos MSC are found in contact with HSC in
the vascular niche, both CAR cells and Nestinpos MSC have been identified in the
endosteal niche (229, 235). Further, CAR cells and Nestinpos MSC can also differentiate
into osteoblasts (230, 235), which are the key cellular component of the endosteal niche.
Megakaryocytes are located in the vascular niche but increased number of
megakaryocytes results in an increase in the number of osteoblasts and bone mass (238).
Megakaryocytes can increase osteoblasts proliferation in a cell to cell contact manner
(238-240). Taken together, these data demonstrate a possible interaction between the
endosteal niche and the vascular niche.
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Development of Lymphoid and Myeloid Progenitors from HSC
The most immature BM progenitors are the Linneg CD117pos (c-kit) and Sca1pos
cells and thus are termed LSK cells. The LSK population contains HSC and their
immediate progeny the multipotent progenitors (MPP). Expression of Flt3 distinguishes
HSC from MPP within the LSK population; while HSC lack the expression of Flt3, MPP
express Flt3 (241). As previously mentioned, HSC are self-renewing and can be divided
into LT-HCS and ST-HSC. LT-HSC lack the expression of CD34 while ST-HSC express
CD34 (242). LT-HSC proliferate infrequently and maintain self-renewal and
multipotentcy throughout life. ST-HSC are derived from LT-HSC, have limited selfrenewal ability (243), and give rise to MPP (244). MPP have the ability to generate
erythroid, myeloid, and lymphoid progenitors (Fig. 7). The progression to MPP is the
first step in lineage commitment since MPP no longer have self renewal ability (241).
The development of myeloid and lymphoid progenitors from MPP is still being
untangled as the direct progenitor/progeny relationships have proven to be complicated.
Evidence to support a common myeloid progenitor (CMP) and a common lymphoid
progenitor (CLP) led to the hypothesis that these two lineages diverge from the MPP
(245). However, it was later identified that erythroid and megakaryocytic lineage is the
first lineage divergence from MPP (246-248) (Fig. 7). Current evidence demonstrates
that several lymphoid progenitors still contain myeloid potential (249, 250). Thus,
hematopoiesis is more complicated than the original CMP and CMP models predicted.
In an attempt to identify populations that contain predominantly myeloid or
predominantly lymphoid potential, MPP population was separated into several different

44

Thymus
Naïve T
cell

ETP

Bone Marrow

HSC

MPP

MPP
Flt3pos

ELP

CLP

B Cells

CMP

MegE

GP

Megakaryocytes

Erythrocytes
MP

Granulocytes

Monocytes
Figure 7: Hematopoiesis in the mouse bone marrow. All blood cells develop from HSC.
For clarification the HSC population contains LT-HSC and ST-HSC. (Adapted from
Zlotoff et al 2011).

45
subsets based on different cell surface molecules as well as expression of the
recombination activating gene (Rag). MPP that express low levels of Flt3 can give rise to
CMP (247). In contrast, MPP with high expression of Flt3 expression display high
lymphoid potential and low myeloid potential (246, 247). MPP that do not express
VCAM-1 gave rise to T and B cells in vivo; whereas, MPP that expressed VCAM-1 were
able to generate myeloid cells (248). A subpopulation of MPP has been shown to express
Rag and is termed early lymphoid progenitors (ELP) or lymphoid primed multipotent
progenitors (LMPP); from here on, the ELP/LMPP population will be identified as ELP
(246, 251) ELP have both lymphoid and myeloid potentials (251). ELP gave rise to
CLP, which have high B lineage potential but retain some myeloid potential and T
lineage potential (82, 252). ELP also express CCR9 and are thought to contain the
thymic seeding progenitor as these cells efficiently seed the thymus (253-255). A current
paradigm of hematopoiesis is presented in Figure 7.

Development of T cell Progenitors in the Bone Marrow
The thymus does not contain lymphoid stem cells to maintain the development of
naïve T cells. The BM is the source of stems cells that maintain thymopoiesis through
out life (10, 11). While several populations of cells in the BM have T lineage potential,
not all are capable of settling in the thymus. The exact phenotypes of cells from the BM
that circulate through the blood to enter the thymus and become ETP are not known due
to the fast transition to ETP phenotype upon arrival in the thymus (82). HSC, MPP, and
CLP all have T lineage potential; however, HSC do not express the chemokine receptors
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required for homing to the thymus (82, 254). Both CLP and MPP are able to home to the
thymus when intravenous transferred. MPP gave rise to a higher number of DP T cells
than CLP, suggesting that the MPP contains the predominant thymic seeding progenitor
(254). Because a subpopulation of ETP expresses both Flt3 and CCR9, and thus is
phenotypically similar to MPP, it is suggested that the MPP population contains the BM
precursor to thymic ETP (256, 257) (Fig. 8).
Several chemokine receptors including CXCR4, CCR7, and CCR9 have been
implicated in the homing of T cell progenitors to the thymus as their respective
chemokines CXCL12, CCL21, and CCL25 are expressed in the thymus (258). It is likely
that all three contribute to homing of T cell progenitor to the adult thymus as all three are
important and play redundant roles in homing to of T cell progenitors to the embryonic
thymus (258). Deficient CXCR4 signaling does not result in altered homing to the
thymus; however, CXCR4-/- mice have a block in thymopoiesis as CXCR4 is required for
migration of DN subsets through the cortex (74, 259). CCR7-/- mice, CCR9-/- mice, as
well as CCR7-/- CCR9-/- double knock out mice have reduced number of ETP, but display
normal thymic cellularity (254, 260). These data suggest that while recruitment of T cell
progenitors is reduced, T lineage potential and expansion is intact and the thymus can
compensate for the low number of thymic seeding progenitors (254, 260). CCR7 and
CCR9 are expressed on MPP and CLP (254, 257, 260). Flt3 signaling is required for the
generation of CCR9pos MPP as FLT3-/- or FLt3L-/- MPP do not express CCR9 (254).
While several progenitors in the BM have T lineage potential, the ability to home to the
thymus for further maturation is not equivalent. Current data support the notion that the
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MPP population is the predominate BM population that seeds the thymus as they express
the chemokine receptor required for thymic homing and efficiently give rise to a large
number of thymocytes when intravenously transferred (252).
HSC give rise to T cell progenitors (likely MPP) that travel to the thymus for
further maturation and development. In addition, the presence of both γ/δ and α/β T cells
in athymic mice indicate that extrathymic sites for T cell development also exist (261263). The presence of T cell in the BM of athymic and normal mice has identified the
BM as a possible organ for extra thymic T cell development (264-267). Identification of
sj-TREC in athymic bone marrow cells further implicates the BM as a possible site that
supports T lineage commitment and T cell development (268). A novel population of T
cell progenitors has been identified independently by two groups (269-271). These two
groups that identified this population of T cell progenitors have different views on where
these T cell progenitors develop and whether expression of Foxn1 is required for the
generation of this population of T cell progenitors.
Strober and colleagues identified a committed T cell progenitor (CTP) in the BM
that they believe gives rise to T cells, independently of the thymus (269, 270, 272). CTP
are defined as Linneg CD90pos and CD2neg and develop into an intermediate CIP stage that
requires up regulation of CD2 (269, 273). When CTP are cultured, single positive T cells
are generated; however, the presence of mature TCRα/βpos T cells inhibit this thymic
independent pathway at the CIP stage (273). It could be argued that the presence of T
cells in the cultures are due to small amounts of contaminating mature T cells that expand
in vitro and that the CTP and CIP populations require the thymic environment for
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development. When CTP were injected into lethally irradiated congenic mice, donor
TCRα/βpos T cells were found in the thymus; however, the number was low compared to
that seen in the BM or spleen, indicating to Strober and colleagues that the CTP
preferentially develop by an extra thymic process (270). The presence of donor
TCRα/βpos T cells in the thymus may be an artifact of irradiation that grants access of
CTP to the thymus and does not reflect the in vivo ability of CTP to home the thymus.
Alternatively, CTP may in fact home to the thymus as proposed by Krueger et al. (271).
Independently, Krueger et al. identified a circulating T cell progenitor in the blood
which was also termed “CTP” (271). Phenotypically, Krueger’s CTP overlap with
Strober’s CTP (271). Krueger et al. also showed that CTP express preTα and have high
T lineage potential with very limited B and myeloid potential (271). Krueger
demonstrated that the CTP in the blood express thymic homing molecules such as CCR9
and P-selectin and home to the thymus (271). Thus, whether CTP are thymic
independent or thymic dependent is still debatable. Figure 8 is a simplified diagram of
hematopoiesis that includes the CTP and CIP populations that may home to the thymus
and generate T cells.
It also remains controversial whether the functional development of CTP requires
Foxn1 expression. When isolated donor CTP from nude Foxn1-/- BM were injected into
nude congenic hosts, donor T cells failed to develop suggesting to Strober’s group that
Foxn1 is required for the generation of functional CTP from HSC (274). Furthermore,
Strober’s group demonstrated that the number of CTP in nude BM was equivalent to Wt;
however, CTP from nude BM showed reduced proliferation and increased cell death,
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resulting in a reduced total number of CIP (275). Kruger et al. also reported that the
number of CTP in nude mice was equivalent to Wt (271), just as reported for CTP in the
BM of nude mice by Strober (275). Contrary to Strober’s findings, Krueger
demonstrated that CTP from nude mice develop into DP cells at levels equivalently to
that found in Wt CTP when cultured on the OP9-DL1 (271). These data demonstrate that
either the functional development of CTP does not require Foxn1, or that any dysfunction
of CTP from nude mice can be overcome by a high level of Notch signaling.

Cytokine and Transcriptional Regulation of the Development of Myeloid and
Lymphoid Progenitors from HSC
Cytokines and transcription factors can influence myeloid and lymphoid lineage
decision in hematopoietic progenitors. In few instances, expression of a specific
transcription factor or signaling though a cytokine receptor is required for lineage
commitment of a progenitor population. In other instances, the presence or absence of
transcription factors or cytokine does not directly indicate specification toward or away
from a specific lineage. Differentiation to myeloid or lymphoid lineage is a complicated
balance between multiple signals that have the potential to influence lineage choice fate.
Interest in identifying factors that influence the development of myeloid and lymphoid
progenitors was made possible with the bone marrow colony assay. In this assay
methylcellulose media allows for the formation of identifiable granulocyte and
macrophage colonies (276). This assay set into motion investigations to identify colony
stimulating factors, also known as hematopoietic growth factors and cytokines that
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promote the development of different hematopoietic lineages (277). Currently, several
different cytokines that influence lineage development from HSC as well as cytokines
responsible for maintaining HSC function have been identified (summarized in Fig. 9).
HSC express c-kit (278) and signaling by its ligand SCF is important for HSC survival
(279, 280). SCF assists in maintaining HSC in their quiescent state and prevents HSC
differentiation (281). HSC also express the G-CSF receptor (282), and G-CSF signaling
mobilizes HSC from their vascular niche (283).
Cytokines and signaling that promote the development of MPP from HSC
remains to be resolved; however, several cytokines have been identified to play a role in
lymphoid lineage commitment and development. Mice deficient in Flt3 signaling have a
reduced number of CLP, indicating that Flt3L is important for the generation of CLP and
their B lineage progeny (284-286). IL7 was also demonstrated to be critical for B cell
development. Addition of IL7 to methylcellulose cultures allowed for the development
of pre-B cell colonies whereas these colonies do not develop without IL7 (287). The
ability of IL7 to support the development of lymphoid lineage has also been
demonstrated in vivo. B cell development is arrested when there is a deficiency in IL7 or
IL7 receptor as signaling through IL7 is required for the up regulation of transcription
factors required for B lineage development (288, 289).
Cytokines that promote the development of myeloid and erythroid cells have also
been identified. Perhaps the most well known hematopoietic cytokine is erythropoietin
(EPO), which promotes the development of red blood cells. GM-CSF promotes the
development of granulocytes and monocytes; however, mice deficient in GM-CSF have
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normal hematopoiesis (290), suggesting redundant functions among the cytokines that
can promote the generation of granulocytes and monocytes. In fact, GM-CSF, G-CSF,
and M-CSF all support the development of granulocytes and monocytes. The number of
neutrophils and monocytes are reduced in mice deficient in either M-CSF or GM-CSF
(291). The number of monocytes and neutrophils are present but reduced in tripled
knock out mice deficient in M-CSF, G-CSF, and GM-CSF suggesting that these
cytokines are not essential for lineage commitment, but are required for the survival and
expansion of progenitors (292).
Two models of how cytokines regulate hematopoiesis have been proposed, the
stochastic model and the instructional model (293). The stochastic model suggests that
cytokines are not required for the commitment of multipotent cells to a specific lineage,
but that cytokines promote survival and expansion of lineage specific progenitors. In the
instructive model, cytokines transmit signals that result in lineage commitment. The
finding that triple knock out mice deficient in M-CSF, G-CSF, and GM-CSF have
monocytes and granulocytes but at a reduced number supports the stochastic cytokine
model (292). M-CSF, G-CSF, and GM-CSF is not required for lineage commitment as
granulocytes and monocytes are present; however, they are required for the expansion
and survival as the number of granulocytes and monocytes are reduced. The stochastic
model was also supported by studies in which the cytoplasmic tail of the G-CSF receptor
was replaced with erythropoietin, which did not result in the development of erythrocytes
at the expense of granulocytes (294, 295). Support for the instructional model of
cytokines was observed when the IL-2 receptor is ectopically expressed on CLP and
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signaling through IL2 receptor by its ligand IL2 resulted in the differentiation of CLP to
myeloid cells (296, 297). When CLP ectopically expressed the GM-CSF receptor and
not the IL7 receptor, CLP differentiated to myeloid cells, indicating that GM-CSF cannot
replace the critical role of IL7 in the development of B cells (297). Thus, the current data
in the literature support both the stochastic model and the instructional model of how
cytokines influence hematopoiesis.
Several transcription factors have been identified to play a role in lineage
commitment during hematopoiesis. However, both myeloid and lymphoid lineage
progenitors expresses the same transcription factors, but at different levels. The
transcription factor PU.1 is expressed in common myeloid progenitors (CMP) as well as
lymphoid lineage progenitors (298-300). It is thought that the timing and level of
expression of transcription factors during hematopoiesis dictates lineage development.
PU.1 is expressed at high levels in CMP and at lower levels in B lineage progenitors
(299). The expression level of PU.1 is crucial for lineage specification as high levels of
PU.1 in progenitors of the fetal liver was shown to induce macrophage generation
whereas lower levels resulted in B lineage formation (301). PU.1-/- B cell progenitors are
able to give rise to B cells at reduced rates indicating that PU.1 assists in B lineage
development, but is not required (302). Thus, the expression level of PU.1 can influence
lineage decisions.
The transcription factor E2A regulates B lineage commitment and is required for
the development of mature B cells (303). E2A-/- HSC give rise to T, NK, erythroid and
myeloid cells but fail to develop into mature B cells when adaptively transferred (304).
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A binding site for E2A has been identified in the regulatory region of early B cell factor
(EBF) and forced expression of E2A was shown to up regulate EBF expression (305,
306). Forced expression of EBF in the absence of E2A or PU.1 can promote B lineage
differentiation, suggesting that E2A and PU.1 function to up regulate EBF in B lineage
commitment and development (307, 308).
Ikaros is required for both B and T lineage development; Ikaros expression in
hematopoietic progenitors represses expression of transcription factors and signaling
molecules required for erythroid and myeloid lineage, and induces those required for
lymphoid (313,309). Ikaros is required for the development of CLP as Ikaros-/- BM does
not contain CLP (310). Ikaros null mice contain the ELP population suggesting that
Ikaros is not required for the development of ELP (311). Ikaros-/- mice also retain normal
levels of ETP indicating that ETP develop independently of CLP and that Ikaros is not
required for the development of T cell progenitors (82); however, Ikaros is required for
development of T cells in the thymus and T cell progenitors in Ikaros null mice have a
slow progression to the DN2 and DN3 stages (312).
As mentioned previously, T cell development required Notch signaling and that T
cell commitment does not occur until the DN3 stage of thymopoiesis (89, 90, 314).
Down regulation of the transcription factors PU.1 and C/EBPα at the DN3 stage is
required for T lineage commitment (315-317). PU.1 and C/EBPα expression in early
thymocytes can result in the development of dendritic cells and macrophages (317).
Notch activation results in the inhibition of PU.1 and C/EBPα thus promoting T lineage
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commitment in the thymus (317). A summary of transcription factors that influence
lineage commitment is summarized in Figure 9.

Hematopoiesis and Aging
HSC and Aging
Aging results in intrinsic changes in HSC and thus hematopoiesis. Intrinsic
alterations in aged HSC was demonstrated by transferring young and aged HSC in to
irradiated young hosts. Aged HSC had reduced homing and engrafting potential
compared to young HSC (318, 319). Intrinsic changes in HSC contribute to differences
in lineage development and commitment. The occurrence of leukemia increases with age
(320). Interestingly, there is a difference in the types of leukemia found in the elderly
compared to young individuals. The predominant form of leukemia in adults is myeloid
lineage, while the predominant form of leukemia in young is lymphoid lineage,
suggesting alterations in HSC lymphoid and myeloid potential with age (321). Young
BM cells transformed with the BCR-ABL (P210) oncogene gave rise to both myeloid and
lymphoid malignancies; however, transformed aged BM cells predominantly gave rise to
myeloid with rare instance of lymphoid malignancies (321). This is in line with previous
reports showing that the lymphoid lineage potential is reduced with age while myeloid
potential of HSC is maintained with age (318, 322-324). Experiments by Kim et al.
demonstrated that changes in the HSC potential with age are intrinsic as aged HSC
adaptively transferred to a young environment still resulted in a reduced B lineage
engraftment and higher myeloid engraftment compared to young HSC transferred into a
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young environment (322). Furthermore, lymphoid specific genes are expressed at lower
levels in aged LT-HSC while myeloid specific genes are expressed at higher levels
compared to young, suggesting intrinsic skewing toward myeloid lineage in aged HSC
(288, 289, 323).
Despite the decline in lymphoid potential in aged HSC, the number of HSC
increase with age (318, 323, 324). Changes in the number of HSC with age are mouse
strain dependent (325). In C57BL/6 mice (318, 323, 324), as well as in human (326,
327), the number of HSC increase with age. It was hypothesized that the increase in the
number of HSC results from a feedback mechanism compensating for functional decline
in the lymphoid potential of HSC (324, 328). It was also suggested that the increase in
the number of HSC is the result of a differential block in the development of HSC to
MPP as supported by a reduced number of MPP with age (13). The exact mechanism for
the increase in the number of HSC with age remains to be determined.
The MPP give rise to CLP, ETP, and myeloid progenitors. With age, the number
of MPP decline, which is thought to contribute to the reduced number of ETP in the aged
thymus (13). This finding suggests that thymic involution is initiated in the BM with a
reduction in the number of thymic seeding progenitors. Besides giving rise to ETP, the
MPP population gives rise to CLP which also decline in numbers with age, contributing
to reduced B lymphopoiesis in aged BM (329, 330). Despite the decline in the number of
MPP, the numbers of myeloid progenitors do not decline with age (330). A summary of
the age associated changes in the number of BM progenitors is shown in Figure 10.
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Figure 10: Changes in BM and thymic populations with age. The number of ETP
decreases with age and the decline in the BM precursor to ETP, MPP also declines in
aged mice. The number of CLP and B cells decreased in aged BM. No changes in the
number of myeloid progenitors occurred with age. It is not known how CTP and CIP are
affected in aged mice.
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Aging and the HSC Niche
A limited number of studies have examined effects of the aged microenvironment
on HSC and the HSC niche. Early studies in which young and aged bones were placed
subcutaneously in young mice demonstrated that young HSC reconstituted the aged BM
environment at lower levels then the young environment (331). This experiment
suggested that there are age-associated differences between the young and aged HSC
niches. This notion is supported by the fact that long term BM stroma cultures from aged
mice fail to completely support the development of hematopoietic progenitors (332).
Furthermore, aged HSC are located a greater distance away from the endosteal niche than
their young counterparts (333), suggesting that the aged endosteal HSC niche does not
retain HSC as well as the young. This was also shown when young and aged mice were
treated with GM-CSF. GM-CSF is known to mobilize HSC from their BM niches into
circulation; however, a larger number HSC are mobilized in aged mice treated with GMCSF than young mice suggesting reduced adhesion of aged HSC to their niche (283).
Taken together these experiments demonstrate age-associated alterations in the HSC
niche that can affect HSC function.

Foxn1 and Nude Mice
Nude mice were first described in 1966 (135). These mice are born without hair
or vibrissae, have reduced body weight by 3 weeks of age, reduced fertility, and
increased mortality (135). Survival of nude mice past 2 weeks of age is 45% and past 12
weeks of age is approximately 10% (135). It was later identified that nude mice also
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lacked a thymus (334). It took another 30 years before the gene responsible for the nude
phenotype was identified as Foxn1 (15, 16). Foxn1 is located on chromosome 11 in mice
(chromosome 17 in humans) and contains 9 exons with two alternative first exons and
two promoters (335, 336) .
In the fifteen years since the discovery that the Foxn1 gene is responsible for the
athymic condition in nude mice, little information into the regulation of Foxn1 has been
published. The existing known information about genes that regulate Foxn1 as well as
genes regulated by Foxn1 was obtained from studying skin. Nude mice produce hair
fibers, but the fiber coils in the hair canal and fails to penetrate the epidermis due to
defective keratinization (337, 338-340), suggesting that Foxn1 regulates keratin
expression.
Beside alterations in the skin and thymus, Zipori et al. showed that nude mice also
have alterations in their BM. The average number of nucleated cells in the BM of a nude
mouse is 30 million compared to 40 million found in Wt BM (19). The frequency of
nude BM to form CFU in Wt spleen when adoptively transferred were equivalent to Wt
mice however the total number of CFU are reduced based on the reduced number of total
nucleated cells (19). Nude BM also failed to protect against lethal irradiation when
adaptively transferred into lethal irradiated Wt hosts (19), suggesting a role for Foxn1 in
hematopoiesis. Of the few irradiated mice that survived to 100 days after receiving BM
from nude, the antibody titer to hemagglutinin and hemolysin after injection with sheep
red blood cells was lower than host mice that received Wt BM (19). Taken together,
these data suggest a decreased in HSC homeostasis and hematopoiesis in nude BM.
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Despite these observations the numbers of HSC and MPP in nude mice have not been
determined. However, the number and function of CTP and CIP from nude mice have
been examined.
It was shown that the cell cycle activity of CTP and the number of CIP are
reduced in nude mice (275), suggesting a role for Foxn1 in the development of T cell
progenitors. As mentioned previously, a role for Foxn1 in the generation of functional
CTP and whether CTP develop extrathymicly remains controversial. With age, nude
mice experience an increase in the number of CD90pos T cells found in the periphery
(341). Thus it is possible that the increase in the number of T cells in the periphery of
aged nude mice is the result of an age associated increase in extrathymic T cell
development pathway.
The nude mouse model served a valuable system in identifying Foxn1 as the
critical gene responsible for thymic organogenesis and TEC differentiation (15, 16). A
role for Foxn1 in the post natal thymus is just starting to be elucidated. It has been shown
that the decline in Foxn1 expression correlates with the decline in thymocyte number
with age and that postnatal reduction of Foxn1 results in premature thymic involution as
seen by a decrease in the number and proliferation of mTEC (14, 17, 18). However, it is
not known if over expression of Foxn1 could prevent thymic involution. As mentioned
above, the BM of nude mice have alterations in hematopoiesis and possibly the
development of T cell progenitors (19, 275). It has not been shown whether Foxn1
affects the development of progenitors in the BM and if Foxn1 is expressed by BM cells.
To better understand the role of Foxn1 in postnatal life, it is important to know how
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expression of Foxn1 affects the postnatal thymus and if Foxn1 has a role in BM which
produces T cell progenitors.

CHAPTER III
OVER EXPRESSION OF FOXN1 ATTENUATES AGE-ASSOCIATED
THYMIC INVOLUTION
Introduction
The thymus is the primary site for the development of naïve T cells in post natal
life (2, 3). Despite this important role, the thymus involutes with age and the number of
naïve T cells produced from the thymus is reduced (4, 5). To compensate for reduced
naïve T cell output, memory T cells in the periphery undergo homeostatic proliferation to
maintain the size of the peripheral T cell pool (143-146). The switch from a naïve T cell
phenotype in the periphery to a memory phenotype, combined with alterations in
functions of the peripheral T cells, culminates in a reduced immune response in the
elderly (147, 164, 167-171, 174, 175). Thus, thymic involution has a profound effect on
the number and functions of naïve T cells and memory T cells. Approaches to prevent or
reverse thymic involution and to promote the development of naïve T cells with age
could ameliorate the immune system of the elderly.
A reduction in thymopoiesis with age is reflected by changes in both the number
and function of T cell progenitors as well as alterations in the thymic architecture. The
number of ETP as well as their T lineage potential is reduced in the aged mice (12). ETP
require interaction with TEC for proper development. TEC are the predominate stromal
cell of the thymus responsible for thymopoiesis (4-9). With age, the number of TEC
64
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declines (81) and the architecture of cTEC and mTEC is disrupted (4, 5, 149).
Expression of Foxn1 in thymic stroma decreases with age and correlates with a decrease
in thymocyte number, suggesting that Foxn1 has a role in thymic involution (14). Foxn1
is expressed predominantly in mTEC but scattered cTEC also are positive for Foxn1
(124). Studies in which Foxn1 was deleted postnataly have shown that thymic involution
occurs prematurely with reduced number and cycling of mTEC, suggesting that Foxn1 is
required to maintain mTEC in the postnatal thymus (17, 18, 342). Using a Foxn1
transgenic (Foxn1Tg) mouse model that over expressed Foxn1 under the human keratin
14 (K14) promoter, experiments in this chapter were designed to test the hypothesis that
over expression of Foxn1 prevents thymic involution. We generated two Foxn1Tg lines
(line 5 and line 60) on the C57BL/6 background. Data from these lines were pooled as
we observed no functional differences among the transgenic lines.

Results
Expression of Foxn1 in thymic stroma of young and aged Wt and Foxn1Tg mice.
The levels of Foxn1 expression in the thymic stroma of Foxn1Tg were measured
using quantitative RT-PCR. Primers that do not distinguish between endogenous Foxn1
(Foxn1endo) transcripts and transgene transcripts (Foxn1Tg) were used to determine the
total levels of Foxn1 (Foxn1Total). To determine the contribution of the transgene to total
levels a second set of primers was used that only recognize the transgene transcripts
(Foxn1Tg). The specificity and locations of the primers in endogenous and transgene loci
are shown in Figure 11. The endogenous Foxn1 (Foxn1Endo) RNA levels were calculated

by subtracting transgene levels from total Foxn1 (Foxn1

endo

= Foxn1

Total
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– Foxn1 ). In
Tg

two month old Foxn1Tg mice, expression of the transgene in the thymic stroma was 4fold higher than endogenous Foxn1 (Fig. 12A). In both lines of Foxn1Tg mice, line 5
and line 60, the expression of total Foxn1 was equivalent and did not decline with age
even in thymi from very old transgenic mice 35 months of age (Fig. 12B). Similar to
BALB/c mice (14), expression of Foxn1 declined in aged Wt C57BL/6 thymic stroma
(Fig. 12B). The endogenous Foxn1 expression in 2 months old (line 60) thymic stroma
was 7.2-fold higher than endogenous levels in 2 month Wt (Fig. 12 A compared to 12B),
suggesting that expression of the transgene induced expression of the endogenous Foxn1.

High levels of Foxn1 expression do not affect thymic architecture in young mice.
Immunofluorescence staining was performed on young Wt and Foxn1Tg thymi to
determine if high levels of Foxn1 alter the thymic architecture. A rabbit polyclonal
antibody raised against the mouse Foxn1 peptide revealed that Foxn1 was expressed
predominantly in the medulla of a Wt thymus (2-3 mo) with scattered Foxn1pos cells in
the cortex (Fig. 13, panels A, B inset b). Expression of Foxn1 was similar in Foxn1Tg
thymus with Foxn1 detected primarily in the thymic medulla and scattered Foxn1pos cells
in the thymic cortex; however, the staining appeared more prominent in Foxn1Tg
compared to the Wt thymus (Fig. 13, panels A, B, D and E, insets b, e). The enhanced
intensity staining of Foxn1 reflected the increase in the expression at the mRNA levels of
both the transgene and endogenous Foxn1. Thus, the staining pattern of Foxn1 in young
Wt and Foxn1Tg thymi were similar with an apparent higher intensity in Foxn1Tg.
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Figure 11. A-B: Locations of Foxn1 primers and specificity by RT-PCR. A. RT-PCR
shows specificity of primers that detect both the endogenous and transgene Foxn1 and
primers that only detect transgene Foxn1 transcripts. Each lane represents results from a
Wt or Foxn1Tg mouse (line 60). B. Diagram showing the relative positions of the
forward and reverse primers that detect either both endogenous and transgene (black
arrows) or only transgenic (red arrows) Foxn1 transcripts.
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Figure 12: Quantification of endogenous and transgenic Foxn1 expression by
quantitative RT-PCR. A. Expression of the endogenous and transgene Foxn1 in 2 mo
(n=3) and 23-28 mo (n=3) old transgenic line (line 60).The numbers of transcripts/µg
total RNA were calculated from a standard curve after normalization with the mouse
house keeping gene Gapdh; each sample was performed in triplicates. The endogenous
Foxn1 levels were determined by subtracting the total Foxn1 (endogenous plus
transgene) from that of the transgene. White bars denote the total Foxn1 levels; gray bars
are transgenic Foxn1; black bars are endogenous Foxn1. Errors bars are standard
deviations; B. Expression of total Foxn1 in Wt (n= 2 at 2 mo; n= 3 at 24 mo) and in the
two Foxn1 transgenic lines (line 60: n=3 at 2 mo and n= 3 at 24 mo; line 5: n= 4 at 25-35
mo). Wt: white bar is 2 mo of age and gray bar is 24 mo of age. Foxn1Tg: white bar is 2
mo, and gray bar is 24 mo (line 60); crossed bars are 25-35 mo of age (line 5). Y axis is
in logarithmic scale; errors bars are standard deviations.
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Figure 13. Detection of Foxn1 expressing stroma cells in the thymus of Wt and
Foxn1Tg mice (2-3 mo) by immunofluorescent staining. Frozen sections (4-5 µm) were
fixed in acetone and stained with a rabbit anti-Foxn1 antibody (IgG fraction) or purified
rabbit IgG control antibody, followed by incubation with FITC-conjugated goat antirabbit IgG F(ab)2’. Panels A, B, D and E were stained with anti-Foxn1 antibody; C and F
were stained with purified rabbit IgG antibody. Slides were studied using Zeiss confocal
microcopy at 25X (A, D, C and F) and 50X (B, E). Insets b and e represent an
enlargement of the medulla regions in B and E respectively. Bar scales are 50 µm.
M=medulla. C=cortex.
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High levels of Foxn1 expression do not affect the distribution of thymocyte subsets
and thymopoiesis.
To determine if high levels of Foxn1 affect the distribution of thymocytes
populations, and thus disrupt thymopoiesis, the frequencies of DN, DP, SP CD4, and SP
CD8 cells were measured using flow cytometry. No differences were observed in the
relative proportions of these populations between young Wt and young Foxn1Tg (Fig.
14A). The distribution of DN, DP, and SP CD4 and SP CD8 was not affected by age in
Wt or in Foxn1Tg mice (Fig. 14B). The only noticeable difference between young Wt
and young Foxn1Tg was the percent of CD8pos T cells that expressed CD3. There was a
slightly higher percent of CD8pos CD3pos cells in the thymi of young Foxn1Tg compared
to young Wt (Fig. 14). Taken together over expression of Foxn1 does not affect
thymopoiesis and the distribution of thymocye population in young or aged mice.

Over expression of Foxn1 attenuates the age-associated decline in thymocyte
number.
Because thymopoiesis did not appear to be affected by high expression levels of
Foxn1, total numbers of thymocytes were enumerated to determine if over expression of
Foxn1 prevented the decline in their number with age. Thymocyte numbers in young
Foxn1Tg were equivalent to young Wt (Fig. 15). With age, the total number of
thymocytes declined; however, the decline was less severe in Foxn1Tg compared to Wt.
When compared to 3 months of age, Wt mice 16-10 months had a 3.7- fold decline while
Foxn1Tg experienced a 1.4-fold decrease. By 20-26 months of age Wt experienced a
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Figure 14: Distributions of CD4pos, CD8pos thymocyte populations and expression of
CD3 within the CD4pos, CD8pos, DP and DN thymocyte subsets in Foxn1Tg and Wt mice
with age. Young Wt and Foxn1Tg mice were 2-3 months of age. Aged Wt and Foxn1Tg
were 16-32 months of age. Representative flow cytometric profiles of one young and
aged Wt and one young and aged Foxn1Tg mouse. Number in each quadrant represents
the average percentage ± SD of each subset from 5 young Wt, 5 young Foxn1Tg, 4 aged
Wt, and 6 aged Foxn1Tg mice.
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Figure 15: Thymocyte numbers in 3 mo, 16-19 mo and 20-26 mo old Wt (white bars)
and Foxn1Tg (line 60) (black bars). p values from comparison between Wt and Foxn1Tg
as determined by t-test or Mann-Whitney are: *p = 0.043 ** p= 0.012, respectively.
Numbers in parentheses denote the number of mice.
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5.3-fold reduction while Foxn1Tg had a 3-fold reduction compared to mice 3 months of
age. In aged thymi, not only did Foxn1Tg have a higher number of thymocytes
compared to aged matched Wt, but the thymi were larger with few foci of adipose tissue
(Fig. 16, fat denoted with *). Thus, over expression of Foxn1 attenuated the decline in
thymopoiesis with age as seen by a higher total thymocyte number with a normal
thymocyte population distribution. In agreement with this interpretation, two way
ANOVA analysis shows that while age negatively affects the number of thymocytes in
Wt mice, over expression of Foxn1 in aged mice results in a higher number of
thymocytes and minimizes the affect of age. Table I and Table II summaries of all twoway ANOVA and can be found on pages 185-186.

Over expression of Foxn1 prevents the decline in ETP frequency and attenuates the
decline in ETP number in aged mice.
Naïve T cells develop from ETP in the thymus (82, 83). In aged Wt thymi, the
frequency and total number of ETP decline, contributing to the decline in thymopoiesis
(12). To begin elucidating a mechanism by which over expression of Foxn1 attenuates
the decline in thymocyte number and thymopoiesis, frequency and total number of ETP
in young and aged Wt and Foxn1Tg mice were determined using flow cytometry. ETP
were identified as thymocytes that are Linneg CD117pos CD44hi CD25neg and CD127neg
(82, 83) (Fig. 17). In agreement with others, the frequency of ETP/105 cells declined in
aged Wt (#p=0.009) (12); however, aged Foxn1Tg mice had an ETP frequency equivalent
to young and 2.6-fold higher than aged Wt (Fig. 18A *p=0.038). Two way ANOVA
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analysis of ETP frequency revealed that over expression of Foxn1 has an affect on ETP
frequency and that over expression of Foxn1 prevents the decline with age. Age also
affected the total number of ETP. The total number of ETP in aged Wt and Foxn1Tg
thymi was reduced compared to young (#p=0.003 Wt; ##p<0.001 Foxn1Tg), but aged
Foxn1Tg have a 2.7-fold higher ETP number per thymus compared to aged Wt (Fig. 18B
*

p=0.047). Two way ANOVA analysis of ETP number demonstrates that age results in a

decrease in the number of ETP in Wt mice; however, over expression of Foxn1 results in
a higher number of ETP in aged mice and minimizes the effect of age. Taken together,
over expression of Foxn1 prevented the decline in ETP frequency and attenuated the
decline in ETP number potentially contributing to higher number of thymocytes observed
in the aged thymus.

ETP from Foxn1Tg and Wt mice display similar T lineage potential.
ETP in the thymus have high T lineage potential, however they also have myeloid
and B lineage potential (82, 84, 85). To determine if over expression of Foxn1 in TEC
increases T lineage potential of ETP, ETP were electronically sorted and cultured on a
BM stroma cell line that over expresses the Notch ligand DL1 (OP9-DL1). After two
weeks in culture, cells were harvested and flow cytometry was used to determine T
lineage commitment and differentiation as measured by the expression of CD90 and
CD25. OP9-DL1 cells that express GFP were excluded from the analysis by gating on
GFP negative cells and GFP negative cells were analyzed for the expression of CD90 and
CD25 (Fig. 19). The cell surface molecule CD90 is the first molecule that is up regulated
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upon commitment to T lineage, and CD25 is expressed in the developing thymocytes at
the DN2 and DN3 stages (86, 87) (Fig. 19). Approximately 95% of cells in culture from
Wt ETP 1-4 months of age expressed CD90 (Fig. 20A). The commitment potential of
ETP to T lineage did not change in aged Wt ETP cultures (Fig. 20A). The percent of
cells that expressed CD90 in cultures from Foxn1Tg ETP 1-4 mo of age was equivalent
to aged matched Wt (Fig. 20A). Similar to that found in aged Wt mice, T lineage
potential of ETP did not change with age in Foxn1Tg mice, suggesting that over
expression of Foxn1 does not affect ETP T lineage potential with age.
Differentiation of ETP to the DN2/DN3 stages of T cell development is marked
by the up regulation of CD25 (86, 87). To determine if over expression of Foxn1
affected ETP differentiation, expression of CD25 was measured amongst the cells that
expressed CD90. No differences were seen between young and aged Wt ETP cultures
(Fig. 20B). There was also no age difference in the expression of CD25 amongst
CD90pos cells from young and aged Foxn1Tg ETP cultures. Furthermore, there was no
difference in T lineage differentiation between Foxn1Tg and aged matched Wt. Together,
these data indicate that over expression of Foxn1 does not affect T lineage differentiation
potential of ETP to the DN2/DN3 stages (Fig. 20B).

Aged Foxn1Tg thymic microenvironment does not increase the generation of ETP
but may increase Rag activity.
To determine if the higher number of ETP found in aged Foxn1Tg thymi resulted
from an increase in the generation of ETP, adaptive transfer experiments were performed

SSC

SSC

81

GFP

SSC

SSC

FSC

CD25

CD90

Figure 19: Flow cytometry analysis of ETP cultured on OP9-DL1 (GFP). Cells that
were GFPneg were analyzed for the expression of CD90 to determine T lineage
commitment. Within the GFPneg CD90pos population cells that expressed CD25 were
measure to determine T lineage differentiation.
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Figure 20: ETP commitment to T lineage and differentiation to DN2/DN3 stage. ETP
were electronically sorted from 1-4 and 21-32 months of age Wt and Foxn1Tg mice.
Cells were cultured for 2 weeks on OP9-DL1 in the presence of SCF, Flt3L, and IL7. A.
Percent of cells in culture that have committed to T lineage as indicated by expression of
CD90. B. Differentiation of T lineage cells to DN2/DN3 as measured by expression of
CD25. Error bars are SD. Numbers in parentheses denote the number of mice.
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using BM LSK cells from the H2-SVEX transgenic mice (CD45.1 background, a gift
from Dr. Rachel Gerstein, University of Massachusetts). If the Foxn1Tg thymic
environment promotes the generation of ETP, then we would expect a higher number of
donor derived ETP in the aged Foxn1Tg thymus compared to Wt thymus. H2-SVEX
LSK cells also allowed us to measure Rag activity in donor ETP generated in the
Foxn1Tg hosts versus Wt hosts. H2-SVEX mice contain a construct in which the H2-K
promoter drives expression of a violet activated GFP (VEX) (343). The VEX gene is
orientated in the antisense direction and is flanked by V(D)J recombination signal
sequences (RSS) (343)(Fig. 21). When a cell from the H2-SVEX mice expresses Rag,
Rag binds to the RSS and rearranges the VEX gene such that it reverses to the sense
orientation allowing VEX expression (343) (Fig. 21). The expression of VEX reflects
Rag activity in developing lymphocytes (343). Once the VEX construct is inverted the
cell will continue to express VEX even after a cell no longer expresses Rag (343). If the
Foxn1Tg thymic environment promotes Rag activity in ETP, then we would expect to see
more VEXpos donor ETP in the aged Foxn1Tg thymi compared to aged Wt.
Donor LSK cells (8,000-16,000 cells) from young CD45.1pos H2-VEX mice were
transferred into non-irradiated Wt and Foxn1Tg hosts 17-21 months of age. Ten weeks
post transfer, flow cytometry was used to determine the generation of ETP by measuring
the frequency of ETP among donor cells in aged Wt and Foxn1Tg thymi. The expression
of VEX amongst donor ETP was used to determine Rag activity in ETP which is required
for TCR gene rearrangement. The gating of donor ETP frequency and VEX expression
among donor ETP is shown in Figure 22.
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Figure 21: Recombination of the VEX construct. The VEX construct is driven by the
H2-K promoter and is flanked by RSS (yellow triangles). In cells that do not express Rag
the VEX construct is in the antisense orientation. When Rag is expressed in a cell the
RSS direct inversion of the VEX construct allowing for its expression.
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Aged Wt and Foxn1Tg hosts generated the same frequency of donor ETP per
100,000 donor thymocytes, suggesting that the aged Wt and Foxn1Tg thymic
microenvironments are equivalent in the generation of ETP from young donor LSK cells
(Fig. 23A). Previously it was shown that in H2-SVEX mice 1-2 months of age,
approximately 50% of ETP express VEX, reporting Rag activity (84). We found that
approximately 36% of the CD45.1 donor ETP in aged Wt thymi expressed VEX (Fig.
23B). The frequency of VEXpos donor ETP in aged Foxn1Tg host was approximately
60% (Fig 23B). While not statistically different this trend may suggest that over
expression of Foxn1 in the thymic microenvironment increase the efficiency of Rag
activity.

Over expression of Foxn1 minimizes age-associated changes in thymic architecture.
Aged mice experience disruptions in the thymic architecture including a
contraction in the thymic epithelial compartment that supports thymopoiesis and an
expansion of the perivascular tissue filled with adipose and fibroblasts that do not support
thymopoiesis (4, 5). Figure 24A and C shows thymi in situ from a Wt mouse 24 months
of age (A) and a Foxn1Tg mouse 31 months of age (C). The yellow arrows in Fig. 24C
point to numerous translucent areas representing adipose in the aged Wt thymus; in
contrast, a thymus from the older Foxn1Tg appears opaque with no obvious appearance
of adipose. Hematoxylin and Eosin (H&E) staining on these thymi revealed that the Wt
thymus (Fig. 24B) had histological changes associated with aging such as the loss of the
cortical-medullary boundary and adipose tissue deposition (marked with an asterisk). In
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Figure 22: Identification of CD45.1pos VEXpos ETP. Donor cells were gated based on
expression of CD45.1. Donor cells that were Linneg CD117pos CD44hi CD25neg and
CD127neg (ETP) were examined for VEX expression.
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Figure 23: Frequency of donor ETP and percent of ETP that express VEX in aged Wt
and Foxn1Tg hosts. A. The frequency of CD45.1pos donor ETP in the thymus of aged Wt
and Foxn1Tg hosts. B. Percent of donor ETP that have Rag activity as measured by the
expression of VEX in aged Wt and Foxn1Tg thymi. Error bars are SD.

88

Figure 24: Changes in gross thymic morphology and histology of old Wt and Foxn1Tg
mice (line 60). A) Gross thymic morphology of a 26 months of age Wt mouse with
adipose tissue present (arrows); B) H&E staining of the same thymus shows the loss of
cortical-medulla demarcation and the abundance of adipose tissue, denoted with *. C)
Gross thymic morphology of a 31 mo Foxn1Tg mouse with intact parenchymal tissue
with little adipose tissue deposition; D-F) H&E staining of the same thymus shows a
clear cortical-medulla demarcation and little adipose tissue deposition. Bar scales are 50
µm. C=cortex and M=medulla.
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comparison, the Foxn1Tg thymi showed little adipose tissue deposition and displayed a
well defined cortical-medullary boundary (Fig. 24 D-F).
Differences in the thymic architecture of aged Wt and Foxn1Tg thymi were
further observed when stained for keratin 8 and keratin 5, which is expressed in cortical
and medullary TEC, respectively. In aged Wt thymus (26 mo), the intensity of keratin 8
(red) staining was less and areas that were devoid of staining were prominent compared
to that seen in young Wt (2 mo) (Fig. 25 B, C versus A). Additionally, keratin 5 staining
(green) in aged Wt demonstrated a collapse of the medullary region from several small
foci into a large fused filamentous area (Fig. 25 B, C). Contrary to aged Wt, aged
Foxn1Tg thymus (31 mo) displayed intense keratin 8 staining with few areas that were
devoid of keratin 8 expression (Fig. 25 E, F). Aged Foxn1Tg thymi also retained
numerous, well defined keratin 5pos foci similar to that seen in the young thymi (Fig. 25
D-F). Thus, over expression of Foxn1 dampened the age-associated alterations in thymic
architecture.

Foxn1Tg thymus has a larger mTEC pool
With age, the number of TEC declines (81). Preventing or minimizing the decline
in number of TEC with age could be one mechanism in which Foxn1Tg mice minimize
alterations in the thymic architecture. The total numbers of cTEC and mTEC were
calculated from the thymi of young and aged Foxn1Tg and Wt mice. Flow cytometry
was used to determine the total number of cTEC and mTEC amongst the stroma cells.
Thymi were digested and stroma cells were isolated using a percoll gradient. Cortical
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Figure 25: Double staining of cortical keratin 8 (red) and medullary keratin 5 (green) in
the thymus of Wt and Foxn1Tg mice (line 60). Acetone-fixed frozen sections of thymi
from 2 mo (A) and 26 mo (B, C) Wt mice and 2 mo (D) and 31 mo old (E, F) transgenic
mice were stained with a rabbit-anti mouse keratin 5 (green) and rat-anti mouse keratin 8
(red). Sections were analyzed with a Zeiss confocal microscope. Bar scale is 200 µm.
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(Fig. 26). The number of cTEC per thymus in young Foxn1Tg was equivalent to young
Wt (Fig. 27). With age, the number of cTEC per thymus declined in both Wt and
Foxn1Tg thymi and aged Foxn1Tg had cTEC numbers equivalent to aged Wt, suggesting
that over expression of Foxn1 does not affect the size of the cortical epithelial
compartment and does prevent the decline in the number cTEC with age. This is
supported by two-way ANOVA in which age results in a decrease in the number of cTEC
and over expression of Foxn1 has no affect on the number of cTEC.
In contrast, over expression of Foxn1 significantly affects the mTEC population.
Medullary TEC were identified as CD45neg EpCAMpos Ly51neg and were further divided
into either MHCIIpos or MHCIIhi (81) (Fig. 26). Two–way ANOVA revealed that age
negatively affects the number of MHCIIpos and MHCIIhi mTEC and over expression of
Foxn1 increases the number of MHCIIpos and MHCIIhi TEC. However, over expression
of Foxn1 can also attenuate the affect of age on both MHCIIpos and MHCIIhi mTEC
number. Young Foxn1Tg had a 2.5-fold increase in the number of MHCIIpos mTEC and
a 5-fold higher number of MHCIIhi mTEC compared to young Wt (Fig. 27 and 28).
While the number of MHCIIpos and MHCIIhi mTEC declined with age in both Wt and
Foxn1Tg, aged Foxn1Tg had a 2-fold higher number of MHCIIpos and MHCIIhi compared
to aged Wt (Fig. 27 and 28). The MHCIIhi mTEC population has been identified as the
transient amplifying population that is responsible for maintaining the mTEC pool (81).
To determine if the larger mTEC pool in Foxn1Tg is due to an increase in proliferation of
MHCIIhi mTEC, expression of Ki-67 was examined using flow cytometry (Fig. 26). No
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Figure 26: Identification of TEC subsets by flow cytometry. Enriched thymic stromal
cells were stained for CD45, MHCII, EpCAM, and Ly51. CD45neg cells were gated for
MHCIIhi, MHCIIpos, and MHCIIneg and then analyzed for expression of EpCAM and
Ly51. Within each MHC subsets medullary TEC were identified as EpCAMpos Ly51neg
and cortical TEC were identified as EpCAMpos Ly51pos. The percent of MHCIIhi mTEC
in cell cycle was determined using Ki67. Numbers represent percent of cells in each
quadrant. Figure represents data from a 3 mo Wt mouse.
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Figure 27: Number of cTEC in thymi from 2-3 and 18-23 mo Wt and Foxn1Tg mice.
Cortical TEC were defined as CD45neg MHCIIpos EpCAMpos and Ly51pos. Numbers in
parentheses denote the number of mice. Error bars are SD.
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Figure 28: Number of MHCIIpos mTEC in thymi from 3 mo and 18-20 mo Wt and
Foxn1Tg mice. MHCIIpos mTEC were identified as CD45neg MHCIIpos EpCAMpos and
Ly51neg. The number of MHCIIpos mTEC declined in aged Wt (#p=0.012) and Foxn1Tg
(*p=0.016). Foxn1Tg had a higher number of MHCIIpos mTEC compared to aged
matched Wt (p=0.012 young Foxn1Tg vs. young Wt; p=0.023 aged Foxn1Tg vs. aged
Wt). Numbers in parentheses denote the number of mice in each group. Error bars are
SD.
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Figure 29: Number of MHCIIhi mTEC in thymi from young and aged Wt and Foxn1Tg
mice. MHCIIhi mTEC were identified as CD45neg MHCIIhi EpCAMpos and Ly51neg.
The number of MHCIIhi mTEC declined in aged Wt (p<0.001) and Foxn1Tg (p=0.016).
Foxn1Tg had a higher number of MHCIIpos mTEC compared to aged matched Wt
(p<0.001 young Foxn1Tg vs. young Wt; p=0.04 aged Foxn1Tg vs. aged Wt). Numbers
in parentheses denote the number of mice in each group. Error bars are SD.
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Figure 30: MHCIIhi mTEC cell cycle activity in 3 mo and 18-20 mo Wt and Foxn1Tg.
The percent of MHCIIhi mTEC in cell cycle was determined using Ki-67. The percent of
MHCIIhi mTEC in cell cycle decreased with age (#p<0.001 aged Wt vs. young Wt;
*p=0.002 aged Foxn1Tg vs. young Foxn1Tg). Aged Foxn1Tg had a larger percent of
MHCIIhi mTEC expressing Ki-67 compared to aged Wt (p=0.017). Numbers in
parentheses denote the number of mice. Error bars are SD.
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Table III

Mouse
Strains

Wild type
Foxn1Tg

EpCAMpos Ly51pos
MHCIIpos cTEC
Number
2-3 mo
18-23 mo
12,032
13,100
(5,125)
(7,490)
n=5
n=7
4,980
3,560
(2,215)
(2,210)
n=3
n=7

EpCAMpos Ly51neg
MHCIIpos mTEC
Number
3 mo
18-20 mo
27,481
7,400
(11,622)
(1,871)#
n=4
n=5
15,189
68,149
(4159)*, §
(18,842)‡
n=5
n=5

EpCAMpos Ly51neg
MHCIIhi mTEC
Number
3 mo
18-20 mo
4,996
554
(902)
(175)##
n=5
n=4
1,044
25,600
(297)**, §§
(4,860) ‡‡
n=5
n=5

Percent Ki67pos
3 mo
18-20 mo
53.1
15.1
(21)
(5.4) †
n=5
n=4
56.7
29.4
(7.3)
(12.5)$, $$
n=5
n=5

The numbers of EpCAMpos Ly51pos MHCIIpos cTEC, EpCAMpos Ly51neg MHC IIpos
mTEC and MHCIIhi Ly51neg mTEC were calculated based on the total cell number in the
CD45neg compartment and the percentage cells within the MHCIIpos and MHCIIhi subsets
as determined by flow cytometry. Statistical significance was determined by t-test
(SigmaStat, Version 2). # p= 0.012, vs. young Wt; *p = 0.016, vs. young Foxn1Tg; ‡p =
0.003, vs. young Wt; §p = 0.023, vs. age Wt; ##p <0.001, vs. young Wt; **p = 0.016, vs.
young Foxn1Tg; ‡‡p < 0.001, vs. young Wt; §§p = 0.040, vs. age Wt; †p <0.001, vs. young
Wt; $p = 0.002, vs. young Foxn1Tg; $$p = 0.017, vs. age Wt. Numbers in parentheses are
SDs.

hi
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difference was seen in the percent of Ki-67 positive in MHCII mTEC in young
Foxn1Tg versus young Wt (Fig. 29). With age the percent of Ki-67pos MHCIIhi mTEC
decreased in both Wt and Foxn1Tg (Fig. 29). However, aged Foxn1Tg had a larger
percent of MHCIIhi mTEC in cell cycle compared to aged Wt, suggesting that the higher
mTEC pool in aged Foxn1Tg was due to increased cell cycle of the MHCIIhi mTEC (Fig.
29). Data on all TEC subsets are summarized in Table III.

Summary
Results from experiments in this chapter showed that Foxn1 is over expressed in
the thymic stroma of Foxn1Tg mice. Contrary to Wt mice (14), expression of Foxn1 did
not decline with age in Foxn1Tg thymic stroma. Foxn1 was expressed primarily in the
medulla with scattered positive cells in the cortex in both Wt and Foxn1Tg thymi.
Furthermore, high levels of Foxn1 did not alter thymopoiesis in Foxn1Tg, establishing
Foxn1Tg mice as a model to determine if high levels of Foxn1 could can prevent ageassociated thymic involution. The Foxn1Tg mouse model also revealed the novel finding
that Foxn1 is auto-regulated. While the target genes of Foxn1 are not known, expression
of the Foxn1 transgene resulted in an increase in the level of endogenous Foxn1. Thus,
the Foxn1Tg mouse model also proves to be a potential model to determine other targets
of Foxn1.
With age, the decline in thymocyte number was attenuated in Foxn1Tg mice. In
Wt mice, the frequency and number of ETP declined with age contributing to reduced
thymopoiesis (12). We also demonstrated that the frequency and number of ETP
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declined with age in Wt mice; however, in Foxn1Tg the frequency of ETP was not
changed and the decline in ETP was attenuated. Interestingly, when young CD45.1pos
donor LSK cells were adaptively transferred into aged Foxn1Tg and aged Wt host, no
difference was observed in the frequency of donor ETP. This may be the result of young
donor cells in an aged host environment. It is possible that the young donor LSK cells
can compensate for the alteration in the aged Wt thymic microenvironment resulting in a
donor ETP frequency equivalent to aged Foxn1Tg.
While not significantly different, a higher percent of donor ETP expressed VEX
in aged Foxn1Tg hosts than aged Wt hosts. This may suggest that the aged Foxn1Tg
thymic microenvironment promotes Rag activity in ETP with a higher efficiency than
aged Wt thymic microenvironment. However, ETP from aged Foxn1Tg did not show an
increased T lineage potential or differentiation when cultured on the OP9-DL1 stroma
cell line. It was previously shown that in wild type mice, aged ETP have reduced T
lineage potential as measured by the number of DP cells generated from fetal thymic
organ cultures (12). However, I was not able to confirm these conclusions using the
OP9-DL1 stromal cell culture system. This may result form an efficient culture system
as evident by the fact that approximately over than 90% of cells in all cultures committed
to T lineage by two weeks. Since this system does not allow us to distinguish differences
in Wt ETP T lineage potential with age, this system may not be able to discriminate
difference in ETP T lineage potential from Foxn1Tg compared to Wt.
With age in Wt mice age-associated alterations in the thymic environment
contributes to reduced thymopoiesis (4, 5). Aged Foxn1Tg had decrease adipose
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accumulation and maintained distinction of the corticomedullary junction. While the
number of cTEC and mTEC decrease with age, aged Foxn1Tg had a higher number of
mTEC compared to aged Wt. This is likely the result of increased MHCIIhi mTEC cell
cycle activity seen in aged Foxn1Tg. Taken together, data from this chapter support my
conclusion that over expression of Foxn1 attenuates thymic involution.

CHAPTER IV
OVER EXPRESSION OF FOXN1 PROMOTES THE GENERATION OF T CELL
PROGENITORS IN THE BM
Introduction
Thymopoiesis requires a functional thymus that is capable of recruiting BMderived T cell progenitors to the thymus and supports their development toward T lineage
(252). Because the thymus does not contain self renewing cells, it relies on the BM for a
continuous supply of T cell progenitors to maintain thymopoiesis (10, 11). The most
immature BM derived T cell progenitors are the early T cell progenitors or ETP (82, 83).
While the exact BM precursor to ETP has not been clearly identified, a subpopulation of
ETP expresses both Flt3 and CCR9 and is phenotypically similar to the BM multipotent
progenitors (MPP); thus, suggesting that at least a subset of MPP population is the
precursor of ETP (256, 257). With age both ETP in the thymus and MPP in the BM
decline in number and function (12, 13). These findings support the hypothesis that a
decline in ETP contributing to age-associated thymic involution is initiated in the BM
with a decline in MPP (13). In this chapter, I tested if the maintenance of ETP
frequencies and higher numbers of ETP in aged Foxn1Tg results from amelioration of
BM function toward the generation of MPP.
Beside the MPP, another population of T cell progenitors in the BM has been
identified. Work by Strober and colleagues identified a T cell progenitor population in
102
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the BM whose development is altered in Foxn1 mutated nude mice (269). Phenotypically
these cells are lineage marker negative (Linneg) CD90pos CD2neg and are referred to as
committed T cell progenitors or CTP. Subsequent development of CTP toward the T
lineage progresses through an intermediate stage, the CIP, which depends on the
proliferation of CTP (269, 270, 274, 275). In nude mice, Chatterjea-Matthes et al.
reported that CTP are present but are not functional, and the development of CTP toward
CIP is reduced (274, 275). However, Krueger et al. reported that CTP from nude mice
are functional when cultured on OP9-DL1 (271). Thus, while a role for Foxn1 in the
development of CTP has been suggested, it remains a controversial issue. In this chapter
I also determined whether Foxn1 affects CTP proliferation and development of CIP.

Results
Over expression of Foxn1 prevents the decline in MPP with age.
MPP are the BM precursor to ETP (256, 257). With age, the number of MPP
declines, contributing to the decline in ETP with age, and suggesting that thymic
involution is initiated in the BM (13). Because the ETP frequency did not decline with
age in Foxn1Tg mice, we were compelled to ask whether the higher level of ETP in aged
Foxn1Tg mice was the result of preventing the age-associated decline in MPP. A
representative flow cytometry gating of MPP is shown in Figure 31. In Wt mice, the
frequency and total number of MPP decreased by 20 months, and further decreased by
24-25 months of age (Fig. 32A ##p<0.001 Wt 1-4 vs. Wt 24-25 mo; Fig. 32B. #p=0.006
Wt 1-4 mo vs. Wt 24-25 mo). Over expression of Foxn1 resulted in the maintenance of
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the frequency and number of MPP as the frequency and number of MPP were not
different among the three age groups, even in Foxn1Tg mice that were 24-35 months of
age (Fig. 32). Moreover, the frequency and total MPP number in the Foxn1Tg 24-35
months of age were higher than aged Wt 24-25 months of age (Fig. 32A ††p=0.001; Fig.
32 B †p<0.001). Two-way ANOVA analysis of MPP frequency and number
demonstrates that with age the MPP pool decreases. However, over expression of Foxn1
prevented the age associated changes in the frequency and number of MPP.

Foxn1Tg mice have a larger HSC pool.
One potential contributing factor to the maintenance of MPP population with age,
could be due to alterations in the immediate precursor to the MPP, the HSC. A
representative gating of HSC is shown in Figure 31. In agreement with previous reports,
the frequency and total number of HSC in Wt mice increased from 1-4 to 20-21 months
of age (Fig. 33A **p=0.007; Fig. 33B *p=0.004) (318, 318, 324). However, Wt mice that
were 24-25 months of age showed a significant reduction of in HSC frequency and
number compared to 20-21 months and 1-4 months of age (Fig. 33A ##p<0.001 Wt 1-4
mo vs. Wt 24-25 mo; 33B #p=0.006 Wt 1-4 mo vs. Wt 24-25 mo). Compared to Wt
mice, I first observed that the number of HSC in 1-4 months old Foxn1Tg was
significantly higher (1.3-fold) (Fig. 33B, ‡p=0.036). As in Wt mice, there was an
increase in HSC frequency and number in the 20-21 months old Foxn1Tg and the number
of HSC was higher than age matched Wt (Fig. 33A ††p=0.03 Foxn1Tg 1-4 mo vs.
Foxn1Tg 20-21mo; Fig. 33B †p<0.001 Foxn1Tg 1-4mo vs. 20-21 mo; ¶p=0.01). The
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Figure 31: Identification of HSC and MPP. Nucleated cells that were Linneg CD117pos
and Sca1pos (LSK) cells were gated on CD135 to identify HSC from MPP. HSC were
defined as Linneg CD117pos Sca1pos and CD135neg. MPP were defined as Linneg CD117pos
Sca1pos and CD135pos.
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Figure 32: Frequency and number of MPP in Wt and Foxn1Tg 1-4, 20-21, and 24-35 mo.
A) Frequency of MPP per 1x106 nucleated cells.
††

##

p<0.001 Wt 24-25 mo vs. Wt 1-4 mo;

p=0.001 Foxn1Tg 24-25 mo vs. Wt 24-25 mo. B) Total number of MPP in two tibia and

femur. #p=0.006 Wt 24-25 mo vs. Wt 1-4 mo; †p<0.001 Foxn1Tg 24-35 mo vs. Wt 24-25
mo. Each symbol represents one animal. Half filled triangles represent Foxn1Tg mice
older than 25 months of age. Error bars are SD.
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Figure 33: Frequency and total number of HSC in Wt and Foxn1Tg 1-4, 20-21, and 2425 months of age. A) Frequency of HSC per 1x106 nucleated cells. **p=0.007 Wt 1-4 mo
vs. Wt 20-21 mo; ##p<0.001 Wt 1-4 mo vs. Wt 24-25 mo; ††p=0.03 Foxn1Tg 20-21 vs.
Foxn1Tg 1-4 mo; §§p=0.004 Foxn1Tg 24-25 mo vs. Wt 45-25 mo. B) Total HSC in two
tibia and two femurs. *p=0.004 Wt 20-21 mo vs. Wt 1-4 mo; #p=0.006 Wt 24-25 mo vs.
Wt 1-4; ‡p=0.036 Foxn1Tg 1-4 mo vs. Wt 1-4 mo; †p<0.001 Foxn1Tg 20-21 mo vs.
Foxn1Tg 1-4 mo; ¶p=0.01 Foxn1Tg 20-21 mo vs. Wt 20-21 mo; §p<0.001 Foxn1Tg 2435 mo vs. Wt 24-25 mo. Each symbol represents one animal. Half filled triangles
represent Foxn1Tg mice older than 25 months of age. Error bars are SD.
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frequency and number of HSC in the 24-35 months old Foxn1Tg group were only
reduced to the level found in 1-4 months of age (Fig. 33A-B) whereas, Wt HSC at 24-25
months of age were about one third the level found in 1-4 months old mice. The
frequency and number of HSC in the 24-35 months old Foxn1Tg were higher than aged
Wt 24-25 months of age even though half of the mice in this age group were older than
the advanced aged Wt (Fig. 33A §§p=0.004; Fig. 39B §p<0.001). Analysis of HSC
frequency and total number using two-way ANOVA showed that aging results in an
initial increase in both frequency and number of HSC, followed by a decrease in
frequency and number. While over expression of Foxn1 resulted in a higher HSC
frequency and number, it did not affect changes associated with aging.

LSK frequency decreases with age in Wt mice, but not Foxn1Tg.
Previously, it was reported that the LSK population which includes HSC and
MPP does not change with age (13). It was shown that as the size of the MPP population
decreases, the HSC population increased, thus the LSK population remains unchanged
with age (13). Since, we observed a decline in both HSC and MPP in Wt mice at the 2425 months of age group we analyzed if these differences were reflected in a decline in the
LSK population. Figure 34 contains a representative gating on LSK cells with age in Wt
and Foxn1Tg mice. In Wt mice, from 1-4 to 20-21 months of age the LSK frequency
remained unchanged (Fig. 34 and 35A). This is because in 20-21 months of age Wt mice
as the MPP decreased the HSC increases. In Wt mice 24-25 months of age, the LSK
population is drastically reduced as a result of a decline in both HSC and MPP (Fig. 34
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Figure 34: Frequency of LSK cells within the Linneg population of Wt and Foxn1Tg mice
1-4, 20-21, and 24+ months of age. Each graph represents the gating of one mouse from
the following groups: Wt 1-4 mo (n=10), Wt 20-21 mo (n=5), Wt 24-25 mo (n=8),
Foxn1Tg 1-4 mo (n=14), Foxn1Tg 20-21 mo (n=6), and Foxn1Tg 24-35 mo (n=12).
Numbers in graph are the percent of LSK cells within the lineage marker negative
population ±SD. *p<0.001 Wt 20-21 vs. 24-45 mo.
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Figure 35: Frequency and total number of LSK in Wt and Foxn1Tg 1-4, 20-21, and 2435 months of age. A) LSK frequency per 1x106 nucleated cells. *p<0.001 Wt 20-21 vs.
24-45 mo; #p=0.002 Foxn1Tg 24-35 vs. Wt 24-25 mo. B) Total LSK in two tibias and
two femurs. †p=0.01 Wt 20-21 mo. vs. Wt 24-25 mo; §p=0.006 Foxn1Tg 20-21 mo vs.
1-4 mo; ¶p=0.02 Foxn1Tg 20-21 vs. Wt 20-21 mo. ‡p=0.003 Foxn1Tg 20-21 mo vs. 2435 mo.

**

Foxn1Tg 24-35 mo vs. Wt 24-25 mo. Each symbol represents one animal. Half

filled triangles represent Foxn1Tg mice older than 25 months of age. Error bars are SD.
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and 35A p=0.002). With age, the LSK frequency remained unchanged in Foxn1Tg mice
#

(Fig. 34 and 35A).
In agreement with previous reports, when the LSK frequency was used to
calculate the total number of LSK cells, we found no difference in the total number of
LSK between 1-4 and 20-21 months of age in Wt mice (Fig. 34 B) (13). However, we
found that the total number of LSK decreased in Wt BM from 20-21 to 24-25 months of
age (Fig. 35B †p=0.01). The total number of LSK in Foxn1Tg increased from 1-4 to 2021 months of age, and then decreased from 20-21 to 24-35 months of age (Figs. 35B;
§

p=0.006 Foxn1Tg 1-3 vs. Foxn1Tg 20-21 mo; ‡p=0.003 Foxn1Tg 20-21 vs. Foxn1Tg

24-35 mo). The number of LSK cells in Foxn1Tg BM of 20-21 and 24-35 months of age
was higher than Wt 20-21 and 24-25 mo respectively (Fig. 35B, ¶p=0.02 Foxn1Tg 20-21
vs. Wt 20-21; **p=0.006 Foxn1Tg 24-35 mo vs. Wt 24-25 mo). When the frequency and
number of LSK cells in young and aged Wt and Foxn1Tg were analyzed using two way
ANOVA, it was shown that both age and over expression of Foxn1 affect LSK frequency
and number (Fig. 35A and B). It also demonstrated that over expression of Foxn1 can
interact with the affect of age in regulating LSK frequency and number. Thus, over
expression of Foxn1 results in a higher number of LSK in aged mice.
Previous work has demonstrated that the number of nucleated cells is reduced in
Foxn1 mutated nude BM, suggesting that Foxn1 plays a role in BM cellularity (19). The
total number of nucleated cells in Wt and Foxn1Tg BM was calculated to determine if
over expression of Foxn1 affects BM cellularity. Wt and Foxn1Tg mice of 1-4 months of
age had equivalent numbers of BM nucleated cells (Fig. 36). As previously reported, I
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Figure 36: Total number of nucleated cells in the BM of Wt and Foxn1Tg mice 1-4, 2021, and 24-35 months of age. Tibias and femurs were flushed and the total numbers of
nucleated cells from Wt and Foxn1Tg mice were counted using a hemocytometer. Each
symbol represents one mouse. Half filled triangles in Foxn1Tg 24-35 months of age
represent mice 26 months of age or older. Error bars are SD.
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found that the number of BM nucleated cells increased from 1-4 to 20-21 months of age
in Wt; a similar change was also observed in Foxn1Tg mice (Fig. 36) (344). While the
number of nucleated cells remained unchanged in Wt mice from 20-21 to 24-25 months
of age, the number of nucleated cells decreased from 20-21 to 24-35 months of age in
Foxn1Tg mice (Fig. 36). Foxn1Tg 20-21 months of age have a higher number of cells
compared to Wt 20-21 months of age. Two way ANOVA analysis demonstrates that
both age and over expression of Foxn1 affects the number of nucleated cells in the BM,
and that over expression of Foxn1 and aging interact to regulate the number of BM
nucleated cells.

HSC and MPP in Foxn1Tg mice are resistant to age-associated cell death.
To begin elucidating a cellular mechanism by which the numbers of HSC and
MPP in advanced age were higher than aged matched Wt, cell cycle activities of HSC
and MPP in young (2-5 mo) and aged (20-29 mo) Wt and Foxn1Tg mice were analyzed.
Flow cytometry gating for DNA content in single cells is presented in Figure 37. We
confirmed that there was no increase in the percentage of HSC in S,G2/M with age in Wt
mice as previously reported (345) (Fig. 38A). However, aged Foxn1Tg mice had a 1.7fold increase in the percent of HSC in S,G2/M compared with young Foxn1Tg
(§p=0.005) and this increase was significantly higher than in aged Wt (*p=0.001). We
observed no changes in the frequency of MPP in S,G2/M with age in either Wt or
Foxn1Tg (Fig. 38C). In aged Wt mice, we detected a significant increase the percent of
cells in the subG0 fraction of HSC (Fig. 38B #p=0.04). While there was a similar trend in
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Figure 37: Flow cytometry gating for cell cycle analysis of HSC and MPP. Sorted HSC
or MPP were fixed and stained with propidium iodine (PI). Singlet cells were gated
based on the PI width. PI area was used to determine the DNA content.
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Figure 38: Cell cycle analysis of HSC and MPP in young and aged Wt and Foxn1Tg
mice. HSC (A-B) and MPP (C-D) from Wt 2 mo, Foxn1Tg 2-5 mo, Wt 20 mo and
Foxn1Tg 20-29 mo were analyzed for DNA content using propidium iodine. A) Percent
of HSC in S,G2/M. §p=0.005 Foxn1Tg 20-29 mo vs. Foxn1Tg 2-5 mo; *p=0.001
Foxn1Tg 20-29 mo vs. Wt 20 mo. B) Percent of HSC in sub G0. #p=0.04 Wt 2 mo vs.
Wt 20 mo; **p=0.03 Foxn1Tg 20-29 mo vs. Wt 20 mo. C) Percent of MPP in S,G2/M. D)
Percent of MPP in sub G0. ##p=0.005 Foxn1Tg 20-29 mo vs. Wt 20 mo. Numbers in
parentheses denote the number of mice in each group. Error bars are SD.
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MPP, the increase in the subG0 fraction was not significant (Fig. 38D). In contrast, the
percentages of HSC and MPP in subG0 were not significantly different between young
and aged Foxn1Tg. Strikingly, the subG0 fractions of HSC and MPP in Foxn1Tg 20-29
months of age were 3.5-fold (Fig. 38B **p=0.03) and 3.7-fold less compared to Wt mice,
respectively (Fig. 38D ##p=0.005). Thus, in aged Foxn1Tg mice, there was an increase
cell cycling of HSC and reduced cell death of HSC and MPP.
Signaling through the CD117 (c-kit) by SCF is critical for HSC survival (279,
280). Preliminary studies in our laboratory demonstrated that the mRNA levels of SCF
were not different between Wt and Foxn1Tg BM (data not shown). Expression of c-kit
receptors on HSC and MPP from 1-2 and 20-35 months of age Wt and Foxn1Tg was
measured to provide a possible explanation for increased survival of HSC in aged
Foxn1Tg. Although the mean fluorescent intensity of CD117 was higher in aged
Foxn1Tg HSC and MPP, this difference was not statistically different (Fig. 39).

HSC from aged Foxn1Tg are able to generate multipotent colonies.
To determine if HSC from aged Foxn1Tg are functional, we determined their
ability to generate CFU-GEMM using methylcellulose bone marrow cultures. The
methylcellulose BM cultures contained cytokines required for the developmental growth
of myeloid progenitors but not T or B lineage progenitors. Five different types of colony
forming units (CFU) can be produced in methylcellulose cultures and can be
distinguished based on their morphology in Figure 40. Each myeloid progenitor gives
rise to a different colony based on the lineage potentials in that progenitor. HSC have
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Figure 39: Mean fluorescent intensity of CD117 on HSC and MPP from young and aged
Wt and Foxn1Tg mice. Flow cytometry was used to determine the relative MFI of
CD117 on HSC and MPP from 1-2 and 20-35 months of age Wt and Foxn1Tg. Each
sample was normalized to the MFI of positively controlled beads coated with antiCD117. Each symbol represents one animal. Error bars are SD.
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lineage potential for granulocyte, erythroid, monocyte, and megakaryocyte. HSC give
rise to the most heterogeneous colony named a GEMM, which has all four lineage
potentials (Fig. 40E). Compared to young Wt, aged Wt cultures produced fewer GEMM
colonies (Fig. 41 *p=0.03). No significant difference was observed in the ability of aged
Foxn1Tg HSC to give rise to GEMM colonies compared to young Foxn1Tg (Fig 41).
Thus, HSC from Foxn1Tg were able to give rise to multipotent progenitors and the
overall number of functional HSC did not decline with age.

Foxn1Tg BM microenvironment promotes the development of MPP.
In order to examine if the Foxn1Tg BM microenvironment promotes the
development of MPP from HSC, LSK cells from CD45.1 H2-SVEX BM were adaptively
transferred intravenously into non-irradiated 17-21 months of age CD45.2 Wt and
Foxn1Tg hosts. After 10 weeks, the frequencies of donor HSC and MPP were
determined using flow cytometry (Fig. 42). The frequency of donor derived HSC was
lower but not statistically different in aged Foxn1Tg BM compared to aged Wt; however,
despite the lower frequency of donor HSC, the frequency of donor MPP in the aged
Foxn1Tg BM was equivalent to that found in aged Wt (Fig. 43A-B). When the ratio of
MPP to HSC was examined to determine the efficiency of generating MPP from HSC,
the MPP/HSC ratio was higher in aged Foxn1Tg BM compared to Wt, indicating that the
aged Foxn1Tg microenvironment was more effective in promoting the development of
MPP from HSC (Fig. 43C *p=0.03). When the CD45.1pos LSK cells were intravenously
transferred into sub-lethally irradiated host, the subtle difference in donor HSC frequency
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Figure 40: Morphology of colonies generated in methylcellulose from BM nucleated
cells. Representative examples of myeloid colonies CFU-M (A), CFU-GM (B), CFU-G
(C), CFU-E (D), and CFU- GEMM.
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Figure 41: Total number of functional HSC in 2 tibias and 2 femurs of Wt and Foxn1Tg
mice 1-4 and 19-25 months of age. The frequency of GEMM colonies generated per
10,000 nucleated cells was multiplied by the total number of nucleated cells isolated from
two tibias and femurs to determine the total number of functionally active HSC.
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was abolished and the frequency of donor MPP was again equivalent (Fig. 43D-E).
When the efficiency of the generation of MPP was examined by the ratio of MPP to
HSC, the difference in irradiated aged Foxn1Tg and Wt hosts was lost (Fig. 43F). Thus,
the Foxn1Tg BM microenvironment promotes the generation of MPP from HSC;
however, the effect is either neutralized by irradiation or the effector cells are sensitive to
the irradiation treatment.

HSC and MPP from Foxn1Tg display no differences in their intrinsic potential to
commit to T lineage.
The increased generation of MPP from HSC can contribute to a higher number of
ETP in aged Foxn1Tg compared to Wt, however it is also possible that over expression of
Foxn1 increased T lineage potential of HSC and MPP, thus further contributing to an
increase in ETP. T lineage potential of HSC and MPP from 1-4 and 21-32 months of age
Wt and Foxn1Tg was determined in vitro. HSC and MPP were cultured on the OP9-DL1
stromal cell line and their commitment and differentiation to T lineage was determined
by expression of CD90 and CD25. MPP were electronically sorted and cultured on OP9DL1 (GFP) cells for 2 weeks in the presence of IL7, SCF, and Flt3L. After two weeks
cells were harvested and flow cytometry was used to determine T lineage commitment
based on expression of CD90 and T lineage differentiation by expression of CD25 (Fig.
44). No difference was seen in the ability of MPP to commit to T lineage between Wt
and Foxn1Tg 1-4 or 21-32 months of age (Fig. 45). There was also no difference in the
differentiation to the CD25 positive DN2/DN3 stages, indicating that MPP developed in
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Figure 42: Identification of CD45.1pos donor HSC and MPP. CD45.1pos LSK (8,00016,000) were intravenously transferred into aged CD45.2pos Wt and Foxn1Tg (17-21
months) hosts. Ten weeks post transfer host BM cells were analyzed for donor HSC and
MPP. CD45.1pos donor cells that were Linneg Sca1pos CD117pos were separated into HSC
and MPP based on the expression of CD135. HSC are CD135neg and MPP are CD135pos.
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Figure 43: Generation of donor MPP in aged Foxn1Tg and Wt non-irradiated (A-C) and
irradiated (D-E) hosts. The frequency of CD45.1pos donor HSC per 1x106 donor cells in
non-irradiated (A) and irradiated (D) Wt and Foxn1Tg hosts. The frequency of CD45pos
donor MPP per 1x106 donor cells shown in non-irradiated (B) and irradiated (E) Wt and
Foxn1Tg hosts. The generation of donor MPP per donor HSC was examined by the ratio
of donor MPP to donor HSC in non-irradiated (C) and irradiated (F) hosts. †p=0.06. Each
symbol represents one host mouse. Error bars are SD.
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the BM of Foxn1Tg do not have an increase in T potential or differentiation toward T
lineage (Fig. 45).
The commitment and differentiation of HSC in Wt and Foxn1Tg was also
examined. HSC were cultured on OP9-DL1 with SCF, Flt3L, and IL7 for three week
prior to flow cytometry analysis. There was a decrease in the percent of harvested cells
that expressed CD90 with age in Wt HSC cultures (Fig. 46A *p=0.02). Cells harvested
from Foxn1Tg HSC 1-4 months of age had reduced frequency of CD90 expression
compared to aged matched Wt (Fig. 46A #p=0.006). Interestingly, with age there was no
decline in the percent of CD90 positive cells harvested from Foxn1Tg HSC cultures. Of
the committed T lineage cells, there was no difference in the ability to differentiate to
DN2/DN3 stages with age or between Wt and Foxn1Tg (Fig. 46B). Taken together, over
expression of Foxn1 does not increase T lineage potential or differentiation ability of
HSC; in fact, the percent of committed T lineage cells in culture from young Foxn1Tg
was less compared to young Wt.

Notch 3 but not Notch 1 expression is reduced in the BM of Foxn1Tg.
Notch1 signaling has been shown to increase HSC self-renewal (218, 219). The
mRNA levels of Notch 1 were measured in the BM of aged Wt and Foxn1Tg to
determine if the reduced level of CD90 expression in Foxn1Tg HSC cultures could
possibly be the result of increased Notch 1 signaling in the total BM (Fig.47). No
difference in the mRNA expression of Notch 1 was observed in the BM of Wt and
Foxn1Tg 17-20 month of age. However, expression of Notch 1 in total BM may not
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Figure 44: HSC and MPP commitment to T lineage and differentiation to DN2/DN3.
MPP were cultured on OP9-DL1 (GFPpos) for 2 weeks and HSC were cultured on OP9DL1 for 3 weeks in the presence of SCF, Flt3L, and IL7 (10ng/mL each). Cells in culture
that were GFP negative were analyzed for T lineage commitment based on expression of
CD90. Differentiation of CD90pos cell to the TN2/TN3 stages were identified by
expression of CD25 and CD44.

132

1-4 mo
21-32 mo

100

(3)

80

(17)

(3)

60
40
20
0
Wt

Foxn1Tg

(12)

Percent of CD25pos in CD90pos
(%)

Percent of CD90pos cells
(%)

MPP cultured on OP9-DL1

100

(3)

(17)

(3)

(12)

80
60
40
20
0
Wt

Foxn1Tg

Figure 45: Commitment and differentiation of MPP from Wt and Foxn1Tg 1-4 and 2132 months of age. MPP were cultured on OP9-DL1 for 2 weeks and the percent of cells
in culture that committed to T lineage was determined by CD90 expression (A).
Differentiation of HSC to DN2/DN3 was determined based on CD25 expression within
the CD90pos population (B). Error bars are SD. Numbers in parentheses denote the
number of mice.
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Figure 46: Commitment of HSC to T lineage and differentiation to DN2/DN3. HSC
were cultured on OP9-DL1 for 3 weeks and the percent of cells in culture that committed
to T lineage was determined by CD90 expression (A). Differentiation of HSC to
DN2/DN3 was determined based on CD25 expression within the CD90pos population.
(B). *p=0.02 Wt 1-4 mo vs. Wt 21-32 mo; #p=0.006 Foxn1Tg 1-4 mo vs. Wt 1-4 mo.
Error bars are SD. Numbers in parentheses denote the number of mice.
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accurately measure its expression within HSC or in the HSC niche. It was thought that
there is redundancy in the expression of Notch receptors in hematopoiesis; however,
recently it was demonstrated that Notch 3 has a different role compared to Notch 1 in
thymic lymphopoiesis (346). It remains to be determined if Notch 1 and Notch 3 serve
distinct roles in the BM. Interestingly, the expression of Notch 3 mRNA was 58-fold less
in young Foxn1Tg and 60-fold less in aged Foxn1Tg compared to aged matched Wt (Fig.
48). Whether Notch 3 signaling has an affect in HSC homeostasis or differentiation
remains to be determined.

CTP from Foxn1Tg BM displayed higher proliferative signature and efficiently
generated more CIP.
In Foxn1 mutated nude mice, proliferation of CTP is reduced and coupled to a
reduction in the generation of CIP (275). Thus, we determined if first, over expression of
Foxn1 affects CTP proliferation, and promotes their development into CIP and second if
over expression of Foxn1 lead to an increase in the numbers of CTP and CIP with age.
CTP were identified as Linneg CD90pos and CD2neg, and CIP were identified as Linneg
CD90pos CD2pos (Fig. 49). In mice 2-4 months of age, the total number of CTP was not
significantly different between Wt and Foxn1Tg; however, Foxn1Tg had a 2.2-fold
higher number of CIP (Fig. 50A *p<0.001). In aged mice, the numbers of CTP and CIP
increased in both Wt and Foxn1Tg mice. Aged Wt mice displayed a greater increase in
the number of CTP compared to Foxn1Tg (Wt 2-4 mo 101,764 and Wt 21-25 mo
543,883; Foxn1Tg 2-4 mo 130,628 and Foxn1Tg 21-25 mo 295,846) and the number of
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Figure 47: Expression of Notch 1 mRNA in aged Wt and Foxn1Tg BM. RT-PCR was
used to measure the expression of Notch 1 in the BM of Wt and Foxn1Tg 17-20 months
of age. Error bars are SD. Numbers in parentheses denote the number of mice.
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Figure 48: Expression of Notch 3 mRNA in the BM. Total BM cells from 2 mo and 2024 mo Wt and Foxn1Tg BM was used to determine expression of Notch 3 expression
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CTP in 21-25 month old Foxn1Tg was 1.8-fold lower than Wt (Fig. 50B, #p=0.002). In
contrast, the number of CIP was not significantly different between aged Wt and
Foxn1Tg. Thus, while aged Foxn1Tg displayed a lower number of CTP compared to Wt,
the number of CIP generated from this pool were similar between Foxn1Tg and Wt mice.
Aging results in an increase in both CTP and CIP. Over expression of Foxn1 minimizes
the age associated-increase in CTP, resulting in a lower number of CTP in aged Foxn1Tg
compared to Wt. In addition, over expression of Foxn1 increases the efficacy of
generating CIP from CTP.
When the ratios of CIP over CTP were analyzed using two way ANOVA, over
expression of Foxn1 resulted in an increase in the CIP/CTP ratio. The Foxn1Tg mice
displayed higher ratios in both the 2-4 and 21-25 month groups (Fig. 50C, ‡p=0.047
young; §p<0.001 aged), suggesting that Foxn1Tg BM is more efficient in generating CIP
from CTP. Previously, it was determined that the generation of CIP requires proliferation
of CTP {{90 Chatterjea-Matthes,D. 2003}}. To determine a mechanism which promotes
more CIP generation from CTP, we examined the cell cycle activity of CTP and CIP in
Wt and Foxn1Tg using propidium iodine. CTP from both 2-4 and 21-25 months of age
Foxn1Tg mice showed a higher percentage of cells in S,G2/M compared to Wt (Fig. 51
*

p=0.002, 2-4 months; #p=0.054 21-25 months). There were no differences observed in

cell cycle activities of CIP in Wt and Foxn1Tg mice. With age, we observed no changes
in the cell cycle activity of CTP and CIP. These findings provide direct evidence that the
BM of Foxn1Tg promotes proliferation of CTP and support the previous notion that
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Figure 49: Flow cytometry identification of CTP and CIP. CTP were defined as cells
that are Linneg CD90pos and CD2neg. CIP cells were defined as Linneg CD90pos and
CD2pos.
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Figure 50: Number of CTP and CIP and the generation of CIP in Wt and Foxn1Tg with
age. A) Total CTP and CIP in two tibias and two femurs young (2-4 mo) Foxn1Tg and
Wt mice; *p<0.001 CIP in Wt vs. Foxn1Tg. B) Total CTP and CIP in aged (21-25 mo)
Foxn1Tg and Wt BM. The total numbers of CTP and CIP increased with age in both Wt
and Foxn1Tg (p<0.001 young Wt CTP vs. aged Wt CTP; p=0.006 young Foxn1Tg CTP
vs. aged Foxn1Tg CTP; p<0.001 young Wt CIP vs. aged Wt CIP; 0.002 young Foxn1Tg
CIP vs. aged Foxn1Tg CIP). However, aged Foxn1Tg had fewer CTP than aged Wt
#p=0.002 CTP in Wt vs. Foxn1Tg. C) Ratio of CIP over CTP in Wt and Foxn1Tg;
‡p=0.047 and §p<0.001 were comparisons of Wt vs. Foxn1Tg. Numbers in parentheses
denote number of mice in each group. Error bars are SD.
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Figure 51: Cell cycle activity of CTP and CIP in Wt and Foxn1Tg mice with age.
Electronically sorted CTP and CIP from 2-4 and 21-25 mo Wt and Foxn1Tg were
analyzed for DNA content using propidium iodine and flow cytometry. Data represent
the percent of cells in S,G2/M phase. *p=0.002 CTP from 2-4 mo Foxn1Tg vs. Wt;
#p=0.054 CTP from 21-25 mo Foxn1Tg vs. Wt. Numbers in parentheses denote the
number of mice in each group. Error bars are SD.
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Foxn1 plays a role in the proliferation of CTP which is required for the generation of CIP
(275).

Foxn1Tg microenvironment promotes the development of CIP.
To confirm that the BM environment of Foxn1Tg is more efficient in the
generation of CIP from CTP, donor CD45.1pos LSK cells (8,000-16,000) were transferred
intravenously into non-irradiated CD45.2pos Wt and Foxn1Tg 17-21 months of age. After
10 week, the BM was harvested from host mice and the frequency of donor CTP and CIP
was determined. Identification of donor CTP and CIP is showed in Figure 52. Although
not statistically different, the frequencies of donor CTP was lower in aged Foxn1Tg
compared to aged Wt host while the frequencies of donor CIP in Foxn1Tg and Wt were
equivalent (Fig. 53 A-B). The ratios of donor CIP to donor CTP were used to determine
the efficacy of generating CIP from CTP. Aged Foxn1Tg had a higher ratio of CIP to
CTP compared to aged Wt hosts (Fig. 53C). To increase engraftment of donor cells, we
repeated the experiment in which aged Wt and Foxn1Tg hosts were sub-lethally
irradiated 24 hours prior to adaptive transfer of donor CD45.1pos LSK cells. Sub-lethally
irradiated Wt and Foxn1Tg hosts had equivalent donor frequencies of CTP and CIP (Fig.
53 D and E) and the generation of CIP from CTP in Wt and Foxn1Tg was not
significantly different as determined by CIP to CTP ratios (Fig. 53F). Thus, as seen with
HSC, the Foxn1Tg BM microenvironment promotes the generation of CIP from CTP;
however, the effect is either neutralized by irradiation or the effector cells are sensitive to
the irradiation treatment.
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Figure 52: Flow cytometer gating on donor CTP and CIP. Donor CD45pos cells were
gated for cells that lack lineage specific markers but were CD90pos CD2neg (CTP) and
CD90pos CD2pos (CIP).
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Figure 53: Generation of CIP in aged Foxn1Tg and Wt non-irradiated (A-C) and
irradiated (D-E) hosts. The frequency of CD45.1pos donor CTP (A and C) and CIP (B
and D) per 1x106 donor cells in non-irradiated and irradiated Wt and Foxn1Tg hosts was
determined 10 weeks after injection using flow cytometry. The generation of donor CIP
donor per CTP was examined by the ratio of CIP to CTP in non-irradiated (C) and
irradiated (F) host. †p=0.06. Each symbol represents one host mouse. Error bars are SD.
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Summary
Although the number of MPP decline with age in Wt mice, this population
remained unchanged in Foxn1Tg. Aged Foxn1Tg had fewer MPP undergoing cell death
compared to aged Wt. One progeny of MPP is the ETP, thus the maintained number of
MPP in aged Foxn1Tg may contribute to the higher number of ETP found in the aged
Foxn1Tg thymus. Over expression of Foxn1 does not prevent changes in the HSC
population with age; however, Foxn1Tg mice have a larger HSC pool compared to Wt
mice. Aged Foxn1Tg mice 24-35 months of age have higher percent of HSC in cell cycle
with reduced cell death. While the number of HSC that generate multipotent
progenitors decreased with age in Wt, this did not occur in aged Foxn1Tg. Furthermore,
the aged Foxn1Tg BM microenvironment promoted the generation of MPP from HSC.
Cultures of HSC and MPP on OP9-DL1 demonstrated that HSC and MPP from Foxn1Tg
did not have increased T lineage potential compared to Wt. While a role for Foxn1 in the
development and function CTP remains controversial, this chapter demonstrates that over
expression of Foxn1 increased CTP cell cycle and promoted the development of CIP
from CTP. Taken together, data from this chapter demonstrated a novel function of
Foxn1 in promoting the development of T cell progenitors within the BM.

CHAPTER V
B CELL AND MYELOID PROGENITORS IN FOXN1TG BM
Introduction
MPP are multipotent progenitors that have lost the ability to self renew and are
the immediate progeny of HSC (241, 244). MPP are precursors for ETP that are found in
the thymus, as well as CLP, and myeloid progenitors in the BM (246, 253, 255). I
showed in Chapter III that the number of MPP declined with age in Wt BM but not
Foxn1Tg BM. I also determined that the frequency of ETP, precursor for T lineage cells
within the thymus declined with age in Wt mice but not Foxn1Tg (347). CLP in the BM
display potent B lineage potential and are precursors for B cells (82). With age, the
number CLP declines, resulting in reduced B lymphopoiesis (329, 330). I asked whether
maintaining the MPP pool with age in Foxn1Tg also maintains CLP and B
lymphopoiesis. MPP also give rise to myeloid progenitors; however, the numbers of
myeloid progenitors are not affected by age (330). To obtain a comprehensive view of
hematopoiesis in Foxn1Tg, I also determined whether high levels of Foxn1 altered the
numbers of myeloid progenitors in young and aged Foxn1Tg mice. This chapter will
address whether the effect of over expressing of Foxn1 is specific to T lineage
progenitors or whether high levels of Foxn1 expression also affect the development of B
lineage and myeloid lineage progenitors from MPP.
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Results
Distributions of hematopoietic lineages in the BM of Wt and Foxn1Tg mice.
Analysis of BM cells was performed using flow cytometry to determine if high
levels of Foxn1 altered the distribution of myeloid-, erythroid-, and B- lineage cells with
age. Compared to young (2 mo), aged Wt BM (18 mo) had a 5-fold expansion of Ter 119
positive erythroid lineage cells (p<0.001) and a 2-fold contraction in the B220/CD19
positive B lineage compartment (Fig. 54). There was no change in the percent of
GR1/CD11b myeloid lineage population in aged Wt BM compared to young Wt (Fig.
54). Compared to young Wt (2 mo) months of age, young Foxn1Tg (2-5 mo) had a 1.7fold increase in the percent GR1/CD11b myeloid lineage cells and a 1.8-fold decrease in
the percent of the B220/CD19 B lineage cells (Fig. 54 **p<0.001 myeloid
lineage;*p<0.001 B lineage). In aged Foxn1Tg (17-29 mo), there was no significant
expansion of the Ter 119 positive erythroid lineage but there was a 1.4 fold expansion in
the percent of myeloid lineage cells (p<0.001) compared to young Foxn1Tg (2-5 mo).
Similar to Wt mice, with age there was a 3.2-fold contraction of the B lineage population
in aged Foxn1Tg compared to young Foxn1Tg (p<0.001). When compared to aged Wt,
the BM of aged Foxn1Tg mice had 3 fold less B lineage cells and erythroid cells, and 2.2
fold more myeloid lineage cells (Fig. 54 #p<0.001 B lineage; ###p<0.001 erythroid
lineage; ##p<0.001 myeloid lineage). Overall, the percentage of B lineage cells was lower
while the percentage of cells in the myeloid compartment was higher in Foxn1Tg
compared to aged matched Wt. A summary of all significant comparisons can be found
in Table IV.
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Figure 54: Analysis of hematopoietic lineages with age in Wt and Foxn1Tg mice. One
to two million nucleated cells from the bone marrow of 2-5 and 17-29 months of age Wt
and Foxn1Tg were analyzed for cell surface expression of B lineage markers CD19 and
B220, myeloid lineage marker Gr1 and CD11b, T lineage marker CD3, NK lineage
marker DX5, and erythroid lineage marker Ter119 using flow cytometry. Cells that did
not express any of these markers were grouped into an “other” category that includes the
lineage marker negative population and stromal cells. *p<0.001 B220/CD19 percent Wt
2-5 mo vs. Foxn1Tg 2-5 mo. **p<0.001 Gr1 / CD11b percent Wt 2-5 mo vs. Foxn1Tg 2-5
mo. #p<0.001 B220/CD19 percent Wt 17-29 mo vs. Foxn1Tg 17-29 mo.

##

p<0.001

Gr1/CD11b percent Wt 17-29 mo vs. Foxn1Tg 17-29 mo. ###p<0.001 Ter119 percent Wt
17-29 mo vs. Foxn1Tg 17-29 mo.
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Table IV.
Lineage Population
B220 / CD19 lineage
B220 / CD19 lineage
B220 / CD19 lineage
B220 / CD19 lineage
Gr1 / CD11b lineage
Gr1 / CD11b lineage
Gr1 / CD11b lineage
Ter119 lineage
Ter119 lineage
Other

Comparisons
Wt 2-5 mo vs. Wt 17-29 mo
Foxn1Tg 2-5 mo vs. Foxn1Tg 17-29 mo
Wt 2-5 mo vs. Foxn1Tg 2-5 mo
Wt 17-29 mo vs. Foxn1Tg 17-29 mo
Foxn1Tg 2-5 mo vs. Foxn1Tg 17-29 mo
Wt 2-5 mo vs. Foxn1Tg 2-5 mo
Wt 17-29 mo vs. Foxn1Tg 17-29 mo
Wt 2-5 mo vs. Wt 17-29 mo
Wt 17-29 mo vs. Foxn1Tg 17-29 mo
Wt 2-5 m o vs. Wt 17-29 mo

P values
p<0.001
p<0.001
p<0.001
#
p<0.001
p<0.001
**
p<0.001
##
p<0.001
p<0.001
###
p<0.001
p<0.001

Changes in the BM lineage compartments of Wt and Foxn1Tg mice with age. B lineage
cells were defined as B220 and/or CD19 positive. Myeloid lineage was identified as Gr1
and/or CD11b positive. Erythroid lineage was defined as Ter119 positive. Cells that did
not fall into these categories were grouped into an “other” category which would include
the lineage negative cells as well as stromal cells of the BM.
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Number of B lineage cells and CLP are reduced in Foxn1Tg.
Compensatory changes in the frequency of one BM lineage population may result
in the expansion or contraction in other hematopoietic lineages. Thus, the absolute
numbers of B-lineage cells were calculated to determine if Foxn1Tg mice have fewer Blineage cells compared to aged matched Wt. The total number of B-lineage cells was
reduced 1.7-fold in young Foxn1Tg mice compared to young Wt (Fig. 55 #p=0.01). With
age, the total number of B-lineage cells decline 1.6-fold in Wt mice and 3-fold in
Foxn1Tg (Fig. 55 *p=0.007 Wt; †p=0.002 Foxn1Tg). Further, aged Foxn1Tg mice had a
3-fold lower number of B-lineage cells compared to aged Wt (Fig. 55 §p=0.004). Two
way ANOVA analyses revealed that age results in a reduction in the number of B-lineage
cells. Furthermore, over expression of Foxn1 also results in a lower number of B-lineage
cells and does not prevent the decline with age as seen with MPP. In correlation with the
reduced frequency of B-lineage cells, the absolute number of B-lineage cells was also
significantly reduced in Foxn1Tg compared to aged matched Wt
CLP are B cell progenitors and the number of CLP decline with age in Wt BM,
contributing to the reduced number of B-lineage cells in aged Wt mice (82, 329, 330).
Based on this knowledge, we hypothesized that the reduced frequency and number of Blineage cells in Foxn1Tg could result from a decrease in the number of CLP. CLP were
identified using flow cytometry as Linneg CD127pos CD117low Sca1pos and CD135pos (Fig.
56). Foxn1Tg mice 1-2 months of age had a decreased frequency and number of CLP
compared to Wt 1-2 months of age (Fig. 57 A-B). In agreement with previous reports,
(329, 330), the frequency and number of CLP declined with age in Wt and Foxn1Tg BM
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Figure 55: The number of B lineage cells in 2-3 and 17-18 months of age Wt and
Foxn1Tg BM. B lineage cells were identified as lymphocytes that expressed B220 and/or
CD19. *p=0.007 Wt 21-22 mo vs. Wt 2-3 mo; #p=0.01 Foxn1Tg 2-3 mo vs. Wt 2-3 mo;
†

p=0.002 Foxn1Tg 17-18 mo vs. Foxn1Tg 2-3 mo; §p=0.004 Foxn1Tg 17-28 mo vs. Wt

17-18 mo. Numbers in parentheses denotes the number of mice in each group. Error
bars are SD. Bone marrow cells from male and female mice were pooled as no sex
difference was observed.
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Figure 56: Identification of CLP. CLP were identified as nucleated cells that were Linneg
CD127pos CD117low Sca1low and CD135pos.
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Figure 57: A: Frequency and number of CLP in Wt and Foxn1Tg 1-2 and 21-23 months
of age. A) CLP frequency. *p<0.001 Wt 21-23 vs. Wt 1-2 mo; #p<0.001 Wt 1-2 vs.
Foxn1Tg 1-2 mo; **p<0.001 Foxn1Tg 21-23 mo vs. Foxn1Tg 1-2 mo; ##p<0.001 Wt 2123 mo vs. Foxn1Tg 21-23 mo. B) Number of CLP in two tibias and two femurs.
*

p=0.004 Wt 1-2 vs. Wt 21-23 mo; #p=0.005 Wt 1-2 mo vs. Foxn1Tg 1-2 mo; **p<0.001

Foxn1Tg 1-2 mo vs. Foxn1Tg; ##p<0.001 Wt 21-23 mo vs. Foxn1Tg 21-23 mo. Each
symbol represents one mouse. Error bars are SD.
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(Fig. 57 A-B). The frequency and number of CLP in Foxn1Tg 21-23 months of age was
less than in Wt 21-23 months of age (Fig. 57 A-B). This is supported by the two way
ANOVA in which CLP frequency and number are reduced with age. Over expression of
Foxn1 also results in a decline in CLP frequency and number and over expression of
Foxn1 does not prevent the decline with age. Together these data suggest that the
reduced number of B-lineage cells in the BM of Foxn1Tg results from a reduction in the
generation of CLP from MPP or survival of CLP in Foxn1Tg BM in both young and aged
mice.
The generation of CLP from MPP requires Flt3 signaling (284-286).
Preliminarily data from our laboratory suggest that there is no difference in the mRNA
expression of Flt3L in total BM of Foxn1Tg compared to Wt (data not shown). The
expression level of the CD135 or Flt3, the receptor for Flt3L, on MPP was measured via
flow cytometry to determine if changes in the expression of CD135 is a possible
mechanism for the reduced number of CLP in Foxn1Tg BM. Two way ANOVA analysis
of the mean fluorescent intensity of CD135 on MPP revealed that over expression of
Foxn1 affects the expression level of CD135 (Fig. 58). Both young and aged Foxn1Tg
mice have a higher expression level of CD135 on MPP compared to Wt (Fig. 58). From
these data we conclude that the reduced number of CLP in Foxn1Tg mice is not the result
of reduced CD135 expression on MPP. Whether signaling through CD135 on Foxn1Tg
MPP is effective remains to be determined.
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Figure 58: Mean fluorescent intensity of CD135 on MPP from young and aged Wt and
Foxn1Tg mice. Flow cytometry was used to determine the relative MFI of CD135 on
MPP. Each sample was normalized to the MFI of positively controlled beads coated with
anti-CD135 and ran in the same experiment. The expression of CD135 (Flt3) is not
affected by age, however Foxn1Tg MPP had a higher expression level of CD135
compared to Wt (p=0.002). Each symbol represents one animal. Error bars are SD.
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Myeloid progenitors in Foxn1Tg BM
As mentioned above, the frequency of myeloid lineage cells was higher in
Foxn1Tg mice compared to Wt. Thus, the total numbers of myeloid lineage cells were
determined in Wt and Foxn1Tg with age. Foxn1Tg mice 2-5 months of age had a higher
number of myeloid lineage cells compared to aged matched Wt (Fig. 59 *p<0.001). With
age there was no change in the number of myeloid lineage cells in the BM of Wt;
however, there was an increase in aged Foxn1Tg (Fig. 59 ‡p<0.001). Furthermore,
Foxn1Tg 17-29 months of age had more myeloid lineage cells in the BM compared to
aged matched Wt (Fig.59 #p<0.001). Two way ANOVA analyses indicated that with age
the number of myeloid lineage cells increase in Foxn1Tg but not Wt, and over expression
of Foxn1 resulted in a higher number of myeloid lineage cells compared to aged matched
Wt. Additionally, over expression of Foxn1 alters the effect of age on the number of
myeloid lineage cells as there is no increase with age in Wt, but a significant increase
with age in Foxn1Tg.
Methylcellulose cultures were performed to determine if a higher number of
myeloid lineage cells in the BM of Foxn1Tg were a result of a higher number of myeloid
progenitors. Methylcellulose cultures were performed in duplicate using 10,000
nucleated BM cells from Wt and Foxn1Tg 1-4 and 19-28 months of age. The number of
myeloid colonies and the type of each colony generated per 10,000 cells was used to
calculate the total number of myeloid progenitors as well as the total number of each
CFU-M, CFU-GM, CFU-G, CFU-E progenitors. The total numbers of myeloid
progenitors in Foxn1Tg 1-4 months of age was equivalent to aged matched Wt (Fig. 60).
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Figure 59: Number of Gr1/CD11b myeloid lineage cells in Wt and Foxn1Tg 1-5 and 1729 months of age. Foxn1Tg have a significantly higher number of myeloid lineage cells
compared to aged matched Wt. In aged mice the number of myeloid lineage cells
increased in Foxn1Tg but not in Wt. *p<0.001 Foxn1Tg 1-5 mo vs. Wt 1-5 mo; #p<0.001
Foxn1Tg 17-29 mo vs. Wt 17-29; ‡p<0.001 Foxn1Tg 17-29 mo vs. Foxn1Tg 1-5 mo.
Numbers in parentheses denotes the number of mice. Error bars are SD.
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With age, the total number of myeloid progenitors did not change in either Wt or
Foxn1Tg, and aged Foxn1Tg have the same number as aged Wt (Fig. 60). The total
number of CFU-M, CFU-GM, CFU-G, and CFU-E was calculated to determine if there
were any differences in the type of myeloid or erythroid progenitors between Wt and
Foxn1Tg mice (Fig. 61A-B). No differences between Wt and Foxn1Tg mice were seen
in the total number of each type of myeloid progenitor or erythroid progenitor; there were
also no changes in the total number of these colonies with age. Thus the increase in the
number of myeloid lineage cells in Foxn1Tg compared to Wt is not the result of an
increase in the number of myeloid progenitors but is likely to be the result of an increase
in the number of mature myeloid cells due to proliferation.

Summary
This chapter determined if over expression of Foxn1 affected the B and myeloid
lineages of hematopoiesis. Young and aged Foxn1Tg mice had a higher number of
myeloid lineage cells compared to aged matched Wt. The increase in the number of
myeloid lineage cells was not the result of an increase in the number of myeloid
progenitors, and over expression of Foxn1 did not appear to affect the development of
myeloid progenitors from MPP. The increased number of myeloid lineage cell is likely
the result of increased proliferation and expansion of mature myeloid cells. The number
of B-lineage cells was reduced in young and aged Foxn1Tg BM compared to aged
matched Wt, thus the number of available niches for myeloid expansion may be higher in
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Figure 60: Number of myeloid CFU in the BM of Wt and Foxn1Tg 1-4 and 18-28 mo.
Numbers in parentheses denotes the number of mice. Error bars are SD.
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Figure 61: Number of CFU-M, CFU-GM, CFU-G, and CFU-E colonies in Wt and
Foxn1Tg 1-4 and 19-28 months of age. A) Number of CFU-M and CFU-GM in Wt and
Foxn1Tg 1-4 and 19-28 months of age. B) Number of CFU-G and CFU-E in Wt and
Foxn1Tg 1-4 and 19-28 months of age. Numbers in parentheses denotes the number of
mice. Error bars are SD.
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Foxn1Tg BM. The reduced number of B-lineage cells in young and aged Foxn1Tg mice
compared to Wt was the result of a reduced numbers of CLP, an immediate progeny of
MPP (246). In aged Foxn1Tg, while the number of MPP was not reduced with age, the
number of CLP declined. Previously we demonstrated that the frequency of ETP did not
decline with age in Foxn1Tg. Since ETP are also a progeny of MPP this suggests that
over expression of Foxn1 affects lymphoid development at the level of the MPP,
resulting in reduced number of CLP but maintained development of ETP. Development
of MPP towards ETP instead of CLP may result from differences in the expression of
Flt3. Flt3 signaling is required for the generation of CLP and its expression is higher on
MPP in Foxn1Tg mice compared to Wt mice. (284-286). However, Flt3 signaling is also
required for the generation of CCR9pos MPP (ELP) (254). MPP with the highest level of
Flt3 have greater T lineage potential than B lineage, thus the higher level of Flt3
expression on Foxn1Tg MPP may reflect the commitment of this population to T lineage
over B lineage.

CHAPTER VI
FOXN1 EXPRESSION IN THE BM
Introduction
It is well known that Foxn1 is expressed in the thymus and skin (16); however,
expression of Foxn1 in other organs has not been extensively investigated. Potential
functions for Foxn1 in the BM have been suggested from previous study in nude mice in
which the Foxn1 gene is mutated. BM from nude mice display reduced HSC function
and generation of committed intermediate progenitors (CIP) (19, 275). Interestingly,
over expression of Foxn1 in aged Foxn1Tg mice resulted in a higher number of HSC and
MPP compared to aged Wt (Refer to Chapter III). Furthermore, the aged Foxn1Tg
microenvironment supports the generation of MPP and CIP (refer to Chapter III).
Surprisingly, the numbers of CLP and B-lineage cells were reduced in Foxn1Tg BM
compared to aged matched Wt (refer to Chapter IV). Taken together, these data indicate
that over expression of Foxn1 affects the development of lymphoid progenitors in the
BM. The effect of over expression of Foxn1 on progenitors in the BM with age can be
the result of endocrine functions of the thymus acting on the BM, or alternatively Foxn1
is expressed in the BM. The focus of this chapter was first to determine if Foxn1 is
expressed in the BM, and second to identify Foxn1 expressing BM cells in Wt as well as
in Foxn1Tg mice.
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Results
Foxn1 is expressed in the BM of Wt and Foxn1Tg mice.
Foxn1 is expressed in epithelial cells of the thymus and skin and plays a critical
role in thymic organogenesis and hair follicle development, respectively (16).
Alterations in hematopoietic lineages in the BM of Foxn1Tg provides a functional basis
to investigate if Foxn1 is expressed in the BM of Wt and Foxn1Tg. Figure 62A reveals
that Foxn1 is expressed in the BM of Wt (1-3 months of age) mice (414 copies / μg of
total RNA). Contrary to the thymus (14), expression of Foxn1 in the BM of Wt mice was
not changed with age (Fig. 62A). In Foxn1Tg, the total level of Foxn1 expression
(transgene and endogenous) was 98-fold higher than Wt mice (Fig. 62B). In agreement
with Wt BM, the mRNA expression level of Foxn1 did not change with age in Foxn1Tg
mice (Fig. 62B). As previously shown in the thymic stroma of Foxn1Tg mice,
expression of the Foxn1 transgene increased expression of the endogenous Foxn1 (Fig.
62A-B). The endogenous Foxn1 levels were 18-24 fold higher in young and aged
Foxn1Tg mice compared to age matched Wt (Fig. 62B compared to Fig. 62A, young
p=0.036; aged p=0.024). Thus Foxn1 is expressed in the BM of Wt mice, and over
expressed in the BM of Foxn1Tg.

Foxn1pos cells are present in the BM of Wt and Foxn1Tg mice.
Foxn1-expressing cells can be detected in the BM of Wt and Foxn1Tg mice using
immunohistochemistry. On the average, 1-3 Foxn1pos cells were identified per 5 sternum
sections (5μm) in young Wt. The Foxn1pos cells appeared as single cell in the central
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Figure 62: Expression of Foxn1 mRNA in the bone marrow of Wt and Foxn1Tg mice.
Quantitative RT-PCR was used to determine the number of Foxn1 copies per μg of RNA
A) Expression of Foxn1 in Wt BM 2 mo and 20-24 mo. B) Expression on Foxn1 in
Foxn1Tg 2 mo and 23-28 mo. Primers that do not distinguish endogenous Foxn1 from
transgene Foxn1 were used to determine the total level of Foxn1. Primers specific for
just the Foxn1 transgene were used to calculate the contribution of the Foxn1 transgene to
the total Foxn1 level. The endogenous Foxn1 level was determined by subtracting the
transgene level from the total Foxn1 level. Samples were run in triplicate. Numbers in
parentheses denotes the number of mice in each group. Error bars are SD.
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marrow cavity in close proximity to sinusoids (Fig. 63). In the BM of young Foxn1Tg
mice, Foxn1pos cells were readily detectable within the vicinity of sinusoids at
approximately 3-6 cells per 5μm-thick section (Fig. 63). Morphologically, the Foxn1
expressing cells were round with abundant cytoplasm and a central nucleus (Fig. 63).
Foxn1 protein appeared homogeneous in the cytoplasm or in patches. In aged Wt and
Foxn1Tg BM, the number of readily detectable Foxn1pos cells per BM section increased;
however, it appeared that there were more Foxn1 expressing cells in aged Foxn1Tg BM
compared to aged Wt.

Foxn1 is not expressed in HSC or MPP.
As shown in the chapter III, HSC and MPP declined in aged Wt mice; however,
their numbers were higher in aged Foxn1Tg. The higher number of HSC and MPP in
aged Foxn1Tg may be in part the result of increase HSC cell cycle and reduced cell death
of HSC and MPP. Based on the morphology of Foxn1pos cells identified in the BM it was
unlikely that HSC and MPP expressed Foxn1. To definitely rule out that HSC and MPP
cell cycle activity in aged Foxn1Tg is the result of intrinsic Foxn1 expression, HSC and
MPP from aged Wt and Foxn1Tg were electronically sorted and RT-PCR was used to
determine Foxn1 expression. Figure 64 reveals that neither HSC nor MPP from Wt or
Foxn1Tg mice express Foxn1.
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Figure 63: Foxn1 staining in Wt and Foxn1Tg BM. Sternums from Wt and Foxn1Tg
mice were fixed, decalcified, embedded in paraffin blocks, and sectioned at 5 microns.
Antigen retrieval was performed using Dako’s antigen retrieval solution and sections
were stained with either rabbit anti-mouse Foxn1 or rabbit IgG at 2μg/ml. Primary
antibodies were incubated overnight at 4°C. Dako Universal LSAB kit or donkey antirabbit biotin (6μg/ml) followed by streptavidin-HRP was used for detection of primary
antibody. Sections were developed with AEC for 1.5 minutes and counterstained with
hematoxylin. Pictures were taken using a Leitz Diaplan microscope with Retiga 2000R
camera. Pictures represent staining from approximately 4-5 mice per group. Yellow
arrows point to Foxn1 positive cells. Sinusoids are outlined in blue and denoted with an
S.
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Figure 64: Foxn1 is not expressed in HSC and MPP. HSC and MPP were electronically
sorted from the BM of Wt and Foxn1Tg mice and RT-PCR was used to determine if HSC
and MPP express Foxn1.
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cells.

In effort to begin to determine a phenotype of the Foxn1pos cells, BM cells from
an aged Foxn1Tg mouse were electronically sorted based on the expression of CD45,
which is a hematopoietic cell marker. RT-PCR was used to determine if Foxn1 was
expressed within the CD45pos or CD45neg population. In the thymus, Foxn1 is expressed
within CD45neg TEC (17, 18). To our surprise, in Foxn1Tg mice, Foxn1 was expressed
within the CD45pos population in the BM (Fig. 65). A percoll gradient was used to
separate fractions of BM cells from Wt mice based on cell density. This gradient allowed
for isolation of an adipose layer, a middle layer which we would expect to find epithelial
cells and stromal cells, and a dense bottom layer that contains predominantly
hematopoietic CD45pos cells. Since Foxn1Tg BM cells expressed Foxn1 in CD45pos cells,
we expected that the dense layer of the percoll gradient in Wt mice would express Foxn1.
Indeed, Foxn1 was expressed in the third percoll layer from young and aged Wt BM cells
(Fig. 66).

A subset of Linneg/low EpCAMpos Syndecan-1neg cells express Foxn1.
In the thymus, medullary thymic epithelial cells (mTEC) are the predominant
TEC expressing Foxn1 (17). Medullary TEC also express EpCAM (348). Thus, I set out
to determine if a population of cells in the BM of Wt and Foxn1Tg mice expresses
EpCAM. EpCAMpos cells were identified in both Wt and Foxn1Tg BM amongst the
Linneg/low population (Fig. 67). With age the frequency of the Linneg/low EpCAMpos cells
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Figure 65: Foxn1 is expressed in CD45pos cells. Tibias and femurs from a Foxn1Tg
mouse were flushed and BM cells were sorted for CD45pos and CD45neg subsets. RTPCR was used to measure if Foxn1 expressed in CD45neg and CD45pos cells. Vertical
lines represent repositioning of gel.
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Figure 66: Foxn1 expression in the third fraction of a percoll gradient in Wt BM.
Young and aged Wt BM cells were separated into three fractions based on density using a
percoll gradient. The densest fraction in young and aged Wt BM expressed Foxn1.
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increased in both Wt and Foxn1Tg mice; however, the frequency was higher in aged
Foxn1Tg compared to aged Wt (Fig. 67).
Linneg/low EpCAMpos cells were electronically sorted from aged Foxn1Tg BM and
assessed for Foxn1 expression by immunohistochemistry staining. We determined that
12.8% of the Linneg/low EpCAMpos cells were positive for Foxn1 in aged Foxn1Tg mice
(Fig. 68). Plasma cells also express EpCAM (349) and have a morphology similar to the
Foxn1pos cells found in the BM. The Linneg/low EpCAMpos population was sorted for cells
that were negative for Syndecan-1, a common marker of plasma cells (350) (Fig. 69).
We determined that 23% and 40% of the Linneg/low EpCAMpos were negative for
Syndecan-1 in Wt and Foxn1Tg, respectively. Among the Syndecan-1neg population on
average 45% and 68% of these cells were positive for Foxn1 in Wt and Foxn1Tg,
respectively (Fig. 69). The frequencies of Linneg/low EpCAMpos Syndecan-1neg Foxn1pos
cells per 100,000 BM nucleated cells were 3±1 in old Wt mice and 95±49 in old Foxn1Tg
mice (Fig. 70). This was the first finding showing that Foxn1 is expressed in the BM by
a subset of cells within the Linneg/low EpCAMpos Syndecan-1neg population..
To further support that Foxn1 is expressed in the BM, I assessed the endogenous
Foxn1 promoter activity in BM isolated from the Foxn1cre-Lac Z reporter mice in which
the Foxn1 promoter drives the expression of the E.Coli LacZ gene encoding βgalactosidase. Electronically sorted Linneg/low EpCAMpos Syndecan-1neg BM cells from
Foxn1cre-LacZ mice were stained with an anti-β-galactosidase antibody. Figure 71
shows that β-galactosidase expressing cells were morphologically identical to the
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Figure 67: Identification of Linneg/low EpCAMpos BM cells. Flow cytometry was used to
determine the frequency of Linneg/low EpCAMpos cells in the BM of Wt and Foxn1Tg 3-4
and 18-23 months.
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B

Figure 68: Linneg/low EpCAMpos cells from Foxn1Tg mice 18-23 months of age were
electronically sorted and stained with rabbit anti-mouse Foxn1 2μg/mL (A) or rabbit IgG
(B). Approximately 12.8% of Linneg/low EpCAMpos cells in from aged Foxn1Tg express
Foxn1. Panel A represents only positive cells with in the Linneg/low EpCAMpos subset from
3 aged Foxn1Tg mice.
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Figure 69: Foxn1 expression in Linneg/low EpCAMpos Syndecan-1neg cells from aged
Foxn1Tg and Wt mice. Linneg/low EpCAMpos Syndecan-1neg cells from Foxn1Tg (23 mo)
and Wt (24 mo) were electronically sorted and stained for Foxn1 (A and C) or rabbit IgG
(B and D). Approximately 23% and 40% of Linneg/low EpCAMpos Syndecan-1neg cells from
Wt and Foxn1Tg express Foxn1 respectively. Panels A and C depict only positive cells.
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Figure 70: Frequency of Foxn1pos cells in the BM of aged Wt and Foxn1Tg mice 18-23
mo. The frequency of Foxn1pos cells was determined by multiplying the percent of
Foxn1pos cells within the sorted Linneg/low EpCAMpos Syndecan-1neg population by the
frequency of Linneg/low EpCAMpos Syndecan-1neg cells in total BM. Numbers in
parenthesis denoted the number of mice in each group. Error bars are SD.
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Figure 71: Endogenous Foxn1 promoter is active in the aged BM. Linneg/low EpCAMpos
Syndecan-1neg cells from the BM of Foxn1-lacZ mice 24 months of age were stained with
rabbit anti-E.coli β-galactosidase or rabbit IgG.
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population of Foxn1Tg and Wt

mice. Thus, the endogenous Foxn1 promoter is active in the BM cells.

Summary
This chapter demonstrated that Foxn1 is expressed in the BM of Wt mice and
over expressed in the BM of Foxn1Tg mice. Contrary to the thymus, the mRNA
expression level of Foxn1 in the BM did not decline with age. However, with age the
number of Foxn1pos cells increased in both Wt and Foxn1Tg BM. The transcriptional and
translational regulation of Foxn1 is not known. Since the mRNA levels did not change
with age, but the number of Foxn1pos cells detected in situ increased, it is possible that
expression of Foxn1 is differentially regulated at the protein levels in aged BM compared
to young BM. Foxn1pos cells were identified within a population of BM cells that are
Linneg/low and EpCAMpos. In agreement with the immunohistochemistry staining showing
that the number of Foxn1pos cells increase with age, the frequency of Linneg/low EpCAMpos
cells increased in aged Wt and Foxn1Tg BM. Thus, it is possible that the number of
Foxn1pos cells found within the Linneg/low EpCAMpos population increases with age.
However, this scenario does not correlate with the mRNA expression level of Foxn1.
Quantitative RT-PCR analysis on the sorted Linneg/low EpCAMpos cells would clarify
whether the mRNA expression level of Foxn1 increases with age. However, since the
frequency of Linneg/low EpCAMpos cells in the BM of young Wt and Foxn1Tg mice is very
low, the approach is technically challenging.

pos

Foxn1
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cells were detected in the BM of Wt and Foxn1Tg mice near sinusoids.

It is possible that the Foxn1pos cells function in the vascular HSC niche where HSC are
proliferating and differentiating into MPP. Morphologically, the Linneg/low EpCAMpos
cells appeared similar to plasma cells which a subset express EpCAM (349). However, a
majority of plasma cells express Syndecan-1 (350). My finding that the Linneg/low
EpCAMpos Syndecan-1neg BM population expressed Foxn1 indicate that they are unlikely
to be plasma cells. Further, sorted Linneg/low EpCAMpos Syndecan-1neg cells from
Foxn1cre-lacZ reporter mice were positive for β-galactosidase, confirming that the
endogenous Foxn1 promoter is active in these cells. Taken together, data from this
chapter demonstrates that Foxn1 is expressed in the BM within a population of Linneg/low
EpCAMpos Syndecan-1neg cells.
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Table I.
Organ

Function

Thymus

Thymocyte
Number
ETP number

Bone Marrow

Age
Effect
Y

Foxn1
Effect
Y

Interaction

Figure

Y

15

Y

Y

Y

18 B

Y

Y

Y

29

Y

Y

Y

28

MHCIIhi mTEC
number
MHCIIpos
mTEC number
Nucleated cell
number
LSK number

Y

Y

Y

36

Y

Y

Y

35 B

HSC number

Y

Y

N

33 B

MPP number

Y

Y

Y

32 B

HSC in S,G2/M N

Y

Y

38 A

HSC in subG0

N

N

Y

38 B

CTP number

Y

Y

Y

50 A-B

CIP number

Y

Y

N

50 A-B

CIP/CTP

N

Y

N

50 C

CTP in S,G2/M

N

Y

N

51

CD135 MFI on
MPP
Myeloid cell
number
CLP number

N

Y

N

58

Y

Y

Y

59

Y

Y

N

57 B

B cell number

Y

Y

N

55

Two way ANOVA analysis summary (more important findings). Table summarized
whether age has an affect on a parameter, whether Foxn1 expression affects the
parameter, and whether over expression of Foxn1 interacts with the age effect.
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Table II.
Organ

Function

Thymus

ETP frequency

Bone Marrow

Age
Effect
N

Foxn1
Effect
Y

Interaction

Figure

Y

18 A

Y
Ki-67 pos
MHCIIhi mTEC
cTEC number
Y

N

N

30

N

N

27

LSK frequency

Y

Y

Y

35 A

HSC frequency

Y

Y

N

33 A

MPP frequency

Y

N

Y

32 A

MPP in S,G2/M N

N

N

38 C

MPP in subG0

N

N

N

38 D

CD117 MFI on N
HSC
CD117 MFI on N
MPP
GEMM number Y

N

N

58 A

N

N

58 B

N

N

41

CIP in S,G2/M

N

N

N

51

CLP frequency

Y

Y

N

57 A

Two way ANOVA analysis summary (less important findings). Table summarized
whether age has an affect on a parameter, whether Foxn1 expression affects the
parameter, and whether over expression of Foxn1 interacts with the age effect.

CHAPTER VII
DISCUSSION
The initial decline in thymocytes number with age correlates to the decline in the
transcription factor Foxn1 expressed in thymic stroma (14). Induced deletion of the
Foxn1 gene leads to reduced Foxn1 expression and results in premature thymic
involution as seen by a decline in the number of thymocytes and mTEC (17, 18); these
above findings led me to predict that Foxn1 is required to maintain thymopoiesis in the
postnatal thymus. Foxn1 was identified in nude mice that do not have a functional
thymus as Foxn1 is required for thymic organogenesis (15). Interestingly, the thymus is
not the only primary lymphoid organ disrupted in nude mice. The BM of nude mice
display reduced cellularity and hematopoiesis (19, 275). Based on these observations, I
predicted that Foxn1 also function in the BM to maintain HSC.
I predicted that manipulating Foxn1 expression affects the decline in
thymopoiesis with age and hypothesized that over expression of Foxn1 prevents the
decline in thymopoiesis with age. Using the Foxn1Tg mouse model, I demonstrated that
age-associated thymic involution is attenuated in Foxn1Tg as seen by a higher number of
thymocytes, ETP, and maintained thymic architecture. I also demonstrated that over
expression of Foxn1 prevents the decline in MPP. Aged Foxn1Tg had a higher number
of HSC with increased proliferation. Additionally, the aged Foxn1Tg BM
microenvironment promoted the generation of MPP from HSC. Over expression of
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Foxn1 also increased CTP proliferation and CIP generation, demonstrating that
over expression of Foxn1 promotes the survival and production of T cell progenitors.
The effect of over expression of Foxn1 was specific to the development of T cell
progenitors as the number of CLP were reduced in Foxn1Tg and myeloid progenitors
were not affected. I identified the Foxn1 expressing BM cells as a population of BM
cells that are Linneg/low EpCAMpos Syndecan-1neg. Taken together, expression of Foxn1
by cells in both the BM and the thymus is important for the generation of T cell
progenitors and thymopoiesis.

Foxn1 Expression in the Thymus
Regulation of Foxn1 expression in the Thymus
Regulation of Foxn1 expression during thymic organogenesis or in the post natal
thymus has not been clearly elucidated. Most of what is known about the regulation of
Foxn1 comes from studies examining its expression in the skin. In the hair follicle,
BMP4 and homeobox C13 (Hoxc13) can up regulate Foxn1 expression (351, 352).
Signaling though the fibroblast growth factor (FGF) receptors in epidermal keratinocytes
has also been shown to increase Foxn1 expression (353). However, there is no evidence
to support this regulatory pathway in the regulation of Foxn1 expression in the post natal
thymus. While BMP4 is expressed in the ventral region of the third pharyngeal pouch
(354), direct evidence linking BMP4 to Foxn1 expression during thymic organogenesis or
in the post natal thymus has not been established. In the hair follicles, Msx2 can regulate
Foxn1 expression that in turn regulates Notch 1 expression (351). This pathway was
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examined in the thymic stroma; however, we were unable to detect Msx2 expression in
Wt or Foxn1Tg thymic stroma (data not shown). It is likely that regulation of Foxn1
expression in the thymus is different than in the skin as two Foxn1 promoters have been
identified and the two promoters are differentially regulated in the thymus and in the skin
(336). Therefore, it is not surprising that factors that regulate Foxn1 expression in the
skin that have not been to be able to regulate Foxn1 expression in thymic epithelial cells.
Foxn1 expression in the thymus has been shown to decline with age (14, 17). In
the fetal thymus, maintenance of expression of Foxn1 requires the three dimensional
meshwork of TEC as it was shown that expression of Foxn1 was reduced in TEC that
were obtained from enzyme-treated thymi and cultured as monolayer (76). It has been
shown that Wnt signaling can up regulate Foxn1 expression in TEC in vitro, and both
TEC and developing thymocytes express Wnt (355). In the aged Wt thymus, expression
of the Wnt inhibitor axin increases in mTEC and promotes adipogenesis in the thymus
(150). Expression of axin thus may contribute to the decline in Foxn1 expression in two
ways: 1) Axin can inhibit Wnt signaling directly, resulting in decreased Foxn1
expression. 2) Axin promotes adipogenesis in the thymus which can disrupt the 3D TEC
meshwork required to maintain Foxn1 expression. In aged Foxn1Tg thymi, we observed
less adipose accumulation. The mechanism by which over expression of Foxn1 prevents
adipogenesis in aged Foxn1Tg thymi remains to be determined. It is possible that Foxn1
negatively regulates expression of Axin thus maintains its own expression.
The targets of Foxn1 in the thymus are also not definitively indentified. However,
using primers that only detect the Foxn1 transgene we were able to measure the
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endogenous Foxn1 levels and determined that one target of Foxn1 is Foxn1. In Foxn1Tg
thymic stroma, expression of the Foxn1 transgene resulted in an increase in endogenous
Foxn1 expression, suggesting that Foxn1 is self-regulating. A DNA consensus sequence
for the Foxn1 binding site has been identified (356). Five possible binding sites for
Foxn1 are located upstream of the start codon. Chromatin immunoprecipitation
experiments could be performed to determine whether Foxn1 regulates its own promoter
directly. It is possible that regulation of the Foxn1 promoter activity by Foxn1 occurs
through an unidentified intermediate protein. Our finding that expression of Foxn1 is
self-regulated agrees with the previous notion that Foxn1 functions in a cell autonomous
fashion and supports the finding that TEC that express high level of Foxn1 are more
sensitive to changes in Foxn1 levels (17, 357). Furthermore, the same induced levels of
the endogenous Foxn1 in young and aged mice suggests that down regulation of Foxn1
with age is reversible and can be manipulated to reverse expression of Foxn1 in the aged
thymus.

A Role for Foxn1 in Thymopoiesis with Age
Our laboratory previously demonstrated that the initial decline in thymocyte
number correlated with the onset in the decline in expression of Foxn1 (14). To
determine if over expression of Foxn1 prevents the decline in thymopoiesis, Foxn1Tg
mice were designed that express mouse Foxn1 under the control of the human keratin 14
promoter. The keratin 14 promoter was chosen because keratin 14 is expressed in
epithelial and thymic epithelial progenitors (358, 359). Expression of Foxn1 mRNA in
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the thymus of young Foxn1Tg was 20-fold higher than young Wt. At the protein level,
the expression pattern of Foxn1 within the thymus of Wt and Foxn1Tg were similar
although the intensity of Foxn1 staining was increased in Foxn1Tg. The higher intensity
staining of Foxn1 in Foxn1Tg thymi is the result of translating a larger number of
transcripts from both the endogenous and transgenic Foxn1 genes. Importantly, the high
levels of Foxn1 did not alter the thymic architecture or the proportion of thymocyte
populations, indicating normal thymopoiesis in young Foxn1Tg mice.
In agreement with previous reports, the distributions of the DN, DP, and SP
thymocytes populations did not change with age in Wt mice (161, 162). This finding
indicates that the decline in thymocyte number in aged Wt mice is not the result of a
block in thymopoiesis, but an overall decrease in the number of developing thymocytes
and consequently naïve T cell output. This was also true in aged Foxn1Tg as the
frequency of each sub-population was not changes with age. However, it is possible that
the kinetics at each stage of development is reduced in aged mice, contributing to the
overall decrease in the number of naïve T cell produced without disrupting the
distribution of DN, DP, and SP thymocytes. As previously reported, expression of Foxn1
declined in aged Wt mice (14). However expression of Foxn1 was not reduced in aged
Foxn1Tg. Thus, aged Foxn1Tg mice do not demonstrate any alterations in the
distribution of DN, DP, and SP thymocyte populations and provide a model for studying
the effects of over expression of Foxn1 on thymic involution.
The size of the thymus is regulated by the available cortical niches for the
expansion of DN cells during thymopoiesis (360). Young Foxn1Tg and young Wt had
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equivalent number of thymocytes and DN, DP, SP thymocyte distribution indicating that
Foxn1 does not increase the number or function of cortical niches that support
thymopoiesis in young mice. With age, in Wt mice there was a drastic decline in the total
number of thymocytes from 3 months to 16-19 months and from 16-19 to 20-26 months.
The total thymocyte numbers declined with age in Foxn1Tg, however the decline was
delayed. The total number of thymocytes in Foxn1Tg mice 20-26 months of age was
equivalent to Wt 16-19 months of age, suggesting that the decline in thymocytes number
was attenuated by approximately least 6 months. The higher number of thymocytes with
equal distribution of DN, DP, and SP thymocyte populations in aged Foxn1Tg compared
to Wt indicated a higher total number of DN cells in Foxn1Tg, and the size of the thymus
in aged Foxn1Tg was larger than aged Wt. This suggests a higher number of cortical
niches in aged Foxn1Tg. The total number of cortical TEC was not different between
aged Wt and aged Foxn1Tg; however, cTEC by themselves do not constitute a functional
niche. As previously mentioned, scattered Foxn1pos cells can be detected in the cortex.
Previously, it was shown that Foxn1neg cells in the thymus arise from Foxn1pos cells, and
that only Foxn1pos cells contribute to thymopoiesis (361). It is possible that the number
of Foxn1pos cells in the cortex of Wt mice decrease with age contributing to the reduced
number of DN cells and the production of naïve T cell. If the number of Foxn1pos cTEC
did not decline with age, or if the decline in Foxn1pos cTEC was attenuated in aged
Foxn1Tg mice, then we would expect to find a larger number of DN in aged Foxn1Tg as
supported by our finding.
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The recruitment of thymic progenitors to the thymus is also regulated by the
number of available cortical niches (361). The frequency of ETP and number of ETP in
young Wt and young Foxn1Tg were equivalent suggesting that over expression of Foxn1
in young mice did not increase the number of cortical niches. A reduction in the number
of cortical niches with age can contribute to the decreased frequency and number of ETP
found in aged mice (12). In agreement with previous reports, we detected a reduction in
the frequencies and number of ETP in aged Wt mice (12). However, over expression of
Foxn1 in aged mice prevented the decline in the frequency of ETP and lessened the
decline in ETP number. To determine if the aged Foxn1Tg thymic environment is more
efficient at the recruitment of thymic progenitors and generation of ETP adaptive transfer
experiments were performed. In the adaptive transfer experiments, aged Foxn1Tg and
Wt thymi showed the same frequency of the donor CD45.1pos ETP suggesting that
recruitment of thymic progenitors was not enhanced in the aged Foxn1Tg. This could be
explained by the fact that LSK cells from young mice were more effective in homing to
the thymus. These data suggest that the aged Foxn1Tg and aged Wt thymic
microenvironments are equivalent in recruiting young cells. Alternatively, young ETP
maybe able to compensate some of the age associated defects in the aged Wt thymic
microenvironment resulting in an ETP frequency similar to that seen in aged Foxn1Tg.
Using fetal thymic organ culture, aged Wt ETP showed reduced T lineage
potential (12), indicating functional defects in aged ETP. Using the OP9-DL1 culture, I
did not see a difference in the commitment of aged Wt ETP to T lineage or development
to the DN2/DN3 stages compared to young Wt. This is likely the result of an optimized
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culture system for both young and aged cells. Using this system we were unable to
determine if high levels of Foxn1 prevented the functional defects in aged ETP.
Interestingly, data from the adaptive transfer experiments indicate that the aged Foxn1Tg
thymic microenvironment may promote Rag expression and activity in ETP compared to
the aged Wt thymic microenvironment. The aged Foxn1Tg hosts generated a higher
frequency of ETP that expressed VEX than aged Wt hosts. The aged Foxn1Tg hosts had
a 20% increase in the percent of ETP that expressed VEX, indicative of Rag expression
and activity, compared to aged Wt hosts. This suggests that the Foxn1Tg
microenvironment may be more efficient in inducing Rag expression and activity and in
the initiation of TCR gene rearrangement during thymopoiesis.

A Role for Foxn1 in Maintaining Thymic Architecture with Age
Thymic involution is associated with alterations of the thymic architecture and
deposition of fat. As previously mentioned, Wnt signaling in TEC decreases with age
resulting in decreased Foxn1 expression (150, 362). In aged TEC, when Wnt4 signaling
is decreased, LAP2α expression increases (362). LAP2α expression results in an increase
in peroxisome proliferator activated receptor γ (PPARγ) which is a transcription factor
expressed in pre-adipocytes (362). It was suggested that epithelial cells transition to
mesenchymal cells, which then transition to adipocyte, and that this differentiation is a
potential mechanism of adipose deposition in the aged thymus (362). The thymus of
aged Foxn1Tg is smaller than young Foxn1Tg; however, compared to changes seen in Wt
mice, there is little fat deposition and the corticomedullary junction remains intact. The
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reduced deposition of fat in aged Foxn1Tg mice may be the result of inhibition of the
transition of epithelial cells to adiopcytes via the EMT pathway. In the caloric restricted
mice, the epithelial mesenchymal transition is blocked and adipogenesis is prevented
through inhibition of PPARγ expression (154). A direct role of Foxn1 in adipogenesis
remains to be determined; however, it is possible that Foxn1 negatively regulates PPARγ
expression in Foxn1Tg.
Previous work has shown that reduced Foxn1 expression in the post natal thymus
causes rapid thymic atrophy mainly due to severe deterioration of mTEC compartment,
indicating that Foxn1 expression is critical for the maintenance of mTEC population in
the postnatal thymus (17). It was also noted that the MHCIIhi mTEC display the highest
proliferative rate and are responsible for generating the mTEC pool (17, 81, 363). The
higher number of MHC IIpos and MHCIIhi mTEC in aged Foxn1Tg are in agreement with
the above finding as there are more mTEC when Foxn1 is over expressed. The larger
number of mTEC in aged Foxn1Tg is the result of a higher level of MHCIIhi mTEC that
are engaged in cell cycle. The elevated number of mTEC and higher proliferation of the
MHCIIhi mTEC in the aged Foxn1Tg than in Wt suggest that the presence of a larger
mTEC pool may be responsible for limiting alterations in thymic architecture.
Young Foxn1Tg had a higher number of MHCIIhi and MHCIIpos mTEC compared
to young Wt without increased proliferation. The mechanism that results in an increased
number of mTEC in young Foxn1Tg is unknown. During thymic organogenesis,
differential patterning of the thymic and parathyroid primordium could result in more
epithelial cell progenitors are recruited into differentiating into thymic epithelial cells
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(126, 127). Alterations in the patterning of the thymic primordium are unlikely to be the
cause in the higher number of mTEC in young Foxn1Tg mice. The Foxn1 transgene is
driven by the human K14 promoter and would not affect patterning of the thymic and
parathyroid primordium as expression of the human keratin 14 promoter is not detected
until 14 days post birth (359). Thymic epithelial progenitors capable of differentiating
into cTEC and mTEC express K14 and reside in the corticomedullary boundary (129131). It is possible that after the Foxn1 transgene is transcribed, a larger percent of the
epithelial progenitors commit to mTEC differentiation over cTEC. However, if this were
the case, then we would expect a reduced number of cTEC in young Foxn1Tg compared
to young Wt, and this did not occur. It is possible that the higher number of mTEC in
young Foxn1Tg is the result of altered cell cycle activity. The mTEC express the highest
level of Foxn1 (17, 18). While young Foxn1Tg mTEC do not display increased cell
cycle activity as measured by Ki-67, we did not determine cell death of mTEC. It is
possible that high levels of Foxn1 prevent cell death in mTEC, thus resulting in an
increase in their number in young Foxn1Tg compared to young Wt.
Foxn1Tg had a higher number of mTEC compared to Wt; however, the number of
cTEC was equivalent to aged matched Wt. Despite the fact that Foxn1 expression can be
detected in cTEC, over expression of Foxn1 does not prevent their decline in number
with age. It remains to be determined how and if the number of Foxn1pos cTEC change
with age and if over expression of Foxn1 affects aged Foxn1pos cTEC. It also remains to
be determined if Foxn1Tg have a higher number of Foxn1pos cTEC compared to Wt.

197
Foxn1 and the Bone Marrow
The Effect of Foxn1 on HSC
Zipori et al. demonstrated that BM from nude mice display a reduction in
cellularity and a limited protection against lethally irradiation in adaptive transferred
hosts (19); a reduced number of HSC and their functions could be responsible for the
observed defect. In this context, Foxn1-expressing BM cells could play a potential role
in regulating HSC number through regulating cell cycle activity at several different
developmental stages through out the postnatal life.
Compared to young Wt, young Foxn1Tg BM contained a higher number of HSC.
I determined that the higher number was not due to an increase in cell cycle or reduced
cell death of HSC. Alternatively, an established larger HSC pool could provide an
explanation for our finding. It has been observed that increased HSC niche size, as
determined by an increase in the numbers of osteoblasts and trabecular bone, correlates
with a higher number of HSC (210, 211); however, we observed no obvious difference in
the amount of trabecular bone in Foxn1Tg and Wt mice by microscopy (data not shown).
During embryogenesis, the size of the HSC pool is regulated by the sry-related high
mobility group box 17 (sox17) (205). At four weeks post birth, Sox17 expression is
down regulated as highly proliferative fetal HSC transition to the slowly proliferating
adult phenotype, establishing the adult HSC pool (205). It is possible that a larger HSC
pool in Foxn1Tg BM may result from prolonged Sox17 expression during embryonic
development.
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In agreement with others, we found that the number of HSC in Wt BM increased
from 1-4 months of age to 20-21 months of age (318, 324). It has been suggested that
this increase in HSC with age is not due to increased cell cycling (345) but rather due to a
block in the differentiation of HSC toward the immediate progeny MPP as their numbers
are reduced with age (13). Alternatively, it was suggested that the increase in HSC
number is a compensatory mechanism for the reduced number of HSC that differentiate
to lymphoid lineage (324, 328). We found that with advanced age, in Wt mice (24-25
mo), the initial increase was followed by a dramatic reduction in HSC number that is
coupled with increased cell death. If the increase in HSC is in fact a compensatory
mechanism to increase the number of HSC that are able to differentiate to the lymphoid
lineage, then the drastic decline in Wt 24 mo and older may be the result of HSC
proliferative exhaustion. In Foxn1Tg 24-35 mo, the number of HSC declined; however,
the total number of HSC was reduced to levels equivalent in young Foxn1Tg, suggesting
that the HSC pool in aged Foxn1Tg is not exhausted even though half of the mice are
older than 25 months of age. In contrast to aged Wt, we observed a higher percent of
HSC from aged Foxn1Tg in S,G2/M and a reduced fraction of the cells was in G0
characteristic of cell death. We suggest that the increase in cell cycling and reduced cell
death culminates in preventing proliferative exhaustion and restoring HSC number in
aged mice to that found in young Foxn1Tg mice.
A mechanism by which Foxn1 expression affects cell cycle activity of HSC
remains to be elucidated. RT-PCR revealed that Foxn1 is not expressed in HSC or MPP,
again suggesting cell-cell interaction between the Foxn1pos cells and HSC play a critical
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role in homeostasis of HSC with age. Recently, it has been shown that HSC express the
E3 ligase Itch and HSC in Itch deficient mice display increased cell cycling, suggesting
that Itch negatively regulated HSC development and function (364). The increase in cell
cycling of HSC in Itch deficient mice resulted in an increase in the numbers of HSC and
MPP (364). These data are similar with our observation in BM of aged Foxn1Tg mice,
but not young Foxn1Tg mice. While it remains to be determined if expression of Itch
increases with age, it is possible that with age Foxn1-expressing BM cells negatively
affect Itch expression, leading to HSC proliferation and a larger number of HSC and
MPP. The cyclin dependent kinase inhibitor p16INK4a which controls the G1 check point
is expressed in aged but not young HSC and contributes to proliferation and number of
HSC observed in aged mice (365). Conversely, aged p16INK4a -/- mice have an increase in
the number of HSC due to increased cell cycling and with decreased cell death as
determined by BrdU labeling (365). It is possible that Foxn1pos cells in the BM
environment affect age-associated changes in p16INK4a expression in HSC, thus resulting
in the proliferation of HSC in responding to stress with advanced age. In contrast, the
number of HSC in Wt mice are exhaustedly depleted with advanced age.
Signaling through c-kit receptor is important for HSC survival (279, 280). The
level of c-kit on embryonic and adult HSC is equivalent, thus its levels are not affected
with age (206, 278, 366); however, the sensitivity of the response of c-kit to its ligand
SCF decreases from fetal to adult HSC (366). Although it was not significantly different,
the MFI expression level of c-kit on aged Foxn1Tg HSC appears higher than young
Foxn1Tg and aged Wt. Eight out of ten HSC from aged Foxn1Tg mice had a higher level
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of c-kit expression compared to the average seen on aged Wt HSC. Whether this
expression level of c-kit on aged Foxn1Tg HSC has a physiological effect remains to be
determined. If the sensitivity of c-kit to SCF decreases with age in Wt mice, then HSC
cell death would increase. Indeed, I found more cell death in HSC from aged Wt mice.
A compensatory mechanism commonly found in responding to a decrease in receptor
signaling is to up regulate expression of the receptor; I found that expression of c-kit
increase in HSC from our aged Foxn1Tg If up regulation of c-kit resulted in increased
signaling, then this would result in increased survival which also was observed in aged
Foxn1Tg HSC. Because signaling through c-kit is also required to maintain HSC selfrenewal and proliferation, the increase in expression of c-kit may also contribute to the
increase in HSC proliferation seen in aged Foxn1Tg HSC (367-369).

A Role for Foxn1 in Hematopoiesis
Based on cell surface phenotype, young Foxn1Tg have a larger HSC pool
compared to Wt; however, the number of functional HSC as determined by the CFU
assay in young Foxn1Tg was equivalent to young Wt. The number of HSC in Foxn1Tg
1-4 months of age was 2-fold higher than Wt as determined by flow cytometry.
However, the number of functional HSC that gave rise to multipotent progenitors (CFUGEMM) as determined by methylcellulose cultures was not different between young Wt
and Foxn1Tg. This is likely due to a limited and small number of active HSC that is
required to maintain hematopoiesis. As seen in young and aged CTP as well as aged
HSC, high levels of Foxn1 can affect their cell cycle activity. Thus, it is possible that in
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young Foxn1Tg a larger percent of the HSC pool are in the quiescent state. In our
experiments, PI staining was used to determine the cell cycle activity of HSC in Wt and
Foxn1Tg mice. Identification of quiescent HSC in G0 can not be separated from HSC in
G1 using propidium iodine. In the future, HSC in G0 and G1 can be separated using Ki67 to determine the percent of quiescent HSC (Ki-67 negative) in young Foxn1Tg BM.
While the number of functional HSC is similar between young Wt and Foxn1Tg,
with age the number of functional HSC declined in Wt but not in Foxn1Tg. The initial
larger HSC pool may act as a reservoir, extending the maintenance of hematopoiesis in
aging mice. It is estimated that each long term repopulating HSC replicates only 5 times
in the life span of a mouse (370). With a larger HSC pool, the number of times each
HSC from Foxn1Tg replicates for the same number of months as in a Wt mouse would be
less, thus exhaustion of HSC would occur much later in life or that age-associated
proliferative exhaustion is attenuated. This notion corroborates the previous observation
that increased longevity was associated with a larger HSC pool (325). Our data suggest
that HSC exhaustion in Wt BM can be seen in mice 24-25 months of age; however, the
functional decline can be seen even earlier as the number of GEMM colonies generated
in aged Wt methylcellulose cultures 21 months of ages are not different than at 25
months of age. While longevity studies have not been preformed on Foxn1Tg mice, we
collected data from numerous mice in our two colonies that are healthy and between 25
to 35 months of age.
Aged Foxn1Tg HSC also do not experience an age associated decline in the
ability to commit to T lineage when cultured on the OP9-DL1 stromal cell line. While
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the percent of cells that expressed CD90 did not change with age in Foxn1Tg, the percent
of young Foxn1Tg HSC that expressed CD90 was less than young Wt. This lower
percent of cells that express CD90 in young Foxn1Tg may not result from decreased T
lineage commitment, but of increased self renewal. HSC from Foxn1Tg may have
increased expansion when cultured on OP9-DL1. Notch signaling in vitro was shown to
be important for HSC self renewal (218, 219). Cells harvested from culture on the OP9DL1 were not stained for HSC cell surface markers to determine if HSC from Foxn1Tg
expanded in vitro. The expression level of the notch receptors on HSC from Foxn1Tg
and Wt have yet to be examined; however, it is possible that HSC from Foxn1Tg expand
and proliferate more than Wt HSC.
The aged Foxn1Tg microenvironment not only has a higher number of functional
HSC, but the aged BM microenvironment promotes the generation of MPP from donor
HSC. The increased generation of MPP in aged Foxn1Tg is not due to an intrinsic effect
in HSC. This difference in the generation of MPP from donor Wt and Foxn1Tg HSC was
abolished when sub-lethally irradiated hosts were used, reinforcing the notion that the
increase in generation of MPP in aged Foxn1Tg is an environmental effect.
The number of MPP in the BM of Foxn1Tg at advanced age was equivalent to
mice 1-4 months of age. MPP give rise to myeloid progenitors as well as CLP which are
the B cell progenitors. The total number and various lineages of myeloid progenitors
were not different between Foxn1Tg and Wt mice. However, Foxn1Tg had a lower
number of CLP and subsequently a reduced number of B-lineage cells compared to aged
matched Wt mice, suggesting that Foxn1 expression affects B lymphopoiesis (Fig. 72).

203

Foxn1
ETP
HSC

T Cells

MPP
Flt3+

CLP

B Cells

Figure 72: MPP differentiation into ETP and CLP in aged Foxn1Tg mice. Aged
Foxn1Tg mice have decreased CLP numbers, with a higher number of ETP compared to
aged Wt. Foxn1 may work at the level of the MPP to inhibit CLP / B lineage
development and priming toward ETP and T lineage development.
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Furthermore, although the number of CLP in young Foxn1Tg was less than Wt, over
expression of Foxn1 did not prevent the decline in CLP with age, indicating that the
effect of Foxn1 with age is T lineage specific. Because the number of MPP is not
reduced with age but the generation of CLP is reduced, Foxn1 expression in the BM may
limit the development of MPP to CLP, thus providing a larger pool of the MPP as
precursors for ETP (Fig. 72). If this were true, then we would expect a higher number of
ETP in Foxn1Tg, which is in agreement with our finding that aged Foxn1Tg thymus have
a higher number of ETP then aged Wt. This scenario would also result in increased
production of T cells which we also saw in the aged Foxn1Tg mice compared to aged
Wt.
The increase in MPP development toward ETP over CLP may be the result of
priming MPP toward T lineage or alternatively, of inhibiting B lineage development (Fig.
73). T lineage commitment requires Notch signaling (44, 45). It is possible that Foxn1pos
cells in the BM express Notch ligands and thus prime MPP to differentiate to T lineage as
opposed to B lineage. It is also possible that through cell-cell contact, Foxn1pos cells alter
the combinatory transcription factor codes in MPP required for B lineage commitment
and development. The transcription factor Ikaros is required for the generation of CLP
(310); however, Ikaros null mice retain normal levels of ETP (82). Whether over
expression of Foxn1 in the BM environment results in decreased Ikaros expression in
MPP leading to reduced CLP development in Foxn1Tg BM remains to be determined. It
has also been shown that mice deficient in the fms-like tyrosine kinase 3 ligand (Flt3L) or
its receptor have reduced numbers of CLP and pro B cells, resulting in decreased B
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Figure 73: Skewing of MPP in Foxn1Tg mice toward T lineage or away from B lineage
development. Foxn1pos cells in the BM may express Notch ligands priming MPP towards
T lineage resulting in a higher number of ETP in the thymus. Alternatively, Foxn1pos
cells may negatively regulate IL7 secretion, Ikaros expression in MPP, or reduced Flt3
signaling all of which are required for CLP and B lineage development.
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lymphopoiesis (284-286). Furthermore, signaling through both the Flt3 and IL7 receptor
enhances B lineage commitment and differentiation (371). Preliminary data from our
laboratory showed no differences in the mRNA levels of Flt3L or IL7 in the BM of Wt
and Foxn1Tg mice. Interestingly, we find a higher level of CD135 (Flt3 receptor) on
MPP in Foxn1Tg mice compared to Wt. Whether the increase in CD135 expression is a
compensatory mechanism for reduced Flt3 signaling or whether high expression of
CD135 promotes T lineage development instead of B lineage development needs to be
examined.

Role for Foxn1 in the Development of CTP and CIP
CTP are T cell progenitors that are capable of contributing to the peripheral T cell
pool (269-271). In the BM of Foxn1 mutated nude mice CTP are generated but display
reduced cell cycling, resulting in a decline in development of CIP (275). Our data showed
that over expression of Foxn1 enhanced proliferation of CTP in both young and aged
mice; although it is not known how cell cycling of CTP is affected. The notion that
Foxn1 functions in an autonomous fashion suggests that cell-cell contact may be
responsible for the increase in CTP proliferation. Since over expression of Foxn1 does
not affect cell cycle activity of CIP, the higher number of CIP found in young Foxn1Tg is
due to the increase in CTP proliferation and differentiation to CIP. The higher ratio of
CIP to CTP in Foxn1Tg suggests that Foxn1 expression promotes the generation of CIP
from CTP. This was confirmed in our adaptive transfer experiments in which a higher
ratio of donor CIP to CTP was found in aged Foxn1Tg hosts compared to Wt hosts. The
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difference in the generation of CIP from CTP between Wt and Foxn1Tg was abolished
when donor cells were transferred to a sub-lethally irradiated host, suggesting that the
cells responsible for the generation of CIP may be sensitive to irradiation. My findings
are not the first to demonstrate that irradiation affects the outcomes of donor cells in the
aged hosts (13). Irradiation results in increased cytokine production and increased
proliferation of HSC to replenish hematopoietic cells killed by irradiation treatment. It is
possible that the elevated cytokine levels affects the proliferation of CTP and the
generation of CIP from CTP in a manner in which differences in the environment are no
longer obvious. It is also possible that irradiation of Foxn1Tg mice results in death of the
cells that promote the generation of CIP, thus eliminating the effect seen in non-irradiated
Foxn1Tg hosts.
In the Wt BM, the number of CTP and CIP increase with age. Although it is a
controversial issue, it was previously suggested that the generation of T cells from the
CTP and CIP pathway is thymic independent (269, 270, 274). If CTP and CIP develop
independently from the thymus, then the increase in the number of CTP and CIP with age
may be a compensatory mechanism for thymic involution. With age, the development of
MPP is reduced. Development of T cells from MPP requires homing to and development
within the thymus. As the thymus involutes, aged mice may take advantage of a thymic
independent pathway to maintain some level of T cell production (Fig. 74).
The development of T cell from CTP is inhibited by the presence of mature TCR
α/β+ T cells (273). Although the total number of mature peripheral T cells is not reduced
with age, the distribution of naïve and memory T cells changes as the number of naïve T
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Figure 74: Age-associated alterations in T lineage progenitors within the BM of Wt
mice. HSC give rise to MPP as well as CTP. Both MPP and CTP have the potential to
develop into T cells through different pathways. With age, the MPP pathway is reduced
while the CTP pathway is enhanced.
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cells is reduced due to thymic involution, and the number of memory T cells increases via
homeostatic proliferation (147). If the production of CTP is inhibited by naïve T cells,
then we would expect that the number of CTP increases with age as thymic output of
naïve T cells is reduced. Indeed, we found that CTP numbers increase with age in Wt
mice, but the increase was 2-fold less in our Foxn1Tg mice. The lower magnitude of the
increase in CTP could be due to a higher level of naïve T cells produced in the aged
thymus of Foxn1Tg (347). Because the contribution of T cells developed from CTP
progenitors has not been demonstrated, it is not clear how the increase in the number of
CTP and CIP with age affects the peripheral T cell pool and its function; however, this
potential effect is limited in the Foxn1Tg mice.

Expression and Regulation of Foxn1 in the Bone Marrow
Changes in various T lineage subsets and HSC observed in Foxn1Tg compelled
us to search for Foxn1 expressing cells in the BM of Foxn1Tg and Wt mice. Foxn1pos
cells were found located not adjacent to trabecular bone but were instead found within the
central marrow and either immediately adjacent to or within an estimated 3 cell length
distance to sinusoids. Thus, Foxn1pos cells appear associated with the previously
described vascular niche rather than the endosteal niche. The quiescent long-term HSC
reside within an endosteal niche, while the short- term HSC are located within the
vascular niche adjacent to sinusoids; HSC in this niche are readily proliferating and
differentiating into MPP (208). Based on the location of the Foxn1pos cells in the BM, we
speculate that Foxn1 expressing cells within a vascular niche may contribute to the
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proliferation of HSC thus, contributing to the maintenance of higher number of MPP with
age.
Morphologically, Foxn1pos cells have a large amount of cytoplasm and a
prominent nucleus, resembling plasma cells in morphology and size. However, it is
unlikely that plasma cells express Foxn1. Plasma cells express the epithelial cell
adhesion molecule EpCAM (349, 350); however, plasma cells also express Syndecan-1
(350). Since the Foxn1pos cells are a large subset of the Linneg/low EpCAMpos that do not
express Syndecan-1, it is unlikely that the Foxn1pos cells are plasma cells. Linneg/low
EpCAMpos cells that were negative for Syndecan-1 were sorted from the BM of Foxn1Tg
mice and stained for Foxn1. Approximately 68% of the EpCAMpos Linneg/low Syndecan1neg cells expressed Foxn1 in aged Foxn1Tg BM. To verify that the presence of Foxn1pos
cells in the BM is not due to ectopic expression of Foxn1 in Foxn1Tg mice, EpCAMpos
Linneg/low Syndecan-1neg cells from aged Wt BM were sorted and stained for Foxn1.
Approximately 45% of Linneg/low EpCAMpos Syndecan-1neg cells isolated from aged Wt
BM were positive for Foxn1. To further confirm the phenotype of Foxn1-expressing
cells within the BM, I electronically sorted cells of identical phenotype from Foxn1crelacZ mice 24 months of age and found that these cells were positive for the bacterial βgalactosidase. This demonstrated that the endogenous Foxn1 promoter is active in a
population of Linneg/low EpCAMpos Syndecan-1neg cells. Furthermore, the morphology of
Foxn1pos cells in the BM from Foxn1cre-lacZ was the same as that seen in Wt and
Foxn1Tg.
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Previous experiments by Takaki et al. suggested that the BM contains precursors
to TEC (372). In these experiments, BM cells from a GFP-H2b donor mouse (B6
background) was transferred directly into the BM of lethally irradiated hosts (372). After
8 weeks, GFPpos donor cTEC and mTEC could be identified in the thymus of host mice
(372). TEC progenitor in the thymus express Foxn1, thus it is possible that any TEC
progenitor in the BM would also express Foxn1. Signals that would require TEC
progenitors in the BM to migrate to the thymus were not examined. However, it is
unlikely that the Foxn1pos cells indentified in the BM are TEC precursors. TEC are
CD45neg and in contrast, the Foxn1pos cells in the BM are CD45pos.
Recently, it was identified that non-myelinating Schwann cells reside in the BM
within the HSC niche (373). It was shown that the non-myelinating Schwann cells
produce TGF-β that is responsible for maintaining HSC in quiescent state (373).
Morphologically these non-myelinating Schwann cells have a lot of cytoplasm and
appear similar to the Foxn1pos cells detected using immunohistochemistry; however, the
Foxn1pos cells are larger in size then the non-myelinating Schwann cells. Whether the
Foxn1pos cells are a neuronal cell or neuroendocrine cell remains to be determined, but it
is thought provoking as regulation of the immune system by the nervous system has been
reported (374).
In young Wt BM the frequency of Foxn1pos cells in sternum sections were low,
and while higher in young Foxn1Tg compared to young Wt, the number of Foxn1pos cells
per sternum section was still rare. Despite the low number of Foxn1pos cells in young Wt
and Foxn1Tg BM, a clear role for Foxn1 in hematopoiesis was demonstrated as the
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number of CLP are significantly reduced in young Foxn1Tg, and young Foxn1Tg have a
higher frequency of CTP in cell cycle. It is possible that Foxn1pos cells are precursors
that give rise to more mature cells that no longer express Foxn1 but expand in number
and that this larger population is responsible for affecting hematopoiesis. It is also
possible that the small population of Foxn1pos cells affects hematopoiesis directly.
Expression of Foxn1 in the BM promotes the development of T cell progenitors but as we
can see the number of B cell progenitors is drastically reduced. A large population of
Foxn1pos cells could completely inhibit B lineage development in the BM and the size of
the Foxn1pos population would need to be tightly regulated. If the Foxn1pos cells are
within the vascular niche interacting directly with MPP to influence T lineage vs. B
lineage fate, then a large number of Foxn1pos cells would not be needed. Rather, a small
number of Foxn1pos cells located in the functionally appropriate niche that interacts with
MPP could influence the cell fate decision as MPP themselves are a small population
within the BM.
Immunohistochemistry analysis of Wt and Foxn1Tg sternums suggest that the
number of cells that express Foxn1 increase with age. The frequency of Linneg/low
EpCAMpos cells in the BM which contain the Foxn1pos cells is low and difficult to sort in
young Wt and Foxn1Tg BM. This is supported by the rare presence of Foxn1pos cells
seen in young BM using immunohistochemistry. The frequency of Linneg/low EpCAMpos
BM cells is higher in aged Wt and Foxn1Tg compared to their young counterparts, and
the presence of Foxn1pos cells in the BM of aged Wt and Foxn1Tg BM were readily
detectable using immunohistochemistry assay. Thus, with age it is likely that as the
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cells within

this subset.
Expression of Foxn1 in the thymus and the skin is well documented; however,
expression of Foxn1 in other organs was not previously investigated. Data from other
laboratories have suggested a potential role for Foxn1 in the BM (19, 275); however,
direct evidence of Foxn1 expression in the BM was lacking. Using quantitative RT-PCR,
we demonstrated that Foxn1 was expressed in the BM of Wt mice; contrary to the
thymus, expression of Foxn1 did not change with age. Foxn1 was expressed 98-fold
higher in the BM of Foxn1Tg and also did not decline with age. As previously reported
in the thymus, expression of the Foxn1 transgene resulted in an increase in the level of
endogenous Foxn1. Also in agreement with data from the thymus, the increase in the
level of endogenous Foxn1 was equivalent in young and aged Foxn1Tg BM. These data
support the previous notion that Foxn1 is auto-regulated. While the direct targets of
Foxn1 in the BM remain to be elucidated, and in agreement with the thymus, one target
of Foxn1 is itself.
In the thymus, the endogenous level of Foxn1 increased 100-fold when the
transgene was expressed. In the BM, the endogenous Foxn1 level was only increased 20fold. This may be due to a different Foxn1 promoter being active in the BM versus the
thymus; it remains to be determined which endogenous promoter is active in the BM.
While expression of Foxn1 in the thymus decreased with age, expression of Foxn1 in the
BM remained the same. This suggests that the control of Foxn1 expression in the BM is
regulated by a different mechanism than in the thymus. A contributing factor to the
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decline in Foxn1 expression with age in the thymus is the decline in the number of Foxn1
expressing mTECs. With age, the number of Foxn1pos cells in the BM does not decline.
In fact our immunohistochemistry staining data suggests the opposite. More Foxn1pos
cells were detected in the BM of both aged Wt and Foxn1Tg compared to their young
counterparts. Since the expression level of Foxn1 mRNA does not change with age it is
possible that differences result from the regulation of translation of Foxn1 transcripts or
Foxn1 protein turnover. Currently, very little is known about the regulation of Foxn1 at
the mRNA level and nothing is known about the post translational regulation of Foxn1.
While the level of Foxn1 mRNA is equivalent in young and aged mice, our data suggest
that post translational regulation of Foxn1 may change with age.

Concluding Remarks
Putting it all Together
This dissertation identified a novel role for Foxn1 in the thymus and in the BM in
promoting thymopoiesis with age. A novel population of Foxn1pos cells in the BM was
identified that I speculate to promote the development of T cell progenitors. The
increased generation of T cell progenitors occurs by regulating the cell cycle activity of
HSC that give rise to MPP. While MPP have multilineage potential, the development of
B lineage progenitors from MPP is reduced in Foxn1Tg mice, resulting in a larger MPP
pool that can differentiate toward T lineage. This results in a larger number of ETP
found in the thymus of aged Foxn1Tg mice. Not only do aged Foxn1Tg thymi have a
higher number of ETP, but the proper thymic architecture required for the development
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of naïve T cell from ETP is not affected in aged Foxn1Tg thymi. Over expression of
Foxn1 minimizes the age associated changes in thymic architecture seen in Wt thymi by
regulating the cell cycle activity of MHCIIhi mTEC. Figure 75 summarizes how over
expression of Foxn1 in the BM and thymus promotes thymopoiesis with age. Data
presented in this dissertation suggest that manipulation of Foxn1 expression in the aged
BM and thymus can be utilized to promote the development of T cells.

Significance
With advances in health care, the average human life span is being extended,
resulting in a larger population of the elderly. Even with advances in health care, the
elderly are highly susceptible to illness and diseases, especially to new emerging diseases
such as SARS, West Nile virus, and H1N1 other wise known as swine flu. Decreased
production of naïve T cells with age contributes significantly to the reduced immune
response in the elderly. Understanding the mechanisms that promote T cell development
in aged individuals would provide new strategies and therapeutic interventions to more
effectively fight infections. In addition to the elderly, individuals that are
immunocompromised due to chemotherapy or HIV infection would also benefit from
such therapeutic approaches to promote T cell production. My dissertation lays the
foundation that stimulates future discovery of molecular and cellular mechanisms that
can be captured to manipulate Foxn1 expression in the BM and the thymus, thus
promoting T lineage development in the context of improving general health in the
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elderly and of restoring T cell production in patients who undergo chemotherapy or
radiation therapy for the treatment of hematologic malignancy diseases.
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Figure 75: Foxn1pos cells are located in close proximity to sinusoids in the BM. The
sinusoids are part of the vascular niche where HSC are proliferating and differentiating
into MPP. In the BM of aged Foxn1Tg mice, there is an increase in HSC proliferation
and the aged Foxn1Tg BM microenvironment promotes the generation of MPP from
HSC contributing to the maintained number of MPP. Over expression of Foxn1 inhibits
development of CLP from MPP, resulting in a larger MPP pool that can leave BM and
seed the thymus becoming an ETP. Within the aged Foxn1Tg thymus ETP encounter an
intact thymic microenvironment that promotes the development of naïve T cells. This
intact environment is in part the result of higher mTEC proliferation and a larger mTEC
pool in aged Foxn1Tg thymi.
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CHAPTER VIII
MATERIALS AND METHODS
C57Bl/6, H2-VEX , and Foxn1cre-LacZ mice
Young and aged C57Bl/6 (Wt) mice were purchased from Harlan or through
contract with the NIA. BM cells from Foxn1cre-lacZ mice were a gift from Dr. Vishwa
Deep Dixit (Pennington Biomedical Research Center, Baton Rouge, LA). H2-SVEX
mice were a gift from Dr. Rachel Gerstein (University of Massachusetts, Worcester,
MA). Both male and female mice were used; comparisons were only made between the
same sexes unless otherwise noted. Mice were sacrificed early in the morning, between 6
am and 9 am. All animal work was performed according to protocols approved by
Loyola University Stritch School of Medicine IACUC committee.

Foxn1 transgenic mice (Foxn1Tg)
The mouse Foxn1 cDNA fragment (2.1Kb) from nucleotide positions 78 to 2255
(NM_008238.1) was cloned into the BamH1 site of the human keratin-14 promoter
expressing cassette pG3ZK14 (Dr. Fuchs, Rockefeller University, New York, NY) (K14Foxn1). The K14-Foxn1 expression construct was sequenced to confirm the correct
orientation and its open reading frame. The 5.5- kb NarI-VspI fragment of the K14Foxn1 construct was used to generate transgenic mice on the B6D2F1 background using
standard protocol. Transgenic founders (line 60 and 5) were first identified by Southern
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blot analysis and subsequently by PCR analysis of tail genomic DNA using Sigma’s
Extract-N-AMP tissue PCR kit (Sigma, St. Louis, MO). Transgenic founders were
identified using primers specific for rabbit β-globin, whnβ-globin intron-Foxn1 (5’ end)
and Foxn1-human K14 polyA (3’ end) junctions (Fig. 76). Founders were back crossed to
the B6 background for 15 generations. Transgene copy numbers were determined by
quantitative PCR using primers specific for exon 3 of Foxn1 gene. Two Foxn1Tg
colonies, line 5 with 10-12 copies and line 60 with 4-5 copies of the transgene were
maintained at Loyola University Medical Center vivarium. Data from both lines were
pooled as no difference was observed between line 5 and line 60.

Isolation of thymocytes from thymic stroma
Thymi were removed and placed into a 6 well dish containing 5mL of RPMI
supplemented with 5% FCS, 10mM hepes, 100 units of penicillin and 100μg of
streptomycin (Invitrogen, Grand Island, NY). Thymocytes were removed from thymic
stoma by gentle teasing with a wire mesh and syringe plunger. Thymocytes were washed
in 2% BSA/PBS and resuspended for cell count. Thymocytes were counted in 2% acetic
acid and trypan blue using a hemocytometer.

Isolation of BM cells
Tibias and femurs were removed and placed in to 5mL of RPMI supplemented
with 5% FCS, 10mM hepes, and 100 units of penicillin and 100μg of streptomycin
(Invitrogen). Bone marrow was flushed from bones using a 21 gauge needle with RPMI
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Figure 76: A-B: Design and specificity of primers used for genotyping mice. A. Design
of primers used to genotype mice. Green arrows represent Foxn1D primers. Black
arrows denote either rabbit β-globin or whnβ-globin that detect the 5’ end of the
transgene. Red arrows denote Foxn1-human K14 polyA that recognizes the 3’ end of the
transgene. B. Representative gel from one transgenic mouse from line 5 and one from
line 60 as well as a Wt mouse.
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media. Bone marrow plugs were separated by gently pipetting and the cells were
washed, resuspended, and counted as for thymocytes.

Digestion of thymus and isolation of thymic epithelial cells
Thymi were removed, injected with 0.2 mL of 0 .05mg/ml Liberase TM (Roche,
Indianapolis, IN) and incubated at room temperature for 8 minutes before dispersing by
gentle teasing and pipetting. Digestion was continued at 37°C for 35 minutes with the
addition of DNAse (0.2 mg/ml, Roche). After 20 minutes in 37°C cells were gently
pipetted, and incubated for another 15 minutes. Thymic stromal cells were released
mechanically and enriched using a 50%-25% step percoll (Sigma) gradient (unpublished
protocol from TD Logan and Dr. Avinash Bhandoola, University of Pennsylvania). Cells
were centrifuged at 900g for 30 minutes with no brake, which separated the cells into
three layers. The top layer of the percoll gradient contained adiopcytes, the middle
interface contained the stromal cells, and the pellet at the bottom contained the
thymocytes. The stromal layer was isolated and washed in PBS followed by staining
with CD45, MHCII, EpCAM, and Ly51 for 30 minutes. After staining with cell surface
molecules, stromal cells were fixed using ebioscience fixation permeabilization kit
(ebioscience, SanDiego, CA). Cells were then washed and incubated with Ki-67 for 30
minutes on ice. Total number of TEC was calculated from the frequencies obtained from
flow cytometric analysis and total number of isolated thymic stromal cells counted with a
hemocytometer.
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Separation of BM Cells using Percoll
BM cells were isolated as mentioned above. Cells were washed and layered onto
a 50%-25% step percoll (Sigma) gradient. Cells were centrifuged at 900g for 30 minutes
at 10°C with no break on the centrifuge. Cells from the three layers were then washed in
PBS twice, prior to lysing in Trizol (Sigma). The top layer was adipose, the middle
interface contained the stromal cells, and the pellet contained hematopoietic cells.
Following RNA isolation, cDNA was synthesis using the Invitrogen’s SuperScript II
synthesis kit according to manufacture’s protocol. RT-PCR was used to determine which
layer of BM cells expresses Foxn1.

Quantification of Foxn1 mRNA levels in thymic stroma and BM
Thymic stroma samples were homogenized in Trizol reagent (Sigma) or total BM
cells were lysed in Trizol. Total RNA was isolated using according to manufacturer’s
protocol. Isolated RNA was then treated with DNase using Ambion DNA-free kit and
0.5-2 µg of RNA was used for cDNA synthesis using the Invitrogen’s SuperScript II
synthesis kit. Quantitative RT-PCR was performed on an Applied Biosystems 7100. To
differentiate the expression levels of the endogenous and transgene Foxn1 in Foxn1Tg
mice, two sets of primer were designed. The first primer set recognize both the
endogenous (Foxn1Endo) and the transgene (Foxn1Tg) Foxn1 transcripts; this primers set
was used to determine the total levels of Foxn1 (Foxn1Total). The second primer set only
detects the Foxn1 transgene (Foxn1Tg). The levels of endogenous Foxn1 mRNA were
then calculated by subtracting transgenic Foxn1 levels from total Foxn1 levels (Foxn1Endo

Total

= Foxn1

Tg
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– Foxn1 ). Sequences for the above primers are presented in Table V.

Expression of target genes were normalized to the house keeping gene Gapdh. Levels of
Foxn1 expression were extrapolated from a standard curve constructed with five known
concentrations ranging from 10 copies/µl to 100,000 copies/μl using the K14-Foxn1
contruct or plasmid with the mouse Gapdh fragment. Levels of Foxn1 were expressed as
copy numbers/µg RNA.

Quantitative RT-PCR analysis of Foxn1 in different BM populations
Sorted HSC, MPP, CD45pos BM cells, and CD45neg BM cells were lysed in Trizol
(Sigma) and RNA was isolated according to manufacture’s instructions. Isolated RNA
was then treated with DNase using Ambion DNA-free kit and 0.5-2 µg of RNA was used
for cDNA synthesis using the Invitrogen’s SuperScript II synthesis kit. PCR was
preformed using an Applied Biosystems thermal cycler. PCR amplification was
performed in 1.2mM MgCl2, 0.125mM dNTPs, 0.25μM primers, and with 0.0576 units/μl
Taq polymerase (ABI Grand Island, NY). PCR reactions were denatured in 95°C for 4
minutes and each amplification cycle consisted of 3 steps; denatured for 95°C for 15
seconds, annealed at 55°C for 20 seconds, and elongated at 72°C for 40 seconds. A total
of 40 amplification cycles were used. Reactions were held at 4°C after the 40th cycle.
PCR products were analyzed by gel electrophoresis in 1.2% agarose gel. Gels were
stained with ethidium bromide (Sigma) for 5 minutes and then de-stained for 10 minutes
in distilled water prior to visualization.

227

Table V.
Genes

Forward

Reverse

Reference

Foxn1D

TTCCTCAAGGGC
AACCACAT

TGTCCACAGGGATCT
CCTCAA

436F 586R

CTGGGCAACGTG
CTGGTT
Rabβglobinwhn ATCCTGCCTTTC
TCTTTATG
GCTTGAGCTATG
βglobin
Foxn1K14poly CCCAACATC
A
Foxn1endo
GACCTTGGGACT
GACCTGGAT
Foxn1endo set #2
ACAGCATCCTCA
TCTTCATGGC
Foxn1Tg
CTTGAGCTATGC
CCAACATCAG
GTGAGGCCGGT
Gapdh
GCTGAGTAT
musHprt
AGCAGTACAGC
CCCAAAATGG
TTCGTGCTCCTG
Notch 1
TTCTTTGTG
GATTTCCCATAC
Notch 3
CCACTTCGG
Whnβ-blobin

TGTGCAGTGGCCCTG 445F 845R
GAT
GTGTTCCTGGCTGGG 322F 1169R
GTAAG
CGAGAATTATGCAAC 2539F 2877R
TCAGATAATGAAG
TGCCTGTTTCTGCCA
GACAA
GCTTTTGCGCACAGC
AATG
GCTGTATTGATTGCC
AGGAGG
CATCCTGCACCACCA
ACTGCTTAGCC
TGCGCTCATCTTAGG
CTTTGT
TCCTCAAACCGGAAC
TTCTTG
TCTTCATTCCCAGTG
CATCTTG

List of primers sequences used for RT-PCR.

NM_008238.1
1663F 1867R
920F 1215R
2537F 2845R
M32599
303F 566R
484F 699R
5279F 5529R
4923F 5179R
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Quantification of HSC, MPP, CLP, ETP, CTP and CIP frequency and total cell
number
Isolated thymocytes or BM cells (1-2 x106 cells) were incubated with anti-mouse
CD16/32 in a total volume of 50μL for 20 min. Cells were then stained with a cocktail of
biotinylated or FITC-conjugated lineage specific antibodies followed by antibodies to
specific cell surface makers as presented in Table VI. If a biotin lineage cocktail was
used cells were stained with streptavidin-FITC. For HSC, MPP, and CLP, cells were
stained for 30 minutes with a cocktail containing CD117, CD127, Sca-1, and CD135.
For ETP cells were stained with a cocktail containing CD117, CD44, CD25, and CD127.
For CTP and CIP cells were stained with a cocktail containing CD90 and CD2. The
frequency of HSC, MPP, CLP, CTP, and CIP were determined using flow cytometry and
the total number was calculated by multiplying the frequency by the number of
thymocytes or BM cells isolated.

Electronic sorting of ETP
Thymocytes were first enriched for CD117 positive cells using the EasySep
procedure (Stem Cell Technologies Vancouver, Canada) according to manufactures
protocol. Briefly, thymocytes were incubated with Fc block followed by incubation with
an anti-mouse CD117 PE antibody. Thymocytes were then incubated with an anti-PE
antibody attached to magnetic beads. A magnet was used to positively enrich for
CD117pos cells. Following positive selection, thymocytes were incubated with a lineage
positive cocktail (CD3, CD8, B220, DX5, Gr-1, CD11b, and Ter119) conjugated to FITC
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Table VI.
Population

Cell Surface Markers

Lin
ETP
HSC
MPP
CLP
CTP
CIP
cTEC
mTEC

CD3, CD8, B220, CD11b, DX5, Gr-1, Ter119
Linneg CD117pos CD44hi CD25neg CD127neg
Linneg CD117pos Sca-1pos CD135neg
Linneg CD117pos Sca-1pos CD135pos
Linneg CD117low Sca-1low CD135pos CD127pos
Linneg CD90pos CD2neg
Linneg CD90pos CD2pos
CD45pos MHCIIpos EpCAMpos Ly51pos
CD45pos MHCIIpos/hi EpCAMpos Ly51neg

Cell surface identification of population using flow cytometry.
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followed by CD44 AF750, CD25 APC, and CD127 PECY7. ETP were identified and
sorted as Linneg CD44hi CD117pos CD25neg and CD127neg.

Electronic Isolation of HSC, MPP, CTP, and CIP
All antibody concentration were the same as staining of 1-2 x 10 6 cells, however
the volume was increased to 150μL. Total bone marrow cells were incubated with
CD16/32 Fc block for 20 minutes followed by a lineage biotin or lineage FITC cocktail
for 30 minutes. Cells were washed twice in 2mL of OptiMEM media supplemented with
10%FCS, 10mM Hepes, 100 units of penicillin and 100μg of streptomycin. For CTP and
CIP populations, cells were stained with CD90 and CD2. For HSC and MPP cells were
stained with CD117, Sca1, and CD135. Cells were sorted according to cell surface
molecules as listed in Table VII.

Cell cycle analysis
Electronically sorted progenitors (HSC, MPP, CTP, and CIP) were washed in
PBS and fixed in 70% ethanol containing 15% FBS and 15% PBS overnight. Cells were
then washed 2 times in PBS and re-suspended in 250μl of a PI solution containing
0.5mg/mL propidium iodine, 0.1mM EDTA, and 0.05mg/mL RNase A at room
temperature for one hour prior to flow cytometry analysis.
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Table VII.
Company
eBioscience
eBioscience

Dilution
used
1 to 5
1 to 5

Florochrome
PE
FITC, biotin

eBioscience

1 to 10

PE

eBioscience

1 to 10

APC, FITC

eBioscience
eBioscience
eBioscience

1 to 8
1 to 10
1 to 5

APC
FITC, biotin
FITC, biotin

eBioscience

1 to 10

PE

eBioscience
BD
Pharmingen
BD
Pharmingen
BD
Pharmingen
eBioscience
eBioscience

1 to 20

AF780

1 to 20

PE

1 to 20

AF780

1 to 20
1 to 5
1 to 100

PERCP
FITC, biotin
PECY5

eBioscience
eBioscience

1 to 5
1 to 5

PE, APC
PECY7

1 to 5
1 to 5
1 to 5
1 to 10

PE
PE
APC
FITC, biotin

1 to 5

AF488

BP1/6C3
MHC class II IE-k
Ly-76

eBioscience
eBioscience
eBioscience
eBioscience
BD
Pharmingen
BD
Pharmingen
eBioscience
eBioscience

1 to 5
1 to 20
1 to 10

Stem cell antigen 1

eBioscience

1 to 5

PE
AF780
FITC, biotin
PECY5,
PECY7

CD
CD2
CD3e

Clone
RM2-5
145-2c11

CD4

GK1.5

CD8a

53-6.7

CD25
CD11b
CD16/32

PC61.5
MI/70
2.4G2

CD19

ID3

CD44

IM7

CD45

30-F11

CD45.1

A20

CD45.2
CD49b
CD90

104
DX5
53-2.1

CD117
CD127

2B8
A7R34

CD135
CD138
CD326
GR1

A2F10
281-2
G8.8
RB6-8c5

Name
LFA-2
TCR
co-receptor for helper T
cell
co-receptor for cytotoxic
T cell
Alpha chain of IL2
receptor
Mac-1
Fc receptor block
Component of B cell coreceptor
Pgp-1, Hyaluronate
receptor
Leukocyte common
antigen
Protein tyrosine
phosphatase
Protein tyrosine
phosphatase
Integrin alpha 2
Thy1
c-kit / Steel factor
receptor
IL7 receptor alpha
Flt3/ Fms-like tyrosine
kinase 3
Syndecan-1
EpCAM
Ly-6G

Ki67

B56

MKI67 nuclear antigen

LY51
MHCII
Ter119

BP-1
M5/114.15.2
Ter-119

Ly-6A/E

Sca-1

Antibodies used for cell surface marker listing company, dilution, and color of
fluorochrome.
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Flow cytometers and antibodies
Samples were analyzed on FACSCanto II (BD San Jose, CA) or sorted using a
FACSAria (BD San Jose, CA). Analysis was performed using FlowJo 7.6.1 (Treestar
Ashland, OR). All antibodies were purchased from eBioscience or BD Pharmigen.
Antibody information is summarized in Table VI.

OP9 Cell Cultures
Sorted ETP, MPP, and HSC were cultured in a 24 well plate with 10,000
previously seated OP9-DL1 (GFP) cells (Gift from Juan Carlos Zuniger Plucker,
University of Toronto). Cultures were supplemented with 10ng/mL each of SCF, Flt3L,
and IL7 (Peprotech, Rocky Hill, NJ). Fresh cytokines and media were added every 3-4
days. Upon confluency cells were split as needed. ETP and MPP cultures were
harvested after 2 weeks. HSC cultures were harvested after 3 weeks. T lineage
commitment was measures by expression of CD90, and differentiation to the DN2 or
DN3 among the CD90 positive cells was measured by expression of CD25 using flow
cytometry.

Colony forming assay methylcellulose cultures
BM cells from Wt and Foxn1Tg were isolated and washed in PBS. Ten thousand
nucleated BM cells were cultured in 1.5mL methylcellulose media (Stem Cell
Technologies, Vancouver Canada) in a 35mM dish. Samples were cultured in duplicate
and after 9 days the total number and types of colonies were counted and averaged.
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CFU-G, CFU-M, CFU-GM, CFU-E, and CFU-GEMM were distinguished based on
morphology. The frequency of each CFU per 10,000 cells was multiplied by the total
number of nucleated cells isolated to calculate the total number of each progenitor in two
tibia and two femurs.

Non-irradiated adaptive transfer
BM cells from CD45.1 H2-SVEX mice were isolated and stained with a lineage
positive cocktail conjugated to FITC followed by CD117 APC and Sca-1 PECY5. LSK
cells were electronically sorted and 8,000-16,000 cells were transferred retro- orbitally
into non-irradiated Wt and Foxn1Tg (CD45.2) hosts 17-21 months of age. Isoflurane
was used to anesthetize mice. After 10 weeks the frequency of donor HSC, MPP, CTP,
and CIP in the BM were determined using flow cytometry. Flow cytometry was used to
determine the frequency of donor ETP as well as the percent of donor ETP that expressed
VEX.

Irradiated adaptive transfers
Sub-lethally irradiation of age Wt and Foxn1Tg (CD45.2) hosts 17-21 months of
age were performed 24 hours prior to adaptive transfer. Mice were irradiated with 900
rads from a cesium source at the Hines VA hospital. LSK cells from CD45.1pos H2SVEX mice were isolated as and retro-orbitaly transferred into host as mentioned for
non-irradiated adaptive transfers. After 10 weeks the host mice were sacrificed and BM
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cells from the tibia and femur were used to determine the frequency of donor CTP, CIP,
HSC, and MPP using flow cytometry.

Immunofluorescence and hematoxylin and eosin (H&E) staining of thymi
Acetone-fixed frozen thymi sections (4-5 μm) in OCT media were used for
immunofluorescent studies. Anti-Foxn1 antibody was raised in rabbits against a Foxn1
peptide (amino acid 303-324, exon 6). Sections were first blocked with Super Block
(ScyTek Logan, UT) and then incubated with either rabbit anti-mouse Foxn1 (IgG, 100150 μg/ml), rabbit anti-mouse keratin 5 (0.1μg/ml, Covance), rat anti-mouse keratin 8
(0.221 μg/ml, DSHB), rabbit IgG (Invitrogen), or rat IgG (BD Biosciences). Sections
were then washed and incubated with either goat anti-rabbit IgG-FITC, goat anti-rabbit
IgGAF488, or goat anti-rat IgG- AF546 (F(ab)2’, 10 μg/ml, Invitrogen). Sections were
analyzed using a Zeiss confocal microscope. For H&E staining, thymic tissues were
fixed in formalin and then embedded in paraffin.

Immunohistochemistry of sternums for Foxn1
Sternums removed from Wt and Foxn1Tg mice were fixed for 48 hours in
Zamboni solution (4% paraformaldehyde with picric acid) and decalcified in 15%
sucrose containing 2% acetic acid for 72 hours. For staining, 5 µm paraffin sections were
deparaffinized using xylene and rehydrated in PBS. Antigen retrieval was performed
with Dako’s Target Retrieval Citrate Buffer (pH 6, Carpinteria, CA) with steam at 89°C
for one hour. Sections were then treated with 3% hydrogen peroxide for 10 minutes.
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Sections were block by incubating with human serum (Invitrogen) for 30 minutes,
followed by superblock (ScyTek) for 20 minutes, anti mouse CD16/32 (5ng/ml,
eBioscience) for 10 minutes, and finally with 2% BSA in PBS for 10 minutes. Rabbit
anti-mouse Foxn1 (Santa Cruz Technologies, Santa Cruz, CA H-270) was used at 2μg/ml
and incubation was performed overnight at 4ºC. To visualize positive cells, biotinylated
donkey anti-rabbit IgG (6µg/ml Jackson Immuno Research Laboratories, West Grove,
PA) followed by streptavidin-HRP or Dako’s labeled streptavidin biotin kit was used.
Sections were developed with 3-Amino-9-ethylcarbazole (AEC) and counterstained with
hematoxylin.

Identification of Foxn1pos cells within the sorted Linneg/low EpCAMpos BM cells
Electronically sorted Linneg/low EpCAMpos or Linneg/low EpCAMpos Syndecan-1neg
cells were cyto-centrifuged on to Superfrost plus microscope slides (Fisher Scientific,
Hanover Park, IL) at approximately 500 cells per slide. Cells were fixed in acetone at 20°C for 5 minutes and stored at room temperature. Prior to staining, slides were
rehydrated in PBS for 5 minutes and then permeabilized using 0.1% NP-40 for 18
minutes at room temperature. Cells were blocked as described for tissue sections and
stained with rabbit anti-mouse Foxn1 (Santa Cruz Technologies H270 2μg/mL) or rabbit
anti-E.coli β-galactosidase (Immunology Consultant Laboratory, Portland OR, RGAL45A-Z 4μg/ml). Purified rabbit IgG was used as control. Visualization of positive cells
was detected as mentioned for tissue sections.
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Statistical analysis
For data in which the affect both age and over expression of Foxn1 were
examined, a two way ANOVA was performed. Two way ANOVA analyses determine if
there was an age affect, an affect of over expression of Foxn1, and if over expression of
Foxn1 interacted with the aged affect. For the two way ANOVA, p values less than or
equal to 0.05 were considered significant. If significance was reported using the two way
ANOVA analysis, the Bonferroni t-test was used for pair wise comparisons. A summary
of the two way ANOVA analysis is presented in Table I. Student t-test was also used for
comparisons between groups in which the populations were normally distributed. For
non-normal distributed populations the Mann-Whitney U test was used for comparisons.
All statistical tests were performed using Sigma Stat 2.03. Significant p values using
student’s t test or Mann-Whitney U are presented in the figures.
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